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CHAPTER 1 
GENERAL INTRODUCTION 
1.1. INTRODUCTORY REMARKS 
Heart and skeletal muscles need considerable amounts of energy for con-
2+ 
traction, for accumulation of Ca ions into the sarcoplasmic reticulum and 
for restoration of the membrane potential of the sarcolemma and T-system. Fur­
thermore, muscle fibers like other cells need energy for the maintenance of 
cellular organization and for anabolic purposes. The energy for these pro­
cesses is generally obtained from the hydrolysis of ATP. So rapid resynthesis 
of ATP is necessary for sustained function of the muscle. The energy required 
for ATP synthesis is mainly obtained from the degradation of carbohydrates and 
fatty acids. The relative contribution of amino acids to the energy supply of 
the muscle is still a matter of debate and research. 
Most amino acids are degraded in the liver (Miller, 1961). Experiments 
with rat muscle in vitro showed that only a few "C-labelled amino acids can 
be converted to '"COi (Chang & Goldberg, 1978a·, Tischler & Goldberg, 1980). 
Among these the branched-chain amino acids (leucine, isoleucine and valine) 
are an important group. Since they are essential amino acids, their total body 
degradation has to be under strict control to prevent their shortage as pre­
cursors for protein synthesis and for other metabolic functions. 
In muscle tissue the branched-chain amino acids have a unique role in the 
regulation of protein turnover. The three branched-chain amino acids or leu­
cine alone stimulate protein synthesis and leucine alone inhibits protein 
breakdown in isolated rat diaphragm (Buse Ь Reíd, 1975; Fulks et al., 1975), 
in the perfused rat hemicorpus (Li Ь Jefferson, 1978), in the perfused rat 
heart (Chua et al., 1979, 1980) and in isolated human skeletal muscle tissue 
(Lundholm et al., 1981). Tischler et al. (1982) have shown that the inhibi­
tory effect of leucine on muscle protein degradation in vitro is attributable 
to 4-raethyl-2-oxopentanoate, since it does not occur when the transamination 
of leucine is inhibited with L-cycloserine. In intact rats leucine failed to 
stimulate protein synthesis in heart and skeletal muscle (McNurlan et al., 
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1982). In perfused rat livers and in rat hepatocytes apart from leucine sev-
eral other amino acids promote protein synthesis and inhibit protein breakdown 
(Woodside & Mortimore, 1972; Seglen, 1978; Poso et al., 1982). The effects of 
leucine persist when its transamination is inhibited (Seglen, 1978) and 
4-methyl-2-oxopentanoate has a smaller effect on liver protein degradation 
than leucine (Poso et al., 1982). 
Branched-chain amino acids and 2-oxo acids may have therapeutic effects 
in a variety of disorders in man (reviewed by Walser, 1984). They have succ-
esfully been applied in hepatic encephalopathy (amino acids) and in chronic 
renal failure (2-oxo acids), and also have potential benefit in conditions 
associated with wasting of muscle protein, such as trauma, sepsis, muscular 
dystrophies and cancer. Since a lot of controversial reports have appeared on 
these subjects, further study is clearly required to establish the exact ther-
apeutic place of these compounds (Walser, 1984). 
Finally, leucine and 4-methyl-2-oxopentanoate stimulate insulin secre-
tion by pancreatic islet cells both in vivo and in vitro in man and rat (e.g. 
Malaisse et al., 1980; Hutton et al., 1980). 
1.2. OXIDATIVE PATHWAYS OF BRANCHED-CHAIN AMINO ACIDS 
The oxidative pathways of the branched-chain amino acids (Fig.1.1) were 
first elucidated in studies on liver preparations (Meister, 1957). The first 
step in their metabolism is a reversible transamination to their 2-oxo acid 
analogues. The branched-chain 2-oxo acids subsequently undergo irreversible 
oxidative decarboxylation to branched-chain acyl-CoA esters. The third step 
is dehydrogenation of the saturated acyl-CoA esters to 2-oxoenoyl-CoA esters. 
After this step the metabolic pathways for the individual amino acids diverge. 
The oxidation of leucine leads to the formation of acetyl-CoA and acetoace-
tato . Valine produces the citric acid cycle intermediate succinyl-CoA and iso-
leucine produces both acetyl-CoA and succinyl-CoA. Leucine and isoleucine 
therefore are ketogenic and valine and isoleucine are glucogenic. The first 
three reactions have been studied in detail in most tissues (see below). 
Although the evidence is not yet complete, it is believed that the further 
degradation route in muscle and most other tissues is similar to that in 
liver. 
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1.1. Schematic presentation of the oxidative pathway of branched-chain 
amino acids 
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1.2.1. BRANCHED-CHAIN AMINO ACID AMINOTRANSFERASE REACTION 
The main enzyme responsible for the reversible interconversion of leu­
cine, isoleucine and valine and their 2-oxo acid analogues (A-methyl-2-oxopen-
tanoate, 3-methyl-2-oxopentanoate and 3-methyl-2-oxobutanoate, respectively) 
is an aminotransferase, with 2-oxoglutarate as amino-group acceptor. This ami­
notransferase occurs in most tissues. Combining data from Krebs (1972), Shin-
nick & Harper (1976), Capuccino et al. (1978) and Ichihara et al. (1981) the 
mean branched-chain amino acid aminotransferase activity measured in rat kid­
ney homogenates amounts to 1.58±0.56 ymol/min per g tissue. Expressing the 
activities of other tissues relative to the kidney activity (taken as 1.0 in 
each study) the following mean relative tissue activities are found: pancreas 
13.2, stomach 5.9, heart 1.4, diaphragm 0.66, brain 0.63, skeletal muscle 
0.48, spleen 0.36, lung 0.30, liver 0.07 and gut 0.05. Although early studies 
(Ichihara & Koyama, 1966; Taylor & Jenkins, 1966) reported that these activi­
ties were mainly present in the cytosol, Kadowaki & Knox (1982) found that 
relatively large amounts are located in the mitochondrial matrix (23% of total 
activity in brain, 55% in skeletal muscle, 67% in liver and 77% in kidney). 
According to Ichihara et al. (1973) there are at least three cytosolic 
isoenzymes. From the quantitative point of view isoenzyme I is by far the most 
important. It is present in all animal tissues tested, but has an extremely 
low activity in the liver. Isoenzyme III occurs only in brain, ovary and pla­
centa and also in several other foetal and newborn rat tissues (Kadowaki Ь 
Knox, 1982). Isoenzyme II occurs only in the cytosol of liver. Isoenzymes I 
and III (EC 2.6.1.42) catalyze the transamination of all three branched-chain 
amino acids, while isoenzyme II (EC 2.6.1.6) is specific for leucine. Mito­
chondria of all tissues examined except brain contain only a type-I isoenzyme 
in adult, newborn and foetal rats (Kadowaki Ь Knox, 1982). 
Since the transamination of branched-chain amino acids in muscle occurs 
almost exclusively with 2-oxoglutarate, the process would deplete the citric 
acid cycle, when the resulting glutamate was the endproduct. The transamina­
tion of branched-chain amino acids in muscle is coupled, however, to the pro­
duction of alanine (Odessey et al., 1974; Chang & Goldberg, 1978a,b). Part of 
the glutamate incorporates ammonia to form glutamine. Skeletal muscle releases 
large quantities of alanine and glutamine both in vivo and in vitro (Ruderman 
& Berger, 1974; Felig, 1981). 
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1.2.2. BRANCHED-CHAIN 2-0X0 ACID DEHYDROGENASE REACTION 
The branched-chain 2-oxo acids are decarboxylated by the branched-chain 
2-oxo acid dehydrogenase complex according to the following equation: 
RC0C00H + NAD"1" + CoASH —s* RCOSCoA + NADH + H + + C02 
The produced NADH is oxidized in the respiratory chain and leads to the gener-
ation of ATP via oxidative phosphorylation. 
The branched-chain 2-oxo acid dehydrogenase complex is located at the 
inner site of the mitochondrial membrane (van Hinsbergh et al., 1979). The 
complex has only recently been identified as an entity and purified (Danner et 
al., 1978, 1979; Parker & Rändle, 1978a,b; Pettit et al., 1978). The isolated 
complexes catalyse the oxidative decarboxylation of all three branched-chain 
2-oxo acids, and less efficiently of a few straight-chain 2-oxo acids 
(reviewed by Rändle, 1983). The complex catalyses the only irreversible reac-
tion in the degradation route of branched-chain amino acids and is considered 
to be the regulatory enzyme. 
Structurally it is very similar to the pyruvate dehydrogenase complex. 
Both complexes contain multiple copies of three enzymes: E. and E„ are spe-
cific enzymes and E. is common to both complexes. E.. is a 2-oxo acid decar-
boxylase forming hydroxyalkyl TPP-E. and CO2. E- is an acyltransferase forming 
acyl-CoA. E,, is a lipoyl dehydrogenase forming NADH. Lipoyl residues, 
attached covalently to E, transfer acyl groups and hydrogen between component 
enzymes of the complex (Rändle, 1983). 
The branched-chain 2-oxo acid dehydrogenase complex is inhibited by the 
principal end-products, branched-chain acyl-CoA (competitive with CoA) and 
NADH (competitive with NAD ). Furthermore, during the course of the present 
investigation evidence accumulated that the complex is subject to covalent 
modification with inactivation by phosphorylation and activation by dephospho-
rylation (reviewed by Rändle, 1983). Phosphorylation of one of three possible 
sites on the o-subunit of the E. component completely inactivates the complex 
(Cook et al., 1983a,с). All these characteristics are common to both the 
branched-chain 2-oxo acid dehydrogenase and pyruvate dehydrogenase complex. 
Even the amino acid sequences surrounding the major phosphorylation sites in 
the complexes show similarities (Cook et al., 1983b). 
Shinnick & Harper (1976) measured branched-chain 2-oxo acid dehydrogenase 
activities in homogenates of rat tissues and Khatra et ai.(1977) did the same 
in tissues of rat, monkey and man. In all mammals liver and kidney had the 
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highest activities, followed by brain, heart and muscle. The oxidation rates 
reported for individual organs varied, however, considerably. Furthermore, 
several investigators observed higher oxidation rates in intact tissue prepa-
rations than in homogenates (Krebs & Lund, 1977; Sans et al., 1980a). It is 
difficult, therefore, to draw quantitative conclusions from these data. 
1.2.3. BRANCHED-CHAIN ACYL-CoA DEHYDROGENASE REACTIONS 
The acyl-CoA dehydrogenases are flavoproteins catalyzing the 
2,3-dehydrogenation of saturated acyl-CoA esters, the first step 
of ß-oxidation of fatty acids. The formed FADH2 is oxidized in the respiratory 
chain and leads to the generation of ATP via oxidative phosphorylation. Five 
distinct acyl-CoA dehydrogenases could be isolated from rat liver mitochondria 
(Ikeda et al., 1983). Two of them were specific for branched-chain acyl-CoA 
esters. Isovaleryl-CoA dehydrogenase converts isovaleryl-CoA (derived from 
leucine) and n-valeryl-CoA (Ikeda & Tanaka, 1983a). 2-Methyl branched-chain 
acyl-CoA dehydrogenase converts 2-methylbutyryl-CoA (derived from isoleucine) 
and isobutyryl-CoA (derived from valine) (Ikeda & Tanaka, 1983b). Rhead et 
al., (1981) estimated the tissue distribution of isovaleryl-CoA dehydrogenase 
in the rat. The highest activities are present in liver and heart, followed by 
kidney. Lower activities are present in skeletal muscle and brain. 
1.3. ROLE OF MUSCLE IN THE DEGRADATION OF BRANCHED-CHAIN AMINO ACIDS 
Skeletal muscle is the main body reservoir of proteins. Since muscle com-
prises about 40% of the body weight of rats and about 50% of man, the tissue 
plays a significant role in the overall metabolism of the body. Based on tis-
sue mass, rat muscle contains 84% of the total body branched-chain amino acid 
aminotransferase activity and about 1% of the branched-chain 2-oxo acid dehyd-
rogenase activity (Shinnick Ь Harper, 1976). Other investigators, however, 
observed much higher branched-chain 2-oxo acid dehydrogenase activities in rat 
and human muscle (Khatra et al., 1977; Veerkamp et al., 1980). According to 
Khatra et al. 8-15% of the total body activity was present in rat muscle and 
even about 60% in human muscle. Starvation markedly increases oxidative decar­
boxylation rates in intact preparations (Goldberg & Odessey, 1972; Adibi et 
al., 1974; Hutson et al., 1980; Tischler Ь Goldberg, 1980) and homogenates 
(Paul & Adibi, 1976, 1978) of rat muscle. Starvation (1-7 days) in man mark­
edly increases the concentration of plasma branched-chain amino acids (Felig 
et al., 1969; Elia & Livesey, 1983). After 3 days of starvation in rats both 
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plasma and muscle concentrations of branched-chain amino acids and 2-oxo acids 
are markedly elevated (Hutson Ь Harper, 1981). After protein feeding there is 
a large uptake of branched-chain amino acids by muscle tissues in man (Wahren 
et al., 1976; Elia & Livesey, 1983) and dog (Felig, 1981). 
Thus the data present at the start of our investigation suggested that 
skeletal muscle could take a large part in the degradation of branched-chain 
amino acids. 
1.4. METABOLIC FATE OF THE CARBON-SKELETONS OF BRANCHED-CHAIN AMINO ACIDS IN 
MUSCLE 
In rats in vivo at least part of the branched-chain 2-oxo acids formed 
in muscle by transamination are released to the circulation and taken up by 
the liver (Livesey & Lund, 1980). Rat diaphragm, soleus muscle and hindquarter 
incubated or perfused with branched-chain amino acids also produce considera­
ble amounts of branched-chain 2-oxo acids (Chang & Goldberg, 1978a; Hutson et 
ai., 1978, 1980; Odessey & Goldberg, 1979; Spydevold, 1979). In man the 
release of branched-chain 2-oxo acids is considerably smaller (Elia & Livesey, 
1983). Little information is available on the metabolic fate of the carbon-
chains which pass the oxidative decarboxylation reaction. Although Spydevold 
(1979) reported the release of 3-hydroxyisobutyrate by rat hindquarters per­
fused with valine, it is generally assumed that the carbon-skeletons are com­
pletely degraded to acetyl-CoA (leucine and isoleucine) and succinyl-CoA 
(valine and isoleucine). Acetyl-CoA may be oxidized by the citric acid cycle 
and deliver energy to the muscle. Complete oxidation of citric acid cycle 
intermediates requires conversion via pyruvate to acetyl-CoA (Goldstein Ь New­
sholme, 1976). Considerable controversy and debate exist (e.g. Chang & Gold­
berg, 1978a,b; Snell, 1980) on the direction of the flux through the pathway 
between citric acid cycle intermediates and pyruvate. This flux determines the 
extent to which the carbon-skeletons of valine and isoleucine are used for 
synthesis of glutamine, for synthesis of alanine and for oxidation. 
1.5. OUTLINE OF THE PRESENT STUDY 
The present investigation is aimed at extending our knowledge of the deg­
radation of branched-chain amino acids and branched-chain 2-oxo acids in mus­
cle. Since we had biopsy material of human heart and skeletal muscle at our 
disposal, we have determined transamination and oxidative decarboxylation 
rates of branched-chain amino acids and branched-chain 2-oxo acids in intact 
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preparations and homogenates of human muscle and compared these with results 
obtained with rat muscles (chapter 3). In order to establish the extent to 
which degradation proceeds beyond the oxidative decarboxylation step, we have 
compared the 1*C02 production rates from amino acids and 2-oxo acids radioac-
tively labelled at different C-atoms, measured the 1*C02 production from 
[l-1*C]branched-chain fatty acids (chapter 3) and identified the radioactive 
products accumulating during incubation with [U-'O]-labelled amino and 2-oxo 
acids (chapter 4). The effect of starvation on oxidative decarboxylation rates 
in intact preparations of rat muscle has been studied, particularly with 
regard to the identity of the precursor pool of the branched-chain 2-oxo acid 
oxidation (chapter 5). The interaction of metabolites and agents with the oxi-
dation of branched-chain 2-oxo acids in intact rat and human muscle prepara-
tions has also been studied (chapter 6), with special attention to the inter-
action of octanoate (chapter 7). 
The reports appearing during the course of our investigation on reversi-
ble phosphorylation of the branched-chain 2-oxo acid dehydrogenase complex 
made it uncertain whether the activities measured in intact preparations and 
homogenates represent the actual activity present in the tissues or whether 
these activities are changed during preparation and incubation. Therefore, we 
have developed an assay to determine the amount of enzyme present in the 
active state by measuring both the actual activity and the total activity 
(100% active state) of the branched-chain 2-oxo acid dehydrogenase complex in 
rat tissues (chapter 8). There was reason to believe that starvation and exer-
cise are attended by increased branched-chain amino acid degradation in mus-
cle. We have, therefore, also applied the assay for the activity state to tis-
sues of starved and exercised rats (chapter 9). Finally, changes in the 
activity state have been studied in diaphragms of fed and starved rats, incu-
bated with and without metabolites (chapter 10). General conclusions and a 
summary of the results are presented in the concluding chapter (chapter 11). 
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CHAPTER 2 
GENERAL METHODS AND MATERIALS 
2.1. MATERIALS 
The specific reagents and materials used in this study are listed below 
together with the suppliers. L-fl-^C]- and L-[U-l*C] leucine, L-fl-^C]- and 
L-[U-1*C]valine, L-fU-^C] isoleucine, L-tU-^CJtyrosine, L-fU-^CJalanine, 
L-tU-^Clglutamine, [l-^CJpyruvate, [ l,5-l*C]citrate, [ 1,4-l*С]succinate, 
L-tU-^CJmalate, [l-^Cjacetate, D(-)-3-hydroxy[3-1*C]butyrate and 
[l-1*C]palmitate: Amersham International, Amershara, U.K. 
[l-^CJoctanoate, 2-oxo[l-1,lC]glutarate, 3-hydroxy-3-['"C]-methylglutarate, 
Omnifluor and Aquasol scintillation fluid: New England Nuclear, Dreieichen-
hain, F.R.G. 
L-[2-l*C]leucine: CEA, France. 
[l-^CJisovalerate and [l-^CJisobutyrate: ICN, Irvine, CA, U.S.A. 
Aqualuma-plus scintillation fluid: Lumac/3M, Schaesberg, The Netherlands. 
[ 1-1*C] lactate was prepared from [І-^С]pyruvate by enzymatic conversion with 
lactate dehydrogenase. 
L-[U-1*C]glutamate was prepared from L-[U-l*C]glutamine by enzymatic conver­
sion with glutaminase. The "C-labelled branched-chain 2-oxo acids were pre­
pared from the corresponding 1*C-labelled amino acids by oxidative deamination 
according to the method of Rüdiger et ai. (1972). 
Leupeptin, pepstatin, creatine kinase (CK, EC 2.7.3.2), CK N-acetyl-L-cystein-
activated monotest, 3-hydroxybutyrate dehydrogenase (EC 1.1.1.30), lactate 
dehydrogenase (EC 1.1.1.27), Phosphorylase a (EC 2.4.1.1), catalase (EC 
1.11.1.6), ADP, ATP, NAD+ (grade 1), NADH and cytochrome c: Boehringer, Mann-
heim, F.R.G. L-amino acid oxidase (type IV, EC 1.4.3.2), glutaminase (EC 
3.5.1.2), lipoamide dehydrogenase (EC 1.6.4.3), amino-oxyacetate, 
D,L-3-aminoisobutyric acid, clofibric acid [2-p-(chlorophenoxy)-2-methyl-pro-
pionic acid], CoA, thiamin pyrophosphate, cycloheximide and bovine serum albu-
min (fraction V): Sigma Chemical Company, St. Louis, MO, U.S.A. 
DOWEX 1 X8 (100-200 mesh), D0WEX SO W X2 (50-100 mesh), L-cycloserine, 
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Tos-Lys-CH2Cl (7-araino-l-chloro-3-Ii-tosylan)idoheptan-2-one) and D,L-carnitine: 
Fluka AG, Buchs, Switzerland. 
Calf serum: Gibco Europe, Paisley, Scotland, U.K. 
2-Cyanociimamate: Pfaltz & Bauer, Stamford, Conn., U.S.A. 
3-Hydroxy-2-cyanocinnamate: Aldrich-Europe, Beerse, Belgium. 
Thin-layer plates (DC-Fertigplatten Kieselgel 60, DC Plastikfolien cellulose) 
and 2,6-dichlorophenol-indophenol: Merck, Darmstadt, F.R.G. 
Chromatography paper no.l and 3MM: Whatman, Maidstone, U.K. 
X-ray film: Sakura, Japan. 
D,L-2-chloro-4-methylpentanoate (2-chloroisocaproate) was a gift from Dr. Ron-
ald Simpson, Sandoz Inc., East Hanover, NJ., U.S.A. 
L-carnitine was a gift from Sigma Tau, Rome, Italy. 
3-Hydroxyisovalerate was prepared from 4-hydroxy-4-methyl-2-pentanon and 
sodium hypochlorite according to Coffman et al. (1958) and purified by destil-
lation in vacuo (boiling point 750C at 2.5 mm of Hg). 
3-Hydroxyisobutyrate was synthesized by the following procedure. 
3-Aminoisobutyric acid (1 mmol) was dissolved in 20 ml of water. Sodium 
nitrite (1 mmol) and 2 mmol of HCl were subsequently added. The reaction mix-
ture was boiled gently for 5 min, and after cooling the resulting 
3-hydroxyisobutyric acid was extracted with ethylacetate. 
Bovine serum albumin was made fatty acid-free according to Chen (1967) and 
dialyzed. 
2.2. SOURCE OF TISSUES 
Animals 
Random-bred male albino Wistar rats, weighing either 90-125 g or 
180-240 g, were used. The rats were fed on a commercial stock diet, containing 
22% protein, 4.8% fat and 67% carbohydrates (RMH-TM, obtained from Hope Farms 
B.V., Woerden, The Netherlands). Rats received water ad libitum. They were 
maintained on a cycle of alternating 12-hr periods of light and darkness 
(light on 7.00 a.m., light off 7.00 p.m.) and were killed by cervical disloca-
tion, routinely between 11.00 a.m. and 2.00 p.m. 
Human muscle biopsies 
Biopsies of pectoralis muscle were obtained from breast carcinoma 
patients and biopsies of gluteus muscle from patients undergoing orthopedic 
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corrections. The biopsies were transported to the laboratory in ice-cold SET 
buffer, consisting of 0.25 M sucrose, 2 mM EDTA and 10 mM Tris/HCl (pH 7.4). 
The transport lasted 1-2 hr for pectoralis muscle and 15-20 min for gluteus 
muscle. 
Right auricular biopsies of 200-500 mg were taken from human myocardial 
tissue during open-heart surgery in adult patients. Immediately after dissec­
tion the biopsies were transported to the laboratory (lasting 5 min, on ice). 
2.3. PREPARATION OF INTACT MUSCLE SYSTEMS 
Several types of striated muscle tissue from both rat and man were used. 
All manipulations and washings of muscle samples were performed immediately 
after dissection or after arrival of the biopsies. They were carried out at 
370C in Krebs-Ringer bicarbonate buffer (lie.5 mM NaCl, 4.74 mM KCl, 2.54 mM 
CaClz, 1.18 mM KH2P0i., 1.18 mM MgSO* and 25.0 mM NaHCO,, pH 7.4) containing 
4 mM glucose and gassed with 0г/С0г (95:5). Rat diaphragm was dissected away 
from the associated ribs, washed, trimmed out of connective and nerve tissue 
and hemisected. Rat soleus, extensor digitorum longus and flexor digitorum 
brevis muscles were exposed, dissected free by cutting the tendons at their 
points of insertion and washed. Teased muscle fibers of about 100 mg were pre­
pared from the biopsies of human pectoralis and gluteus muscle. 
Rat hearts were rapidly excised, cut into halves and washed. Human heart 
biopsies were prepared free of residual fat and connective tissue. Both types 
of heart tissue were divided into oblong slices of about 50 mg. 
2.4. PREPARATION OF H0M0GENATES AND MITOCHONDRIA 
Rat quadriceps muscle, diaphragm, soleus muscle, heart, liver, kidney(s) 
and brain hemispheres were excised and immediately cooled in ice-cold SET 
buffer, consisting of 0.25 M sucrose, 2 mM EDTA and 10 mM Tris/HCl (pH 7.4). 
Biopsies of human muscle were taken up in the same buffer immediately after 
dissection or on their arrival at the laboratory. Further procedures were per­
formed at 0oC. Tissues were washed, blotted, weighed and minced with scissors. 
Homogenates (10%, w/v, for rat quadriceps muscle and brain and human pecto­
ralis and gluteus muscle; 5%, w/v, for all other tissues) were prepared in the 
same buffer by homogenization by hand with a Teflon-glass Potter-Elvehjem 
homogenizer, with three pestles of different diameters (0.35, 0.12 and 0.05 mm 
clearance). With soft tissues the first pestle was omitted. 
For preparation of muscle mitochondria, the homogenates were centrifuged 
11 
twice for 5 min at 60θ£ and the resulting supernatants (termed postnuclear 
fraction) for 10 min at 7000g. The mitochondria were washed with a solution 
of 100 mM KCl, 50 mM Tris/HCl (pH 7.4), 1 mM MgCb, 0.2 mM ATP and 0.5% (w/v) 
fatty acid-free dialyzed albumin, and finally suspended in the same solution 
without albumin. The yield of mitochondria was 10-20%. The mitochondria, iso­
lated by this procedure, were of good quality (Van Hinsbergh et al., 1979; 
Veerkamp et al., 1980). 
2.5. BIOCHEMICAL METHODS 
Assay of brancbed-chain 2-oxo acid oxidation in homogenates 
Oxidation rates were determined in triplicate by a procedure modified 
from Van Hinsbergh et al. (1979) and Veerkamp et al. (1980). A volume (100 μΐ) 
of tissue homogenate was added to 300 μΐ of a medium containing 16.7 mM 
KHiPO«, 25.0 mM NaHCOj, 100 mM Tris/HCl (pH 7.4), 41.7 mM sucrose, 25.0 mM 
KCl, 8.33 mM MgCl2, 1.67 mM EDTA, 1.67 mM 2-oxoglutarate, 8.33 mM ADP and 
3.33 mM L-carnitine. After preincubation for 5 min at 370C, 100 μΐ of 0.5 mM 
[1-1*C]- or [U-1*C]branched-chain 2-oxo acid was added. After incubation for 
15 min at 370C, reactions were terminated by the addition of 0.3 ml 3 M per­
chloric acid to the medium. The 1*C02 released was trapped in 0.3 ml ethanola-
mine-ethyleneglycol (1:2, v/v) in a center well during a 90 min period at 0oC. 
Radioactivity of ll'C02 was measured in 10 ml toluene/methanol (2:1, v/v) con­
taining 0.4% Omnifluor. Oxidation rates were calculated from the specific 
radioactivity in the medium and were expressed in nmol of 1*C-labelled com­
pound metabolized/min per g of tissue. A blank value (incubation without homo­
genate) was substracted. Rates were constant for at least 15 min. 
Addition of 1 mM thiamin pyrophosphate, 1 mM NAD or 1 mM CoA, separately 
or in combination, did not affect the measured oxidative decarboxylation 
rates. This indicates that the mitochondria remained intact during the entire 
procedure. When the mitochondria in the homogenates were broken by freezing 
and thawing, the activity decreased considerably and became markedly dependent 
on these cofactors (Van Hinsbergh et al., 1979; Veerkamp et al., 1980). The 
2-oxo acid concentration of 0.1 mM is below the apparent К in rat muscle 
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mitochondria (Van Hinsbergh et al., 1980). Oxidative decarboxylation rates 
consequently do not represent maximal rates. 
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Assay of branched-chain amino acid transamination in homogenates 
Transamination rates were determined by the incubation procedure 
described by Van Hinsbergh et al. (1979). As substrate 0.5 mM [l-^C] leucine 
and -valine were used. After termination of the reaction 3 volumes of 0.2 M 
eerie sulphate in 2 M HiSO» were added to the medium for chemical decarboxyla­
tion of the accumulated 2-oxo acids. 
Assay of palmitate oxidation in homogenates 
Palmitate oxidation rates were measured as described by Veerkamp et al. 
(1983). After an incubation for 30 min at 370C with 120 yM [ l-l*C]palmitate 
bound to albumin in a 5:1 molar ratio, reactions were terminated by the addi­
tion of perchloric acid. Oxidation rates (in nmol/min per g tissue) were cal­
culated from the sum of radioactivity present in lkC02 and acid-soluble 
metabolites. 
Citrate synthase assay 
Citrate synthase (EC 4.1.3.7) activity was measured in supernatants of 
sonicated homogenates according to the method of Shepherd & Garland (1969). 
The reaction involved is: 
citrate synthase 
Acetyl-CoA + oxaloacetate >• citrate + CoA 
The homogenates were stored at -20oC and assayed within two weeks after prepa­
ration. After sonication (Branson sonifier, set at 45 W, 4 χ 15 s at 0 oC), the 
preparations were centrifuged for 5 min at 10000^ and 4CC in a Burkard Kools-
pin microcentrifuge. Aliquots of the supernatant were used for the assay. The 
method is based on the chemical coupling of the released CoA to 5,5'-dithio-
bis-(2-nitrobenzoic acid), which can be traced by the formation of the absorb­
ing mercaptide ion at 412 mn. All results are given in ymol CoA liberated per 
min at 250C. 
Creatine kinase assay 
Cytosolic creatine kinase (CK, EC 2.7.3.2) activities were measured at 
370C with the CK N-acetyl-L-cystein-activated monotest (Boehringer, Mannheim, 
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F.R.G.)· in which by a coupled assay procedure the formation of NADPH is 
traced at 340 nm. Whole homogenates (1%, w/v) of fresh or incubated muscle 
preparations were prepared in SET buffer, as described above. The homogenates 
were centrifuged for 10 min at 20000; and allquots of the supernatant were 
used for the assay. Creatine kinase activity was also measured in 10 μΐ sam­
ples withdrawn from the incubation media after certain time intervals. All 
results are given as relative activities or in umol/min at 370C. 
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CHAPTER 3 
DEGRADATION OF BRANCHED-CHAIN AMINO ACIDS 
IN HUMAN AND RAT HEART AND SKELETAL MUSCLE* 
3.1. INTRODUCTION 
Our present insights in the metabolism of branched-chain amino acids (see 
chapter 1) have mostly been gained from in vitro and in vivo studies on the 
rat. Studies on the degradation of branched-chain amino acids in man are 
rather limited. More knowledge of these processes in man is required to under­
stand the therapeutic action of branched-chain amino acids and 2-oxo acids in 
a variety of human disorders, such as hepatic encephalopathy, chronic renal 
failure and conditions associated with wasting of muscle proteins (Adibi, 
1980; Walser, 1984). 
In this chapter we describe an incubation system to measure transamina­
tion and oxidative decarboxylation rates of branched-chain amino acids and 
2-oxo acids in intact preparations of rat and human heart and skeletal muscle. 
We also measure these rates in homogenates of the same muscles by means of an 
assay earlier described by Veerkamp et al. (1980). The degradation of 
branched-chain 2-oxo acids beyond the oxidative decarboxylation step is stud­
ied by comparing the 1*C02 production from amino acids and 2-oxo acids 
labelled at different carbon-atoms and by measuring the 1*C02 production from 
[1-1*C] branched-chain fatty acids. We discuss the results obtained with com­
parable preparations of rat and human muscle, and with intact preparations and 
homogenates of the same muscle. 
Adapted from Veerkamp & Wagenmakers (1981) and Wagenmakers Ь Veerkamp (1982) 
IS 
3.2. MATERIALS AND METHODS 
Intact preparations of rat and human muscle were obtained as described in 
section 2.3. Rats weighed 90-120 g. Homogenates were prepared as described in 
section 2.4. For the studies on homogenates rats of 180-240 g were used. All 
rats were starved for 1 day. Results are shown as means ± SD, with the num­
bers of experiments (n) in parentheses. 
Assay of branched-chain amino acid, Z-oxo acid and fatty acid oxidation in 
intact muscle preparations 
The intact muscle preparations were blotted, weighed, and placed in 15 ml 
incubation flasks containing 2.0 ml of Krebs-Ringer bicarbonate buffer (pH 
7.4), gassed with O2/CO2 (95:5), and containing 4 mM glucose. The incubation 
flasks were sealed with rubber stoppers and equipped with plastic center 
wells. Before addition of substrate the muscles were preincubated for 5 min at 
37eC. Concentrations and specific activities of 1*C-labelled substrates are 
given in the tables and figures. Incubations occurred at 370C for 90 min, 
except for fibers of human pectoralis muscle (60 min). At the end of the incu­
bation 0.5 ml 3 M perchloric acid was injected into the medium. The "COz 
released was trapped in 0.3 ml ethanolamine-ethyleneglycol (1:2, v/v) in the 
center well during a 16-hr period at 0eC and transferred to scintillation 
vials, containing 10 ml toluene-methanol (2:1, v/v) and 0.4% Omnifluor, for 
measuring radioactivity. Oxidation rates are calculated from the ''COi produc­
tion and the specific activity in the incubation medium at the start of the 
experiment and expressed as nmol of the "'C-labelled compound metabolized. 
Heart slices and teased fibers were incubated in triplicate. 
Assay of branched-chain amino acid transamination in intact muscle prepara­
tions 
Transamination rates in rat hemidiaphragm were determined by the same 
incubation procedure with [1-"Ό] leucine or [l-ll'C]valine as substrate. The 
reaction was terminated, however, with 0.5 ml 2 M H2SO1, and after extraction 
of radioactive ""СОг, another center well, containing 0.3 ml fresh ethanola­
mine-ethyleneglycol (1:2, v/v), was placed into the incubation flask. After 
the flask had been sealed again, 7.5 ml 0.2 M eerie sulfate in 2 M HjSOi, was 
injected for chemical decarboxylation of the formed 2-oxo acids. After a 4-hr 
incubation at 370C radioactivity of trapped l*C0i could be determined, as 
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described above. 
Other assays 
Oxidation and transamination rates of branched-chain amino and 2-oxo 
acids in mitochondria and homogenates and creatine kinase activities were 
measured as described in section 2.5. The oxidation rates of 
[1-I*C]isovalerate (3-methylbutanoate) and -isobutyrate (2-methylpropanoate) 
in homogenates were measured with the incubation system used to determine 
branched-chain 2-oxo acid oxidation as well as with the incubation system used 
to determine palmitate oxidation (section 2.5.). 
3.3. RESULTS 
Characteristics of the intact muscle preparations 
Rat hemididphragm oxidized [l-l*C]4-methyl-2-oxopentanoate, -3-methyl-2-
oxobutanoate, -isovalerate, and -isobutyrate at a constant rate for at least 
90 min (Fig.3.1). Correlation coefficients of the linear regression lines were 
0.99, 0.99, 0.94, and 0.98, respectively. Human and rat heart slices and 
fibers of human pectoralis muscle, obtained from one human biopsy or one rat, 
oxidized 4-methyl-2-oxopentanoate at a constant rate over a 120-min period. 
Correlation coefficients were 0.98-1.00. 
We tried to estimate the intactness of the muscle preparations from the 
leakage of soluble (cytosolic) creatine kinase during the incubation (Table 
3.1). This parameter seems only valid for rat hemidiaphragm and fibers of 
human pectoralis muscle with a leakage of 8 and 14%, respectively. For these 
preparations the total CK activity after incubation (leaked and residual) was 
equal to the CK activity in fresh preparations of the same muscle. This does 
not hold for rat and human heart slices. The insufficient recovery in combina-
tion with the observation,of decreasing CK activities in the medium, when rat 
and human heart slices are incubated for more than 1 hr, indicated a contempo-
rary degradation or inhibition of the assay by leakage of some proteolytic 
activity or some inhibitor, respectively. A trial to intercept proteolytic 
activity with 3.2% (w/v) bovine serum albumin (BSA), added to the incubation 
medium, surprisingly resulted in no measurable CK activity at all. At 370C 
3.2% BSA was found to degrade or inhibit a CK activity of 60 U/ml Krebs-Ringer 
bicarbonate buffer within 15 min. Addition of protease inhibitors such as leu-
peptin and pepstatin, in concentrations up to 50 vg/ml, did not result in 
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Fig. 3.1. Time dependence of 1*C02 production from [ l-^CJbranched-chain 
2-oxo acids and their derived short-chain fatty acids by rat dia­
phragm. Hemidiaphragms were incubated for the indicated times in 
media containing 0.1 mM of the 1*C-labelled substrate. Specific 
activities in dpm/nmol were about 750 for (o) 4-methyl-2-oxopenta-
noate, 1500 for (a) 3-methyl-2-oxobutanoate, 4000 for (·) 
isovalerate and 2000 for (•) isobutyrate. Values are the means ± SD 
for three hemidiaphragms obtained from different rats on 1 day. 
better recoveries of CK. Therefore, the residual CK activity after incubation 
appears to be the best parameter of the intactness of the heart slices. After 
90 min about 70% of total CK activity appeared to reside in the heart slices. 
L-Carnitine stimulates the oxidation of branched-chain amino acids and 
2-oxo acids in mitochondria and homogenates of rat and human skeletal and 
heart muscle (Van Hinsbergh et al., 1978a,Ь, 1980; Veerkamp et al., 1980). 
D,L-Camitine (4 raM) had no effect, however, on the oxidation of 
4-methyl-2-oxopentanoate by rat hemidiaphragm, soleus muscle, and heart slices 
and by fibers of human pectoralis muscle and human heart slices. This absence 
of a carnitine effect may be indicative of the integrity of these systems. 
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Table 3.1. Creatine kinase activity in muscle preparations and medium after 
incubation 
Preparation of muscle systems (section 3.2) and assay of creatine kinase 
activity (section 2.5) were described. Creatine kinase activity after 
incubation is expressed in percents of the activity present in fresh prep-
arations of the same muscle. Values are means ± SD for the number of 
experiments in parentheses. 
Muscle system 
Rat 
Hemidiaphragm 
Heart slices 
Human 
Pectoralis m. 
fibers 
Heart slices 
(10) 
(9) 
(3) 
(5) 
Incubation 
time 
(min) 
90 
90 
60 
60 
Relative 
Medium 
8 ± 2 
15 ± 10 
14 ± 1 
1 8 + 9 
activity (in %) 
Muscle system 
92 ± 2 
65 ± 4 
8 6 + 1 
71 ± 5 
Rates of transamination and oxidative decarboxylation 
The transamination and oxidative decarboxylation rates of leucine and 
valine were measured in rat hemidiaphragras at 0.1 and 0.5 mM, because these 
concentrations are in the range of plasma and muscle concentrations in various 
conditions (Adibi, 1976; Pozefsky et al., 1976; Hutson & Harper, 1981). For 
both branched-chain amino acids the transamination rates are significantly 
higher than the oxidative decarboxylation rates (Table 3.2). Although the 
transamination rates of the two amino acids are in the same range at both con-
centrations, the oxidative decarboxylation rates of leucine are much higher 
than that of valine. 
In Table 3.2 the oxidative decarboxylation rates for 4-methyl-2-oxopenta-
noate and 3-methyl-2-oxobutanoate are also given. The substrate concentrations 
of 0.1 and 0.5 mM are higher than the concentrations in rat plasma and muscle 
(Livesey & Lund, 1980; Hutson & Harper, 1981) and in human plasma (Schauder et 
al., 1980; Hutson & Harper, 1981), but were chosen to permit comparison with 
the oxidation rates of the branched-chain amino acids. At both concentrations 
the oxidative decarboxylation rates of the 2-oxo acids are four to six times 
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Table 3.2. Degradation of branched-chain amino acids and 2-oxo acids in rat 
h emidiaphragm 
Hemidiaphragms were incubated for 90 min in media containing 
[l-^C]substrates. Oxidative decarboxylation and transamination rates were 
expressed in nmol of the 1*C-labelled substrates converted per min per 
gram muscle and calculated from the ^ СОз production after incubation, and 
before and after addition of eerie sulfate, respectively. Specific activi­
ties in dpm/nmol were 750 for leucine and valine and are given in Fig. 3.2 
for the 2-oxo acids. Values are the means ± SD of the number of experi­
ments in parentheses. Hemidiaphragms were obtained from different animals. 
Substrate 
Concentration Transamination 
(mM) rate 
Oxidative 
decarboxylation rate 
Leucine 
Valine 
4-Methyl-2-oxopentanoate 
3-Methyl-2-oxobutanoate 
0.1 
0.5 
0.1 
0.5 
0.1 
0.5 
0.1 
0.5 
3.4 ± 0.2 (3) 
17.1 ± 2.8 (3) 
3.2 ± 0.1 (3) 
12.6 ± 1.2 (3) 
1, 
11. 
0, 
4. 
5. 
37. 
3. 
29, 
.5 
.7 
.9 
.7 
.7 
.8 
.5 
.9 
± 
± 
+ 
± 
± 
± 
± 
± 
0. 
3, 
0, 
1. 
1, 
3, 
1, 
4. 
.2 
.2 
.2 
.3 
.2 
.9 
.1 
.0 
( 9 ) 
(13) 
( 8 ) 
( 9 ) 
(98) 
( 6 ) 
(48) 
(M 
the values obtained with the corresponding branched-chain amino acid, as was 
previously observed by Buse et al. (1975). With rat and human heart slices 
about the same factor was observed. The oxidative decarboxylation rates of 
0.1 mM leucine were 0.8+0.1 and 1.810.4 nmol/min per g (means ± SD, n=3 and 
4), respectively, and of 0.1 mM 4-raethyl-2-oxopentanoate 3.4+0.7 and 
5.8+1.0 nmol/min per g (n=20 and 23). 
The concentration dependence of the oxidative decarboxylation rate in 
hemidiaphragm is given for 4-methyl-2-oxopentanoate and 3-methyl-2-oxobutano-
ate in Fig. 3.2. The oxidative decarboxylation rate for 4-methyl-2-oxopentano-
ate is maximal at a 1.0 mM medium concentration (50±8 nmol/min per g 
(mean ± SD, n=18). Raising the concentration to 5.0 mM does not result in a 
significant rise. On the other hand a marked increase is still observed with 
3-methyl-2-oxobutanoate at this concentration. 
Transaminase activity at 0.5 mM leucine and valine was markedly higher in 
homogenates from rat heart and diaphragm than in those from human heart and 
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Fig. 3.2. Concentration dependence of 1*C02 production from 
[l-1*C]branched-chain 2-oxo acids by rat diaphragm. Hemidiaphragms 
were incubated for 90 min in media containing various concentra­
tions of 2-oxo acids. Specific activities in dpm/nmol were 750, 
250 and 100 for (o) 4-methyl-2-oxopentanoate and 1500, 500 and 100 
for (•) 3-methyl-2-oxobutanoate at 0.1 and 0.2, 0.5 and 1.0, and 
5.0 mM concentration, respectively. Values are means + SD for at 
least three experiments. 
rat quadriceps muscle (Table 3.3). The activity in homogenates from human 
heart was four times higher than in those from human skeletal muscles. The 
activity in rat liver homogenates was rather low. 
Table 3.4 gives the oxidative decarboxylation rates of both 2-oxo acids 
in homogenates and intact preparations of human and rat muscle at a 0.1 mM 
concentration. The 2-oxo acid dehydrogenase activity is much higher in homo­
genates from heart muscle than from skeletal muscle for both species and is 
similar in rat heart and liver. It is much higher in homogenates from rat than 
from comparable human muscles. The oxidation rates in the intact muscle prepa­
rations are markedly lower than in the homogenates and the differences between 
the species and between heart and skeletal muscle are much smaller or do not 
exist at all. The differences between the activities of homogenates and intact 
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Human 
Heart 
Pectoralis muscle 
Gluteus muscle 
Rat 
Heart 
Quadriceps muscle 
Diaphragm 
Liver 
(6) 
(4) 
(7) 
(6) 
(5) 
(4) 
W 
127 ± 20 
30.0 ± 8.7 
34.7 ± 13.6 
230 ± 38 
64.6 ± 11.5 
218 ± 19 
16.7 ± 1.8 
Table 3.3. Transamination rates of leucine and valine in homogenates of human 
and rat muscle 
Preparation of tissue homogenates and assay of transaminase activity were 
described in section 3.2. Concentration of [ l-^CJamino acids was 0.5 mM. 
Specific activity was 250 dpm/nmol. Transamination rates (in nmol/min 
per g muscle) are means ± SD for the number of experiments in parentheses. 
Tissue Leucine Valine 
92.0 ± 15.9 
16.8 + 4.9 
20.6 ± 10.9 
159 ± 29 
44.6 ± 5.9 
145 ± 6 
4.6 ± 1.3 
preparations of the same muscle vary between more than eighty times (rat 
heart, 3-methyl-2-oxobutanoate) and approximately four times (human pectoralis 
muscle, 4-methyl-2-oxopentanoate). These large differences are also seen in 
the transamination rates of leucine and valine. For rat diaphragm the transa­
mination rates of 0.5 mM leucine in homogenate and intact preparations were 
218±19 and 17.1±2.8 nmol/min per g (means ± SD, n=4 and 3), respectively, and 
the rates of 0.5 mM valine were 145+6 and 12.6±1.2 nmol/min per g (n=4 and 3), 
respectively. In homogenates the oxidation rates for 3-methyl-2-oxobutanoate 
tend to be higher than for 4-methyl-2-oxopentanoate, whereas in intact prepa­
rations the opposite is observed. This is most obvious for rat diaphragm. 
Degradai ion of branched-chain 2-oxo acids beyond oxidative decarboxylation 
In homogenates and mitochondria from skeletal and heart muscle, COj pro­
duction represents only oxidative decarboxylation of the 2-oxo acids. Using 
similar specific radioactivities the "COz production from [1-1*C]-
4-methyl-2-oxopentanoate was about six times that from the [U-* *С]compound and 
from [l-1''C]3-methyl-2-oxobutanoate it was about five times that from the 
[U-^C] compound (Table 3.5). In all intact musle preparations, however, 
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Table 3.4. Oxidative decarboxylation rates of branched-chain Z-oxo acids in 
human and rat tissues 
Preparation of muscle systems and assay of "'СОг production were described 
in section 3.2. Concentration of [l-1*C]-2-oxo acid was 0.1 mM. Specific 
activities in dpm/nmol were 750 for 4-methyl-2-oxopentanoate and 1500 for 
3-methyl-2-oxobutanoate. Rates (in nmol/min per g tissue) are means ± SD 
for at least four experiments. 
Tissue 
Human 
Heart 
Pectoralis muscle 
Gluteus muscle 
Rat 
Heart 
Quadriceps muscle 
Diaphragm 
Soleus muscle 
Extensor digitorum 
longus muscle 
Flexor digitorum 
brevis muscle 
Liver 
4-Methyl-2' 
Homogenate 
25 ± 4 
5 ± 1 
8 ± 2 
231 ± 45 
25 ± 8 
29 ± 3 
_ 
_ 
_ 
229 ± 47 
-oxopentanoate 
Intact tissue 
5.8 ± 
1.2 ± 
1.6 ± 
3.4 ± 
_ 
5.7 ± 
2.9 ± 
1.5 ± 
4.6 ± 
-
1.0 
0.8 
0.4 
0.7 
1.2 
1.0 
0.2 
0.6 
3-Methyl-2-
Homogenate 
42 ± 8 
5 ± 1 
9 ± 3 
240 + 55 
48 ± 13 
103 ± 18 
_ 
_ 
_ 
282 ± 53 
oxobutanoate 
Intact tissue 
5.1 ± 1.2 
0.8 ± 0.2 
1.1 + 0.5 
2.9 ± 0.8 
_ 
3.5 + 1.1 
1.5 ± 0.4 
_ 
_ 
-
further degradation appears to take place and is more pronounced for 
4-methyl-2-oxopentanoate than for 3-methyl-2-oxobutanoate. The ratio for 
oxidative decarboxylation (0.17) is more exceeded with the former substrate 
than with the latter (ratio 0.20). In liver homogenates futher degradation of 
3-methyl-2-oxobutanoate appears to occur. At 1.0 raM concentration (Table 3.6) 
the ratios are markedly lower, especially for 3-methyl-2-oxobutanoate. With 
rat hemidiaphragms the ratios of 1*C02 production from [U-l*C]leucine and 
^-""CJleucine to that from [l-^C] leucine at 0.1 mM were 0.40±0.07 and 
0.44±0.07 (means ± SD, n=3 and 6), respectively. At 0.5 raM leucine concentra­
tion, the former ratio did not change (0.40±0.10, n=3). 
Comparison of the oxidation rates at 0.1 mM (Table 3.4) with those at 
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Table 3.5. Oxidation of 1''C-labelled Z-oxo acids by various preparations of 
human and rat muscle 
Preparation of muscle systems and assay of "COa production were described 
in section 3.2. Ratios of 1*C02 production from the [U-'^C]- to that from 
the [1-1*C] 2-oxo acids were measured in intact preparations of the same 
muscle (paired hemidiaphragms and triples of slices or fibers), or in hom-
ogenates and mitochondria at similar specific activities (750 dpm/nmol for 
4-methyl-2-oxopentanoate and 1500 dpm/nmol for 3-methyl-2-oxobutanoate). 
2-0xo acid concentration was O.ltnM. Values are means + SD for three to six 
experiments. 
Tissue System 
Ratio [U-'-CJ/fl-^C] 
4-Methyl-2-oxo-
pentanoate 
3-Methyl-2-oxo-
butanoate 
Human 
Gluteus muscle 
Fectoralis muscle 
Heart 
Rat 
Quadriceps muscle 
Heart 
Diaphragm 
Liver 
Homogenate 
Homogenate 
Intact fibers 
Homogenate 
Homogenate 
Homogenate 
Mitochondria 
Homogenate 
Slices 
Homogenate 
Hemidiaphragm 
Homogenate 
0.18 ± 0.05 
0.16 ± 0.02 
0.47 ± 0.13 
0.16 ± 0.01 
0.44 ± 0.10 
0.14 ± 0.02 
0.16 ± 0.02 
0.14 ± 0.01 
0.60 ± 0.06 
0.14 ± 0.01 
0.57 + 0.04 
0.13 ± 0.02 
0.22 ± 0.02 
0.20 ± 0.01 
0.28 ± 0.08 
0.26 ± 0.03 
0.37 ± 0.07 
0.19 + 0.03 
0.21 ± 0.05 
0.23 ± 0.03 
0.30 ± 0.02 
0.21 ± 0.03 
0.46 ± 0.09 
0.34 ± 0.03 
1.0 mM (Table 3.6) shows that the effect of an elevation of the substrate con-
centration is comparable in all intact muscle systems. In rat hemidiaphragms 
such an elevation leads to a 8.8-fold and a 12.9-fold increase in the 
oxidation rate of 4-methyl-2-oxopentanoate and 3-methyl-2-oxobutanoate, 
respectively (see also Fig. 3.2). For rat heart slices these factors are 5.3 
and 7.7, for human heart slices 2.3 and 9.1, respectively, and for fibers of 
human pectoralis muscle the first factor is 3.2. 
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Table 3.6. Oxidation of 1''C-labelled 2-oxo acids in intact muscle prepara­
tions at 1.0 mil concentration 
Ratios were obtained as in Table 3.5. Specific activities were 250 
dpm/nmol for 4-methyl-2-oxopentanoate and 500 dpm/nmol for 3-methyl-2-oxo-
butanoate. Oxidation rates (in nmol/min per g tissue) and ratios are given 
as means ± SD for 3 to 16 experiments. NO, not determined. 
4-Methyl-2-oxopentanoate 3-Methyl-2-oxobutanoate 
Muscle system 
Oxidation rate 
[l-^CJacid 
Ratio 
[U-^C]/ 
[ l-^C] 
Oxidation rate 
[ l-^CJacid 
Ratio 
[U-^C]/ 
[l-'-C] 
Human 
Pectoralis muscle 3.8І2.2 0.23 ±0.02 
fibers 
Heart slices 13.2 + 2.0 0.43 ± 0.04 
Rat 
Hemidiaphragm 49.9 ± 7.9 0.39+0.08 
Heart slices 17.9 ± 1.7 0.43 ± 0.12 
ND ND 
46.6 ± 16.7 0.21 ± 0.01 
45.0 ± 10.1 0.27 ± 0.05 
22.2 ± 3.1 0.25 ± 0.05 
In accordance with the found ratios (Table 3.5) no significant amount of 
1
*C02 was produced from [1-1*C]isovalerate and -isobutyrate with homogenates 
of human and rat muscle nor with the assay conditions used to determine 
branched-chain 2-oxo acid oxidation, nor with the appropriate conditions for 
determination of fatty acid oxidation. The same homogenates oxidized 0.1 mM 
[l-'^CJoctanoate quite well, but only with the conditions adequate for fatty 
acid oxidation. In the presence of CoA the octanoate oxidation rate of rat 
quadriceps muscle, diaphragm, and heart homogenates amounted to 2.2±1.2, 
3.9±1.2, and 84.6±7.0 nmol/min per g muscle (n=4 or 5). Thus in muscle homo­
genates the capacity to oxidize branched-chain 2-oxo acids beyond oxidative 
decarboxylation seems to be lost. 
In contrast to homogenates intact muscle systems oxidize isovalerate and 
isobutyrate (Table 3.7). The ''COi production from the latter acid is much 
lower. Maximal oxidation rates were reached in rat hemidiaphragm by raising 
the concentration from 0.1 to 0.5 mM. 
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Table 3.7. l*£702 production from [l-1''C]branched-chain short-chain fatty 
acids in various intact muscle systems 
Specific activities of the [l-^Cjfatty acids are given in Fig. 3.1. Val-
ues (in nmol/min per g tissue) are means ± SD for the number of experi-
ments in parentheses. 
Muscle system 
Concentration 
(mM) 
Oxidation rate 
Isovalerate Isobutyrate 
Human 
Heart slices 
Rat 
Heart slices 
Hemidiaphragm 
(3) 
(4) 
(9) 
w 
(4) 
0.1 
0.1 
0.1 
0.5 
1.0 
5.1 ± 1.2 
7.0 ± 1.0 
5.2 ± 1.3 
12.3 + 4.0 
12.1 ± 2.0 
0.6 ± 0.0 
0.8 ± 0.2 
1.2 ± 0.2 
3.0 ± 0.4 
3.8 ± 0.5 
3.4. DISCUSSION 
In this study we used rat hemidiaphragm and soleus muscle because they 
have proved to be valid in vitro model systems of rat skeletal muscle (e.g. 
Odessey & Goldberg, 1972; Buse et al., 1975; Goldberg & Chang, 1978). The 
results obtained with these preparations can be compared with in vitro model 
systems of human skeletal muscle as teased fibers of pectoralis and gluteus 
muscle. Sliced auricular biopsies from myocardial tissue were taken as in 
vitro system of human heart. Rat hearts were sliced to form a comparable model 
system. Allthough a small part of the cells is damaged in all preparations, as 
appears from creatine kinase leakage, all muscle preparations appeared to be 
valid in vitro systems because of the observed linearity of the oxidation pro-
cesses and the absence of any carnitine effect. 
Oxidative decarboxylation rates of leucine and valine by rat hemidia-
phragm agree quite well with reported values (Odessey & Goldberg, 1972; Buse 
et al., 1973,1975,1976) and at 0.1 mM leucine with a value reported for in 
vivo leucine oxidation in skeletal muscle of resting rats (White & Brooks, 
1981). Transamination rate of 0.1 mM leucine is similar to the rate reported 
by others (Shinnick & Harper, 1976). Both rates at 0.5 mM leucine and valine 
are lower, however, than reported by Chang & Goldberg (1978a) for rats starved 
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for 2 days. The oxidation rate of 4-methyl-2-oxopentanoate is comparable at 
0.1 and 0.5 mM to the values reported by Buse et al. (1975) but higher than 
found in quarter diaphragms (Shinnick & Harper, 1976; Van Hinsbergh et al., 
1979). 
The observation that the transamination rates of leucine and valine in 
rat hemidiaphragms are significantly higher than the oxidative decarboxylation 
rates is in agreement with the production of branched-chain 2-oxo acids found 
with rat hemidiaphragm (Shinnick & Harper, 1976; Chang & Goldberg, 1978a; 
Odessey & Goldberg, 1979), soleus muscle (Odessey & Goldberg, 1979), and 
hindquarter (Hutson et al., 1978,1980; Spydevold, 1979) incubated or perfused 
with branched-chain amino acids. It is probably a reflection of the in vivo 
situation in which 2-oxo acids produced by rat skeletal muscle are released 
into the circulation and taken up by the liver (Livesey & Lund, 1980). The 
higher rate of 1''C0z production in intact muscle preparations from 
[l-'^C^-oxo acids than from their corresponding amino acids suggests that the 
former compounds are transported faster than the amino acids are transported 
and transaminated. 
Oxidation rates of 4-methyl-2-oxopentanoate and 3-methyl-2-oxobutanoate 
by homogenates of heart, diaphragm and skeletal muscle of rat and of human 
heart are markedly higher than values obtained by others (Shinnick & Harper, 
1976; Khatra et al., 1977; Paul & Adibi, 1978; Odessey & Goldberg, 1979; Sans 
et al., 1980a). Similar values were reported for human skeletal muscle (Khatra 
et al., 1977). The differences may result from a milder homogenization proce­
dure and a better adapted homogenization medium in our assays. An important 
reason for these differences probably is that our assay gives total branched-
chain 2-oxo acid dehydrogenase activities (100% active state; see chapter 8). 
It is noteworthy that the oxidation rate (measured by us) of 4-methyl-2-oxo-
pentanoate in rat heart homogenate approximates quite well the rate in per­
fused rat heart (Buffington et al., 1979; Sans et al., 1980a). A second inter­
esting observation is that with our assay rat liver and heart contain a simi­
lar branched-chain 2-oxo acid dehydrogenase activity. On the base of previous 
studies (Shinnick & Harper, 1976; Khatra et al., 1977) liver was assumed to 
have by far the highest activity. Comparison of the transaminase and 2-oxo 
acid dehydrogenase activity in homogenates shows that the activity of the lat­
ter enzyme limits the oxidation of branched-chain 2-oxo acids in rat diaphragm 
and human heart as earlier found in rat and human skeletal muscle (Shinnick & 
Harper, 1976; Paul Ь Adibi, 1978; Van Hinsbergh et al., 1979; Odessey Ь Gold­
berg, 1979; Veerkamp et al., 1980). In rat heart the capacities of both 
enzymes are at the used substrate concentrations of comparable magnitude. 
27 
The variations in the oxidation rates of the branched-chain 2-oxo acids 
among the homogenates are partly related to differences in the content of 
mitochondria. This can be concluded from the fact that the activities based on 
cytochrome с oxidase activity vary only between 0.25 (rat diaphragm) and 0.90 
(human pectoralis muscle) nmol/min per μπιοί cytochrome c/min (Veerkamp & Wag­
enmakers, 1981). 
The fact that the oxidation rates in the intact muscle preparations are 
considerably lower than in the homogenates and mutually do not differ markedly 
may be a consequence of the resting state of these in vitro preparations in 
which they do not use much of their metabolic capacity and may be related to 
differences in the activity state of the branched-chain 2-oxo acid dehydroge­
nase complex during the incubations (see chapters 8 and 10). 
Homogenates of rat and human muscle and mitochondria of rat skeletal mus­
cle have lost their capacity to degrade branched-chain 2-oxo acids to CO2 
beyond oxidative decarboxylation. This was proved by the found ratios of l*C02 
production from [U-^C]- to that from [l-1*C]substrates (Table 3.5) and also 
by the observed incapability of homogenates to produce 1''C0Ï from the 
1
*C-labelled branched-chain short-chain fatty acids. In the next chapter we 
shall identify the accumulating intermediates. 
The ratios found with the intact muscle preparations for the oxidation of 
the [U-1*C]- and [l-^Clbranched-chain 2-oxo acids and leucine indicate that 
they are oxidized more to completeness. The ratios found for leucine oxidation 
in rat hemidiaphragm agree rather well with previous studies on incubated 
hemi- and quarter-diaphragms (Odessey & Goldberg, 1972, 1979; Buse et al., 
1975) and on perfused hindquarters (Hutson et al., 1980). The decrease of the 
ratios of "COi production from [U-1*C]- to that from [І-^Сіг-охо acids at 
higher substrate concentration (Tables 3.5 and 3.6) indicates that a second 
limiting step is present in their degradation to CO2. The further degradation 
of 3-methyl-2-oxobutanoate beyond oxidative decarboxylation appears to be more 
limited than that of 4-methyl-2-oxopentanoate, as can be concluded from the 
smaller extent of excess of the ratio for only oxidative decarboxylation by 
the former substrate. 
Comparison of the luQOi production from the [l-l',C]branched-chain short-
chain fatty acids derived from the 2-oxo acids appears to lead to the same 
conclusion. [l-^CJIsobutyrate loses its 1*C-label in the decarboxylation step 
that formes propionyl-CoA from methylmalonic semialdehyde (Fig. 1.1). The 
"C-label from [ 1-"C] isovalerate is only lost when the "C-labelled acetyl-
CoA derived from it enters the citric acid cycle. In the last case competition 
by endogenous acetyl-CoA may cause a lower '"СОг production. A higher rate is 
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found, however, in all intact muscle preparations for isovalerate (Table 3.7). 
A difference in the rate of one of the processes preceding the formation of 
acyl-CoA esters in the mitochondria may be responsible for this paradoxal 
result. Although not all of these processes are known in detail, the transport 
across the muscle membrane and the formation of acylcarnitine esters from the 
acyl-CoA derivatives and vice versa may be excluded, because there are no 
large differences in the permeability characteristics of the muscle membrane 
to saturated fatty acids of four to six carbon atoms (Schwartz & Dietschy, 
1980) and carnitine isobutyryl transferase activity is even markedly higher 
than carnitine isovaleryl transferase activity (Choi et el., 1977). Therefore 
it is more probable that intramitochondrial degradation of isobutyryl-CoA to 
CO2 is more limited than that of isovaleryl-CoA. The accumulation of 
3-hydroxyisobutyrate in muscle and medium after perfusion of the rat hindquar-
ter with valine (Spydevold, 1979) suggests that the conversion of this com-
pound to methylmalonyl semialdehyde is a rate-limiting step in the degradation 
of 3-methyl-2-oxobutanoate. In the following chapter we shall identify and 
quantify intermediates, which accumulate during incubation of rat diaphragms 
with branched-chain amino acids and 2-oxo acids, and we shall study the meta-
bolic fate of the carbon-skeletons which enter the citric acid cycle. 
3.5. SUMMARY 
Studies were made on the oxidation of the branched-chain amino acids, 
leucine and valine, and their derived 2-oxo acids and branched-chain short-
chain fatty acids in intact preparations and homogenates of muscle of man and 
rat. 
In rat hemidiaphragm the transamination rates of the amino acids are 
higher than the oxidative decarboxylation rates. The oxidative decarboxylation 
rates of the 2-oxo acids are higher than those of the corresponding amino 
acids at the same concentration. The last phenomenon was also observed in rat 
and human heart slices. 
Transaminase and 2-oxo acid dehydrogenase activities are rauch higher in 
homogenates than in intact preparations from the same muscle. Homogenates 
from heart muscle have generally a higher transaminase and 2-oxo acid dehyd-
rogenase activity than those from skeletal muscle and those from rat muscle 
have higher activities than those from comparable human muscle. Homogenates 
from rat heart and liver have similar 2-oxo acid dehydrogenase activities. 
In homogenates and mitochondria, CO2 was only produced by oxidative 
decarboxylation of the branched-chain 2-oxo acids and no C02 was produced from 
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the corresponding branched-chain short-chain fatty acids. In all intact muscle 
preparations the branched-chain 2-oxo acids were oxidized more to completeness 
and COz production from the corresponding short-chain fatty acids was 
observed. Degradation of the branched-chain 2-oxo acids beyond oxidative 
decarboxylation appeared to be limited, for 3-methyl-2-oxobutanoate even more 
than for 4-methyl-2-oxopentanoate. 
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CHAPTER 4 
THE METABOLIC FATE OF BRANCHED-CHAIN AMINO ACIDS AND 
2-OXO ACIDS IN RAT MUSCLE HOMOGENATES AND DIAPHRAGMS 
INCUBATED IN VITRO 
4.1. INTRODUCTION 
The ratios of the I*C02 production from [U-l*C]- to that from 
[l-^Clbranched-chain amino acids and 2-oxo acids reported in the previous 
chapter indicated that these compounds were only partially degraded to CO2. 
Ratios measured in muscle homogenates indicated that 1*C02 was only produced 
by the oxidative decarboxylation reaction. Therefore, there must be an accumu-
lation of pathway intermediates occurring on the route to the citric acid 
cycle (Fig. 1.1) or of compounds derived from these intermediates. In intact 
muscle preparations the conversion to CO2 appeared to be more complete but 
certainly was not total. This probably means that oxidation to CO2 is not the 
only metabolic fate of the carbon-skeletons of branched-chain amino acids, 
which have passed the oxidative decarboxylation reaction. 
Spydevold (1979) and Spydevold & Hokland (1983) found accumulation of 
considerable amounts of 3-hydroxyisobutyrate after perfusion of rat hindquar-
ters with valine, and of isovalerate and 2-methylbutyrate after perfusion with 
leucine and isoleucine, respectively. Octanoate stimulated the oxidation of 
the branched-chain amino acids and increased the output of branched-chain 
fatty acids by the muscle. The release of these compounds may seriously limit 
the further degradation of branched-chain amino acids in muscle. 
Acetyl-CoA derived from leucine and isoleucine may be completely oxidized 
by the citric acid cycle. However, complete oxidation of succinyl-CoA derived 
from valine and isoleucine requires conversion via pyruvate to acetyl-CoA 
(Goldstein & Newsholme, 1976). Pyruvate produced in this way may be transami-
nated to alanine. Citric acid cycle intermediates may also be converted to 
glutamine via transamination of 2-oxoglutarate to glutamate and amidation of 
glutamate. Alanine and glutamine are released by skeletal muscle in vivo 
(Ruderman & Berger, 1974; Felig, 1981) and in vitro (Odessey et al. , 1974; 
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Ruderman & Berger, 1974; Garber et al., 1976; Chang & Goldberg, 1978b) in 
amounts, which by far exceed their relative abundance in muscle protein. 
Therefore valine, isoleucine and other amino acids which may be converted to 
citric acid cycle intermediates in muscle (asparagine, aspartate and gluta­
mate; see Chang & Goldberg, 1978a,b) have been postulated to be the precursors 
for the newly synthesized amounts of alanine and glutamine (Goldstein & New-
sholme, 1976; Chang Ь Goldberg, 1978a,b; Snell, 1980; Snell & Duff, 1982). 
After incubation of rat diaphragms with [U-1*C]valine, -aspartate and 
-succinate Chang & Goldberg (1978b) found that the amount of radioactive label 
in glutamine and glutamate was twice that in lactate and pyruvate and over 
fifty times that in alanine. Thus they concluded that the formation of the 
carbon-skeleton of alanine from other amino acids was of little or no quanti-
tive importance. Others (e.g. Lee & Davis, 1979; Snell, 1980; Snell & Duff, 
1982) cast doubt on this conclusion since Chang & Goldberg added glucose to 
the incubation medium. The rate of glycolysis is many times greater in incu­
bated rat diaphragms than in resting muscle in vivo and in the perfused hindq-
uarter (Maizels et al., 1977). Therefore the disproportionately large accumu­
lation of lactate and pyruvate might have led to a decrease in amino 
acid-derived carbon reaching alanine. 
The present study is aimed at identification and quantification of inter­
mediates accumulating during branched-chain amino acid oxidation. We also 
wanted to obtain information about the extent to which carbon-skeletons of 
branched-chain amino acids are used for oxidation to deliver energy to skele­
tal muscle, and about their importance as carbon-precursors for glutamine and 
alanine synthesis. Therefore, we have incubated rat muscle homogenates and 
rat diaphragms with [U-1*C]branched-chain amino acids and 2-oxo acids. After 
the incubations we separated, identified and quantified all products contain­
ing radioactive label. In the studies with diaphragms we also investigated the 
effect of glucose and octanoate and of starvation. 
4.2. MATERIALS AND METHODS 
4.2.1. STUDIES WITH HOMOGENATES 
Incubations 
Male albino Wistar rats starved for 1 day and weighing 180-220 g were 
killed by cervical dislocation. Heart, liver and quadriceps muscle were 
excised and homogenates were prepared as described in section 2.4. Oxidation 
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rates of [l-^C]- and [U-^Cji-methyl-Z-oxopentanoate and [l-^C]- and 
[U-^CJS-methyl-Z-oxobutanoate were subsequently determined with the assay 
described in section 2.5., except that carnitine was omitted in some 
instances. In experiments in which accumulating products were identified the 
specific radioactivity of substrates was 22200 dpm/nmol; in all other cases 
1000 dpm/nmol. Reactions were terminated by the addition of 0.3 ml 3 M per­
chloric acid to the medium (for the analysis of organic acids) or with 0.5 ml 
10% trichloroacetic acid (for the analysis of carnitine esters). The released 
""СОг was trapped and measured as described in section 2.5. To increase the 
amount of oxidation products the incubation volume was enlarged from 0.5 ml to 
2 ml in some instances and the volumes of the additions in the same propor­
tion. 
Analysis of organic acids 
The protein precipitate in the incubation medium was pelleted and washed 
twice with 0.6 M perchloric acid. The combined supernatants were neutralized 
with 5 M КОН. The KClOi, precipitate was washed with water and discarded. The 
neutralized extract was passed through a 1 cm χ 10 cm column of DOWEX 50 W X2 
(H form; 50-100 mesh) to separate anionic and cationic compounds. The anionic 
fraction was eluted with water and separated on a 1 cm χ 50 cm anion exchange 
column, DOWEX 1 X8 (formate form; 100-200 mesh) according to a procedure modi­
fied from Spydevold (1979). Routinely the first 40 ml were eluted with water, 
followed by 50 fractions of 6 ml eluted with a linear 0-3 M ammonium formate 
gradient (pH 2.7) and 80 fractions of 10 ml eluted with 3 M ammonium formate 
(pH 2.7). The elution rate was 0.35 ml/min. The radioactivity was measured in 
0.3 ml aliquots of each fraction. 
The elution volume of a sample of 4-raethyl-2-oxopentanoate from the DOWEX 
1 X8 formate column was 880-1000 ml. The relative elution volume of other com­
pounds is given in Table 4.1. The recovery of radioactivity of samples of 
3-hydroxyisovalerate, 3-hydroxyisobutyrate, 3-hydroxybutyrate, lactate, isobu-
tyrate and isovalerate was 98-100%. The recovery of the branched-chain 2-oxo 
acids was 82±4% (n=4). The recovery of radioactivity of the anionic fractions 
isolated from the various incubation extracts was 90±7% (n=22). Radioactive 
acetoacetate [prepared enzymatically from D(-)-3-hydroxy- [3-1*C]butyrate 
according to Williamson & Mellanby (1970)] was not recovered from the column. 
Since unlabelled acetoacetate (applied in large amounts and determined enzy­
matically) had a relative elution volume of 0.27 (Table 4.1), the small amount 
of radioactive compound apparently decomposed during the procedure. 
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Table 4.1. Relative elution volumes of organic acids from the anion-exchange 
column 
Organic acids were eluted from a 1 cm χ 50 cm column of DOWEX 1 X8 (for­
mate form; 100-200 mesh) as described in section 4.2.1. Acetoacetate was 
detected enzymatically. Radioactive 3-hydroxyisovalerate and 
3-hydroxyisobutyrate were isolated from incubations of heart homogenates 
with [U-1*C]2-oxo acids (section 4.3) by separation on Whatman no.l chro­
matography paper. All other compounds contained a radioactive label and 
were obtained commercially. The elution volume of 4-methyl-2-oxopentanoate 
was 880-1000 ml. 
Organic acid Relative elution volume 
Acetate 
3-Hydroxyisovalerate 
3-Hydroxybutyrate 
3-Hydroxyisobutyrate 
Lactate 
Acetoacetate 
Isobutyrate 
3-Hydroxy-3-raethylglutarate 
Succinate 
Pyruvate 
Isovalerate 
Malate 
Citrate 
3-Methyl-2-oxobutanoate 
2-0xoglutarate 
4-Methyl-2-oxopentanoate 
0.19 
0.23 
0.23 
0.24 
0.24 
0.27 
0.30 
0.34 
0.37 
0.37 
0.40 
0.41 
0.60 
0.67 
0.77 
1.00 
To obtain more definite proof of the identity of the accumulating organic 
acids radioactive eluates were acidified with HCl to pH 1.0, extracted with 
ethylacetate and concentrated in vacuo. The extracts were spotted on Whatman 
no. 1 chromatography paper. The chromatogram was run for 24 hr with n-butanol 
saturated with 1.5 M NHj by the procedure described by Reid Ь Lederer (1951), 
except that the development was descending. This procedure is very suitable to 
separate branched-chain 2-oxo acids from possible products (Table 4.2). Citric 
acid cycle intermediates in extracts, prepared as above, were identified by 
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Table 4.2. R„-values of ammonium salts of organic acids 
The chroraatogram was run for 24 hr on Whatman no.l chromatography paper, 
with n-butanol saturated with 1.5 M NHj as the developing solvent 
Organic acid Rp-value 
Citric acid cycle intermediates 
Lactate 
3-Hydroxyisobutyrate 
3-Hydroxybutyrate 
3-Hydroxyisovalerate 
Isobutyrate 
3-Methyl-2-oxobutanoate 
3-Methylcrotonate 
Isovalerate 
4-Methyl-2-oxopentanoate 
0.00 
0.09 
0.10 
0.10 
0.24 
0.27 
0.32 
0.35 
0.42 
0.51 
spotting on thin-layer cellulose plates coated on plastic. The plates were 
developed with diethylether/formic acid/water (70:18:12, by vol) according to 
Myers Ь Huang (1969). Radioactive products were identified by co-chromatogra-
phy of unlabelled compounds. For detection of organic acids, paperchromato-
grams and cellulose thin-layer plates were sprayed with 0.1% (w/v) 
2,6-dichloorphenol-indophenol (sodium salt) in ethanol. Radioactivity on the 
chromatograms was detected by autoradiography and/or elution into 3 ml of 
0.1 M NaOH and counting with 10 ml Aqualuma-plus scintillation fluid. 
The relative amounts of radioactive 3-hydroxy-branched-chain fatty acid, 
lactate and 3-hydroxybutyrate could be determined in mixtures by enzymatic 
conversion of lactate and 3-hydroxybutyrate to the hydrazones of the derived 
2-oxo acids (Hohorst, 1970; Williamson Ь Mellanby, 1970) followed by rechroma-
tography. The hydrazones did not elute from the D0WEX 1 X8 formate column. 
The relative amounts of radioactive isovalerate, malate, pyruvate and 
succinate in mixtures could be estimated by extraction to ethylacetate, fol­
lowed by paperchromatography and cellulose thin-layer chromatography as 
described above. This estimation is not very accurate because of the low and 
variable recoveries of the latter procedures. 
Small amounts of the [U-ll,C]branched-chain 2-oxo acids decarboxylated 
spontaneously to [U-1*C]branched-chain fatty acids. Therefore, we have always 
corrected in experiments with 2-oxo acids the amounts of branched-chain fatty 
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acids by running blanks in parallel. This may affect the accuracy of the 
measurement of radioactivity present in the branched-chain fatty acids and the 
relative abundance of products. 
Analysis of carnitine esters 
Carnitine esters were obtained from incubations terminated by the addi-
tion of trichloroacetic acid, since perchloric acid impedes the separation of 
carnitine esters. The protein precipitate was pelleted and washed with 5% 
trichloroacetic acid. The combined supernatants were extracted twice with die-
thylether (Solberg & Bremer, 1970) to remove the trichloroacetic acid and most 
of the radioactive organic acids. The water phase was lyophilized. The residue 
was dissolved in methanol/water (1:1, by vol) and the carnitine esters were 
separated by thin-layer chromatography on silicagel. The chromatograms were 
developed with diethylether/formic acid (9:1, by vol) and, after drying, with 
methanol/chloroforra/water/conc. ammonia/formic acid (55:50:10:7.5:2.5, by 
vol). This twofold thin-layer chromatography was adequate to separate the 
carnitine esters from the organic acids (Van Hinsbergh et al., 1978a). Carni-
tine and carnitine esters do not run with the first solvent. With the second 
solvent (hydroxylated)branched-chain acylcarnitines move to positions with 
R_-values between 0.40-0.50; acetylcarnitine and propionylcarnitine have a Rp 
of about 0.25 and 0.35, respectively (Solberg & Bremer, 1970). Leucine and 
valine move just in front of the carnitine esters (Rp about 0.50). Radioac-
tive spots were located by autoradiography, scraped from the plates and eluted 
from the silicagel with 3 ml 0.1 M NaOH and counted. To identify the (hydrox-
ylated)branched-chain acylcarnitines, they were scraped from thin-layer 
plates, eluted and hydrolyzed (pH 13, 110oC, 75 min). The released organic 
acids were subjected to the anion-exchange chromatography procedure described 
above. When the branched-chain acylcarnitines did not separate from their 
hydroxylated derivatives they were quantified together. 
Gaschromatography-mass spectrometry analysis of organic acids 
Some organic acids were identified by gaschromatography-mass spectrometry 
of the trimethylsilyl derivatives according to Bakkeren et ai.(1984), except 
for the use of a 25 m open tubular fused silica column with chemically bonded 
phase Sil 8 CB (Chrompack, Middelburg, The Netherlands). 
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4.2.2. STUDIES WITH HEMIDIAPHRAGMS 
Incubations 
Male albino Wistar rats (initial body weight 110-120 g) were starved for 
1 or 3 days and were killed by cervical dislocation. Hemidiaphragms were iso­
lated and incubated in 2 ml Krebs-Ringer bicarbonate buffer with radioactive 
branched-chain amino acids and 2-oxo acids as described in section 3.2, except 
for the omission of glucose and the simultaneous incubation of both hemidia­
phragms in some instances (see legends to the Tables). When accumulating 
products were to be identified, the specific radioactivity of the branched-
chain amino acids was 11100 dpm/nmol and that of the 2-oxo acids 
22200 dpm/nmol at 0.1 mM concentration and 1360 dpm/nmol at 1.0 mM concentra­
tion. Reactions were terminated with perchloric acid and the released ^COi 
was trapped and measured as described in section 3.2. 
Extraction of hemidiaphragms and separation of organic acids from amino acids 
The hemidiaphragms were subsequently divided into small pieces with scis­
sors and disrupted with a Polytron tissue homogenizer in the ice-cold 0.6 M 
perchloric acid-containing incubation medium. The resulting protein precipi­
tate was pelleted and washed twice with 0.6 M perchloric acid. The combined 
supernatants were neutralized with 5 M КОН. The KClOi, precipitate was washed 
with water and /discarded. To the neutral extract sodium acetate buffer 
(pH 4.8) was added to a final concentration of 0.1 M. The glutamine present in 
the extracts was quantitatively converted to glutamate by an overnight treat­
ment with 0.2 U glutaminase at 20 C. Anionic compounds were subsequently sepa­
rated from cationic compounds on a 1 cm χ 10 cm column of DOWEX 50 W X2 
(H form; 50-100 mesh). The anionic fraction (organic acids) was eluted with 
water and the cationic compounds (amino acids) with 5 M МНэ, with 100% recov­
ery. 
Analysis of organic acids 
The anionic fraction was separated on a 1 cm χ 50 cm anion-exchange col­
umn, DOWEX 1 X8 (formate form; 100-200 mesh) and further analyzed as described 
in the previous section. 
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Analysis of amino acids 
The cationic fraction was evaporated to dryness. The residue was dis­
solved in 0.5 ml 0.01 M HCl containing 1 mg/ml of glutamate, alanine and the 
appropriate branched-chain amino acid. Aliquots of 10 μΐ were spotted on What­
man no.l chromatography paper (strips of 60 cm χ 2 cm). The chromatogram was 
run for 24 hr with phenol-water (8:2, by weight), containing 0.01% EDTA (Cons-
den et al., 1944). The development was descending. This procedure is adequate 
to separate glutamate (Rp = 0.29) and alanine (RF = 0.59) from valine 
(Rp = 0.79), isoleucine (Rp = 0.80) and leucine (Rp = 0.82). The procedure 
does not separate glutamine and alanine and, therefore, glutamine was con­
verted to glutamate (see above). Radioactivity was eluted from 1 cm wide 
pieces with 3 ml 0.1 M NaOH. The radioactivity found in glutamate and alanine 
was corrected for that found in blanks run in parallel. The recovery of total 
radioactivity was about 90% for incubation extracts, blanks and radioactive 
standards. 
4.3. RESULTS 
Preliminary experiments 
Some preliminary experiments were performed with heart homogenates 
incubated with 4-methyl-2-oxo[U-1*C]pentanoate and З-теіЬуІ-г-охоіи-^СІЫгіа-
noate. After the organic acids had been isolated from the incubation medium 
and separated from the cationic compounds, they were concentrated in vacuo and 
separated as their ammonium salts by chromatography on Whatman no.l paper as 
described in section 4.2.1. Autoradiography of the chromatograms revealed 
three main radioactive spots in both cases, which coincided with 
4-methyl-2-oxopentanoate, isovalerate and 3-hydroxyisovalerate or with 
3-methyl-2-oxobutanoate, isobutyrate and 3-hydroxyisobutyrate. Since most of 
the radioactivity was lost during this procedure, further analyses of the 
organic acids were performed with the anion-exchange chromatography procedure. 
The identity of the 3-hydroxy-branched-chain fatty acids was definitively 
established by incubating heart homogenates with unlabelled branched-chain 
2-oxo acids. The organic acids were separated by anion-exchange chromatogra­
phy. Since the 3-hydroxy-branched-chain fatty acids have a similar elution 
volume as lactate (Table 4.1), the fractions containing lactate (determined 
enzymatically) were analyzed by gaschromatography/mass spectrometry of the 
trimethylsilyl derivatives. Apart from lactate and 3-hydroxybutyrate, 
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3-hydroxyisovalerate was found after incubation with 4-methyl-2-oxopentanoate 
and 3-hydroxyisobutyrate after incubation with 3-methyl-2-oxobutanoate. 
Studies with homogenates 
The radioactive products formed from 4-methyl-2-oxo[U-ll'C]pentanoate by 
homogenates from heart and quadriceps muscle were identified as isovalerate, 
3-hydroxyisovalerate, isovalerylcarnitine and 3-hydroxyisovalerylcarnitine 
(Table 4.3). In liver homogenates the degradation appears to be more complete, 
since considerable amounts of radioactivity were recovered in acetyl-carni-
tine, 3-hydroxybutyrate, citrate and 2-oxoglutarate. No detectable amount of 
"OOj was produced in the liver homogenates by spinning of the citric acid 
cycle. 
The products formed from 3-methyl-2-oxobutanoate by homogenates from 
heart and quadriceps muscle were identified as isobutyrate, 3-hydroxyisobuty-
rate, isobutyrylcarnitine and 3-hydroxyisobutyrylcarnitine (Table 4.4). In 
liver homogenates the degradation was again more complete. This was indicated 
by the higher 1*C02 production and by the formation of propionylcarnitine and 
succinate. The second CO2 in the degradation route of valine is lost by con-
version of methylmalonic semialdehyde to propionyl-CoA (Fig.1.1). Therefore 
the higher ratio of the '"COj production from the [U-l*C]2-oxo acid to that 
from the [l-1*C]2-oxo acid (Table 4.4) probably does not reflect production of 
1
*C02 by spinning of the citric acid cycle. 
Oxidation rates in the presence of 2 mM L-carnitine have been given in 
Table 3.4. L-carnitine stimulated the 1*C02 production from 4-methyl-2-
oxo[U-1*C]pentanoate by heart, quadriceps muscle and liver homogenates with 
69117 (n=13), 126±31 (n=5) and 32 (n=2) %, respectively. Comparable effects of 
carnitine were found previously with mitochondria (Van Hinsbergh et al., 
1978a, 1980; Veerkamp et al., 1980). For 3-methyl-2-oxo[U-I*C]butanoate the 
stimulation by carnitine was smaller or absent [4±7 (n=7), 24±15 (n=9) and 8 
(n=2) % for heart, quadriceps muscle and liver, respectively]. With mitochond-
ria 2 mM carnitine had a comparable effect on the oxidation of 4-methyl-2-oxo-
pentanoate and 3-methyl-2-oxobutanoate (Van Hinsbergh et al., 1980). The pres-
ence of endogenous carnitine in the homogenates and the lower apparent concen-
tration of L-carnitine leading to half-raaximal activation of the oxidation of 
3-methyl-2-oxobutanoate than of 4-methyl-2-oxopentanoate (Van Hinsbergh et 
al., 1980) may play a role in this discrepancy. Apart from affecting the oxi-
dation rates, L-carnitine stimulated the formation of acylcarnitines (Tables 
4.3 and 4.4). 
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Table 4.3. Incorporation of radioactivity passing the oxidative decarboxyla­
tion step into metabolites by rat tissue homogenates incubated 
with 4-methyl-2-oxo[U-l',C]pentanoate 
Homogenates were incubated with 0.1 mM 4-methyl-2-oxo[U-1*C]pentanoate 
with and without 2 mM L-carnitine. Radioactivity accumulating in individ­
ual metabolites was determined as described in section 4.2.1. The total 
amount of radioactivity passing the oxidative decarboxylation step in the 
incubation system was six times the 1*C0j production (see Table 3.5). Val­
ues are given as means ± SD for three experiments or as individual obser­
vations and represent relative amounts of radioactivity (in % of total). 
Heart 
carnitine + 
Quadriceps muscle Liver 
- carnitine + carnitine + 
CO2 16.7 16.7 
Isovalerate 18.2±5.8 9.817.9 
3-Hydroxyisovalerate 61.3±2.3 24.7+1.0 
3-Hydroxybutyrate 
Isovalerylcarnitine 
3-Hydroxyisovaleryl-
carnitine 
Acetylcarnitine 
Citrate 
2-0xoglutarate 
Recovery 
Total dpm χ 10 -4 
101 
29±2 
93 
51+2 
16.7 
20.7 
14.2 
0.0 
16.7 
16.4 
5.1 
0.0 
20.4+0.9 44.3±4.5 
0.0 
0.0 
0.0 
73 
5.5 
0.0 
0.0 
0.0 
83 
13 
16.7 16.7 
2.0 0.4 
17.1 10.7 
1.6 1.0 
6.8 8.7 
2 . 6 
2 .7 
10.7 
60 
31 
6 .6 
10.5 
7.9 
63 
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Incomplete recovery of carnitine esters probably explains the 
occasionally low total recoveries (Tables 4.3 and 4.4). However, the applied 
procedure was adequate for the identification of the accumulating carnitine 
esters, which was the primary object in the homogenate studies. 
Studies with bemidiaphragms 
In rat bemidiaphragms the largest part of the 4-methyl-2-oxopentanoate 
which is subjected to oxidative decarboxylation was further oxidized to CO2 
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Table 4.4. Incorporation of radioactivity passing the oxidative decarboxyla­
tion step into metabolites by rat tissue homogenates incubated 
with 3-methyl-2-oxolU-1*C]butanoate 
Homogenates were incubated with 0.1 raM 3-methyl-2-oxo[U-l',C]butanoate with 
and without 2 mM L-carnitine. The radioactivity accumulating in individual 
metabolites was determined as described in section 4.2.1. The total amount 
of radioactivity passing the oxidative decarboxylation step was calculated 
from the l*C02 production and the ratios of the "COi production from the 
[и-^Сіг-охо acid to that from the [l-^Cja-oxo acid (Table 3.5). Values 
are given as means ± SD for three experiments or as individual observa­
tions and represent relative amounts of radioactivity (in X of total). 
COi 
Isobutyrate 
3-Hydroxyisobutyrate 
Isobutyry1earn it ine 
3-Hydroxyisobutyry1-
carnitine 
Propionylcarnitine 
Succinate 
Recovery 
Total dpm χ Ю - 4 
Heart 
- carnitine + 
20.0 
9.7±0.2 
21.5±3.3 
2.7±1.0 
5.0±0.5 
0.0 
0.0 
59 
74+2 
20.0 
10.5+5. 
8.6±1. 
37.4±2. 
11.2+1. 
0.0 
0.0 
88 
84±1 
4 
8 
8 
4 
Quadriceps muscle 
- carnitine + 
20.0 
8.6 
11.1 
3.5±0.6 
8.5±2.1 
0.0 
0.0 
52 
28 
20.0 
3.6 
6.0 
16.6±l.li 
• 
19.7±0.5J 
0.0 
0.0 
66 
31 
Liver 
- carni 
34.0 
0.0 
14.1 
0.5 
3.1 
24.0 
76 
41 
tine + 
34.0 
0.0 
17.6 
1.9 
17.7 
8.8 
80 
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(Table 4.5). Some radioactivity accumulated in 3-hydroxyisovalerate, 3-hy-
droxybutyrate and citrate. With 3-methyl-2-oxobutanoate as substrate equal 
amounts of radioactive label were recovered in CO2 and 3-hydroxyisobutyrate. A 
smaller amount of radioactivity was present in isobutyrate. With neither of 
the 2-oxo acids was any radioactivity recovered in lactate, pyruvate, alanine, 
glutamate or glutamine. 
Octanoate increased the 1*C02 production from 4-methyl-2-oxo[U-1''C]penta-
noate by 71±4% (n=3) and from 3-methyl-2-oxo[U-1*C]butanoate by 144±9% (n=3)) 
but had only small effects on the product distribution (Table 4.5). Octanoate 
increased the production of isobutyrate and 3-hydroxyisobutyrate about three 
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Table 4.5. Incorporation of radioactivity passing the oxidative decarboxyla­
tion step into metabolites by hemidiaphragms incubated with 
[U-1''C]branched-chain Z-oxo acids 
Hemidiaphragms from 1-day-starved rats were incubated for 90 min in Krebs-
Ringer bicarbonate buffer, containing 4 mM glucose and 0.1 mM 
[U-1*C]branched-chain 2-oxo acid. The effect of octanoate was assayed in 
parallel incubations of hemidiaphragms obtained from the same rat. Ratios 
of 1*C0i production from the IU-1*C]2-oxo acid to that from the 
[l-1*C]2-oxo acid were measured in separate experiments and are given as 
the relative '"СОг production. Total amount of radioactivity passing the 
oxidative decarboxylation step was calculated from these ratios and the 
measured ''СОг production. Radioactivity in metabolites was determined as 
described in section 4.2.2. Values are given as means ± SD for the number 
of experiments in parentheses and represent relative amounts of radioac­
tivity (in X of total). 
4-Methyl-2-oxopentanoate 
Control + 1 mM Octanoate 
C0 2 
3-Hydroxyisovalerate 
3-Hydroxybutyrate 
Citrate 
70 ± 16 (4) 
6.4 ± 2.0 (3) 
3.7 ± 1.2 (3) 
9.4 ± 4.4 (3) 
57 ± 13 (4) 
3.5 ± 0.9 (3) 
2.0 ± 0.6 (3) 
8.0 ± 5.4 (3) 
Recovery 
Total dpm xlO -4 
90 
88 ± 6 (3) 
71 
155 ± 13 (3) 
3-Methyl-2-oxobutanoate 
Control + 1 mM Octanoate 
C02 
Isobutyrate 
3-Hydroxyisobutyrate 
42 ± 6 (4) 
4.0 ± 3.5 (3) 
39.6 ± 1.2 (3) 
31 ± 4 (4) 
3.4 + 1.4 (3) 
39.7 ± 6.0 (3) 
Recovery 
Total dpm χ IO" 67 
86 
± 17 245 
74 
± 81 (3) 
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times, in agreement with the results of Spydevold (1979). The interaction of 
octanoate with the oxidation of branched-chain 2-oxo acids is studied and dis­
cussed in detail in chapter 7. 
Chang Ь Goldberg (1978b) found considerable amounts of radioactive label 
in glutamine and glutamate after incubation of diaphragms with [U-^CIvaline. 
The absence of radioactivity in these compounds when branched-chain 2-oxo 
acids were used as substrate (Table 4.5) clearly illustrates the significance 
of the branched-chain amino acid aminotransferase reaction for the synthesis 
of glutamine and alanine in muscle. Therefore, we have also incubated dia­
phragms with leucine and valine (Table 4.6), omitting glucose from the medium. 
About 20% of the transaminated leucine accumulated as 4-methyl-2-oxopentaiio-
ate. About 50% of the radioactivity of the decarboxylated 4-methyl-2-oxopen-
tanoate was recovered in CO2 and about 25% in glutamine and glutamate. Smaller 
amounts of radioactivity were found in 3-hydroxyisovalerate, 3-hydroxybuty-
rate, citrate and 2-oxoglutarate. With the anion-exchange procedure a small 
peak was found with a relative elution volume of about 0.40. Due to its low 
radioactivity it could not be identified, but according to its elution volume 
(Table 4.2) it probably consists of isovalerate and/or malate. 
The degradation of valine was severely limited. About 45% of the 
transaminated valine accumulated as 3-methyl-2-oxobutanoate. About 40% of the 
radioactivity of the decarboxylated 3-methyl-2-oxobutanoate was recovered in 
CO2 and only about 5% in glutamine and glutamate (Table 4.6). Furthermore, 
about 55% of the radioactivity of the decarboxylated 3-methyl-2-oxobutanoate 
accumulated as isobutyrate and 3-hydroxyisobutyrate (Table 4.6). Since the 
oxidative decarboxylation reaction causes a decrease of the specific radioac­
tivity by 20%, this represents about 70% of the carbon-chains produced by oxi­
dative decarboxylation. Together, these data mean that only 16% of the transa­
minated valine molecules reach the citric acid cycle. No radioactivity was 
found in lactate, pyruvate and alanine. 
Since the alanine synthesis in incubated rat diaphragms increased pro­
gressively during starvation (Snell & Duff, 1979), we also performed some 
experiments with hemidiaphragms from 3-day-starved rats (Table 4.7). In 
incubations with 1 mM 3-methyl-2-oxobutanoate more than 85% of the carbon-
chains produced by oxidative decarboxylation accumulated as isobutyrate and 
3-hydroxyisobutyrate. Glucose did not markedly affect the product distribution 
and the oxidative decarboxylation rates [113±11 (n=6) in the presence and 
81±34 (n=7) imol/min per g in the absence of glucose] . With valine longer 
starvation hardly changed the product distribution (compare Tables 4.6 and 
4.7). 
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Table 4.6. Incorporation of radioactivity passing the oxidative decarboxyla­
tion step into metabolites by rat diaphragms incubated with 
[U-lhC]branched-chain amino acids 
Both hemidiaphragms isolated from a 1-day-starved rat were incubated 
together for 90 min in Krebs-Ringer bicarbonate buffer. The concentration 
of [U-1*C]leucine or -valine was 0.5 mM. Radioactivity in metabolites was 
determined as described in section 4.2.2. Total amount of radioactivity 
passing the oxidative decarboxylation step was obtained by summation of 
radioactivity in individual metabolites. Values are two individual obser­
vations and represent relative amounts of radioactivity (in % of total). 
The radioactivity in the 2-oxo acid analogues of leucine and valine 
4 
amounted to 44/28 and 39/22 dpm χ 10 , respectively. 
Leucine Valine 
CO2 56.7/50.3 
Isovalerate and/or malate 2.1/ 1.8 
3-Hydroxyisovalerate 5.4/ 7.8 
3-Hydroxybutyrate 2.1/ 2.7 
Citrate 6.5/11.7 
2-0xoglutarate 2.3/ 2.3 
Glutamine and glutamate 24.4/23.5 
C0 2 41.5/37.5 
Isobutyrate 20.5/29.8 
3-Hydroxyisobutyrate 33.9/27.2 
Glutamine and glutamate 4.0/ 5.5 
Total dpm χ IO" 160/111 43/29 
In one experiment with [U-I*C]isoleucine (conditions as specified for 
valine in the legend of Table 4.7) 25% of the transaminated isoleucine accumu­
lated as the 2-oxo acid. Of the radioactivity, which had passed the oxidative 
decarboxylation reaction 63% was recovered in CO2, 23% in glutamine and gluta­
mate and 13% in products which were assumed to be 2-raethylbutanoate and 3-hy-
droxy-2-methylbutanoate based on the resemblance of the chromatograms of the 
products from leucine and isoleucine. With the diaphragms from 3-day-starved 
rats again no radioactivity was incorporated in lactate, pyruvate and alanine. 
Absence of radioactive label in lactate, pyruvate and alanine 
The absence of radioactivity in these compounds can be illustrated by 
combining the data from the diaphragm studies. After treatment of the 3-hy-
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Table 4.7. Incorporation of radioactivity passing the oxidative decarboxyla­
tion step into metabolites by diaphragms from 3-day-starved rats 
incubated with 3-methyl-2-oxo[U-l'tC]butanoate or lU-lkC)valine 
Hemidiaphragms from 3-day-starved rats were incubated for 90 min in Krebs-
Ringer bicarbonate buffer with 1 mM 3-methyl-2-oxo[U-1,,C]butanoate. The 
effect of 4 mM glucose was assayed in parallel incubations of hemidia­
phragms obtained from the same rat. Further details on the incubation with 
the 2-oxo acid are given in the legend of Table 4.5. Details of the incu­
bation with valine are given in Table 4.6, except that the rats were 
starved for 3 days. With [U-1*C]valine the radioactivity recovered in 
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3-methyl-2-oxobutanoate amounted to 24 and 31 dpra χ 10 in the 2 
experiments. 
3-Methyl-2-oxobutanoate Valine 
glucose + glucose - glucose 
COi 31 ± 4 (7) 31 ±7 (6) 51.9/43.0 
Isobutyrate 9.5 ± 0.6 (3) 9.2 ± 1.4 (3) 9.0/18.6 
3-Hydroxyisobutyrate 59.7 ± 3.3 (3) 63.4 ± 5.1 (3) 32.3/34.0 
Glutamine and glutamate 1.6 ± 0.2 (3) 1.5 ± 0.2 (3) 6.1/ 4.3 
Recovery 102 105 
Total dpm χ IO"4 126 ± 10 144 + 23 77/51 
droxyisovalerate and 3-hydroxyisobutyrate peaks with lactate dehydrogenase and 
rechromatography, we recovered 99±2% (n=12) of the radioactivity in the origi­
nal peaks. The amount of radioactive alanine eluted from the chromatograms 
and corrected for a blank run in parallel was 4±49 dpm (n=14). The radioactiv­
ity in the pyruvate fractions obtained from incubations with valine and 
3-methyl-2-oxobutanoate did not exceed that of the base-values. 
The absence of detectable amounts of radioactivity in lactate and pyru­
vate contrasts with data obtained by Chang & Goldberg (1978b). After incuba­
tion of rat diaphragms with [U-1',C]valine in the presence of glucose they 
found that the amount of radioactive label in lactate and pyruvate was about 
half of that in glutamine and glutamate. However, in our hands the high-volt­
age electrophoresis procedure used by these investigators (pyridine/acetic 
acid/water, 100:3:879, by vol, pH 6.4) to separate lactate and pyruvate from 
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other metabolites was unsatisfactory. It poorly separated lactate from pyru-
vate and citrate, 3-hydroxyisobutyrate moved together with lactate, while 
3-inethyl-2-oxobutanoate moved between lactate and pyruvate and overlapped 
both. Pyruvate was not separated from succinate and 2-oxoglutarate. There-
fore, the conclusion of Chang & Goldberg (1978b) that radioactivity is present 
in lactate and pyruvate is at least open to discussion. 
4.4. DISCUSSION 
The product distributions observed after incubation of muscle homogenates 
with 4-methyl-2-oxopentanoate and 3-methyl-2-oxobutanoate (Tables 4.3 and 4.4) 
indicate that the enzymes 3-methylcrotonyl-CoA carboxylase and 3-hydroxyisobu-
tyric acid dehydrogenase are inactive during incubation. Quattrochi et si. 
(1982) found also only CO2 generation from the C-l position of leucine with 
rat heart mitochondria. These findings contrast with the enzymatically estab-
lished increase of the production of acetoacetate during incubation of rat 
muscle mitochondria with leucine or 4-methyl-2-oxopentanoate (Sans et al., 
1981). The accumulation of (3-hydroxy)branched-chain fatty acids during the 
incubations with liver homogenates also points to low activities of the 
enzymes mentioned above. This may be the reason for the lower rate of 
ketogenesis from 4-methyl-2-oxopentanoate in liver homogenates and mitochond-
ria than in hepatocytes (Krebs & Lund, 1977) In hepatocytes 4-methyl-2-oxopen-
tanoate is metabolized almost exclusively to acetoacetate, while part of the 
metabolized 3-methyl-2-oxobutanoate may accumulate as 3-hydroxyisobutyrate 
(Corkey et al., 1982). 
The chromatograms of the anionic compounds isolated from our diaphragm 
incubations are similar to those obtained from perfusates of rat hindquarters 
(Spydevold, 1979; Spydevold & Hokland, 1983). We agree with Spydevold (1979) 
that the first peak in the chromatogram of the experiment with valine is 3-hy-
droxyisobutyrate. Spydevold identified the second peak as lactate without 
giving reference to the basis of the identification. In the present study it 
is, however, isobutyrate. The peak in the chromatogram from the experiment 
with leucine, which was identified as radioactive lactate by Spydevold & Hok-
land (1983), contained only unlabelled lactate in our experiments (determined 
enzymatically). The radioactive label was present in 3-hydroxyisovalerate and 
3-hydroxybutyrate. We agree with Spydevold & Hokland that the third peak is 
isovalerate, although it may contain some malate in our experiments. 
Small differences between the metabolism of rat diaphragms and perfused 
hindquarters cannot be excluded. However, it seems unlikely that the diaphragm 
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would not produce any radioactive lactate from branched-chain amino acids, 
while perfused hindquarter produces amounts exceding the radioactivity in the 
accumulating branched-chain 2-oxo acids (Spydevold & Hokland, 1983). Analysis 
of the kinetic data does not sustain the presence of large amounts of radioac­
tive lactate. The oxidative decarboxylation rate of 0.1 mM valine was 
150 nmol/h per hindquarter (Spydevold, 1979). The 3-hydroxyisobutyrate release 
to the perfusate amounted to 120 nmol/h and the lactate release to 78 nmol/h, 
when calculated on the basis of the specific radioactivity of the used valine. 
Neglecting the already existing surplus of released radioactive carbon-chains, 
these results mean at least that all radioactivity entering the citric acid 
cycle must be incorporated into and released as lactate, without loss of label 
to citric acid cycle intermediates, to CO2 released by spinning of the citric 
acid cycle, to glutamine and glutamate, to accumulating and oxidized pyruvate 
and to alanine. Moreover, combining the oxidative decarboxylation rates given 
by Spydevold & Hokland (1981) with the release data from Spydevold & Hokland 
(1983), we calculate that 64% of the radioactivity entering the citric acid 
cycle from leucine is incorporated into and released as lactate. These 
reflections raise considerable doubt about the correctness of the lactate 
identification by Spydevold (1979) and Spydevold & Hokland (1983). In the pre­
vious section we also disputed the finding of radioactive lactate and pyruvate 
by Chang & Goldberg (1978b). 
Pathways for the production of pyruvate from citric acid cycle intermedi­
ates in muscle can involve the decarboxylation of malate by NAD - or NADP -
dependent malate dehydrogenase (decarboxylating), or the conversion of oxal-
oacetate to phosphoenolpyruvate by phosphoenolpyruvate carboxykinase followed 
by pyruvate kinase action (Snell, 1980). The absence of radioactivity in lac­
tate, pyruvate and alanine in our experiments indicates that there is no car­
bon-flux from the citric acid cycle to pyruvate in diaphragms in vitro. 
Therefore, succinyl-CoA derived from valine and isoleucine is not oxidized and 
does not deliver carbon-skeletons for the synthesis of alanine. Its primary 
destination appears to be the synthesis of glutamine. 
'''C-Labelled alanine, glutamine, glutamate, asparagine, aspartate and 
branched-chain amino acids are the only amino acids, from which "ΌΟι can be 
produced by rat muscle in vitro (Goldberg & Odessey, 1972; Chang & Goldberg, 
1978a). However, for these amino acids the ^СОг production does not indicate 
net degradation. Alanine and glutamine are netto synthesized (Ruderman & Ber­
ger, 1974; Odessey et al., 1974; Chang & Goldberg, 1978b) and not oxidized. 
Asparagine, aspartate and glutamate enter the citric acid cycle via transami­
nation and deaminatlon reactions without delivering a significant amount of 
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energy to the muscle. As is the case for succinyl-CoA derived from valine and 
isoleucine, their carbon-skeletons will be used for glutamine synthesis. 
Therefore, the branched-chain amino acids appear to be the only amino acids 
which are able to deliver significant amounts of energy to the muscle. All 
three branched-chain amino acids deliver energy via the reduction equivalents 
produced by reactions in the degradative pathways leading to acetyl-CoA, pro-
pionyl-CoA and acetoacetate (Fig. 1.1). Furthermore, leucine and isoleucine 
deliver energy by oxidation of acetyl-CoA in the citric acid cycle. Leucine 
will be most important in this respect, since one molecule of degraded leucine 
delivers three molecules of acetyl-CoA (two via acetoacetate). 
Chang & Goldberg (1978b) calculated from studies with incubated rat dia-
pragms that the newly synthesized amount of glutamine was equivalent to the 
sum of the amounts of valine, isoleucine, asparagine, aspartate and glutamate, 
which were missing when their experimentally determined production rate was 
compared with the values estimated from protein degradation. Hence, it was 
theoretically possible that the missing amino acids were quantitatively con-
verted to citric acid cycle intermediates and subsequently to glutamine. How-
ever, in our experiments (Table 4.6) only one out of six molecules of valine 
delivered its carbon-skeleton to the citric acid cycle. Although isoleucine 
was degraded more completely, only about 60% of the transaminated molecules 
reached the citric acid cycle. In the study of Chang & Goldberg (1978b) the 
five amino acids, therefore, could not have supplied enough carbon-chains for 
glutamine synthesis, so another anaplerotic carbon-flux had to be present. 
Conversion of glucose via citric acid cycle intermediates to glutamine would 
be the alternative. Pathways for the production of citric acid cycle interme-
diates from glucose in muscle can involve carboxylation of pyruvate by pyru-
vate carboxylase (Lee & Davis, 1979; Davis et al., 1980) and reversal of the 
phosphoenolpyruvate carboxykinase reaction (Krebs, 1975; Chang & Goldberg, 
1978b). 
The newly synthesized alanine must then be derived from exogenous glu-
cose, in accord with the original formulation of the glucose-alanine cycle 
(Malette et al., 1969; Felig et al., 1970). Incubations of diaphragms without 
glucose still produce considerable amounts of alanine (Goldstein & Newsholme, 
1976). In that case glycogen may substitute glucose, since even diaphragms 
from 3-day-starved rats have a glycogen content of 5.9 ymol/g (Snell & Duff, 
1979). Only when the anaplerotic carbon-flux from the amino acids exceeds the 
glutamine synthesis, the surplus can be converted to pyruvate and used for 
oxidation or for production of lactate and alanine. Lee & Davis (1979) may 
have created that condition by perfusing rat hindquarters with 2 mM 
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propionate. 
For many investigators (e.g. Lee Ь Davis, 1979; Snell & Duff, 1979, 1982; 
Snell, 1980; Palmer et al., 1982) a major problem in accepting the glucose-a-
lanine cycle is that it does not of itself provide net carbon for the synthe­
sis of new glucose, which is a physiological necessity during periods of star­
vation. However, amino acids derived from muscle protein may still serve as 
substrates for gluconeogenesis without being converted to alanine. Amino 
acids, 2-oxo acids and other accumulating intermediates may be released to the 
circulation and taken up by liver and kidney for gluconeogenesis. Furthermore, 
glutamine which is synthesized from the five anaplerotic amino acids in mus­
cle, may serve as a gluconeogenic precursor in the kidney (Owen et al., 1969). 
It may also be oxidized to CO2 and converted to lactate and alanine in gut and 
kidney (Felig, 1981). 
The present study indicates that the contribution of branched-chain amino 
acids to the energy supply of muscle and to muscle glutamine synthesis is 
partly limited by the release of branched-chain fatty acids and 3-hydroxy-
fatty acids (especially that of valine). However, the activity of the 
branched-chain 2-oxo acid dehydrogenase complex is the main factor determining 
the significance of branched-chain amino acids in these processes. This 
enzyme regulates the irreversible access to the degradative pathways. Large 
amounts of branched-chain 2-oxo acids are released by rat muscle both in vitro 
(Tables 4.6 and 4.7; Chang & Goldberg, 1978a; Hutson et al., 1978, 1980; Odes-
sey & Goldberg, 1979; Spydevold, 1979; Snell & Duff, 1982; Spydevold & Hok-
land, 1983) and in vivo (Livesey & Lund, 1980). The regulation of the activity 
of the branched-chain 2-oxo acid dehydrogenase complex by the nutritional 
state, metabolites and phosphorylation-dephosphorylation will be studied in 
chapters 5 to 10. 
4.5. SUMMARY 
After incubation of muscle preparations with [U-^CJbranched-chain amino 
acids or 2-oxo acids, radioactive metabolites were separated, identified and 
quantified. 
Homogenates of rat heart and skeletal muscle incubated with 4-methyl-2-
oxopentanoate accumulated isovalerate, 3-hydroxyisovalerate and the 
corresponding carnitine esters. Incubation with 3-methyl-2-oxobutanoate 
resulted in the production of isobutyrate, 3-hydroxyisobutyrate and their car­
nitine esters. Addition of L-carnitine increased the production of the esters. 
The enzymes 3-methylcrotonyl-CoA carboxylase and 3-hydroxyisobutyric acid 
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dehydrogenase apparently are inactive during incubation of muscle homogenates. 
With liver homogenates the degradation of both 2-oxo acids was more complete. 
Rat hemidiaphragms incubated with leucine, valine and isoleucine accumu-
lated the corresponding branched-chain 2-oxo acids, fatty acids and hydroxy-
lated fatty acids. The degradation of valine was markedly limited by the 
release of these metabolites. Considerable amounts (relatively smaller for 
valine) of radioactivity were also recovered in COi and glutamine and gluta-
mate. Incubations with branched-chain 2-oxo acids gave the same radioactive 
products, except for glutamine and glutamate. 
Radioactivity was never found in lactate, pyruvate or alanine. These data 
indicate that the carbon-chains of amino acids entering the citric acid cycle 
in muscle, are not used for oxidation or for alanine synthesis, but are con-
verted exclusively to glutamine. Part of the carbon-chains of the newly syn-
thesized glutamine may also be derived from glucose or glycogen. Only the 
branched-chain amino acids appear to be able to deliver significant amounts of 
energy to muscle, by the energy-producing steps in their degradation routes 
towards the citric acid cycle and by oxidation of acetyl groups derived from 
leucine and isoleucine. 
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CHAPTER 5 
THE EFFECT OF STARVATION ON BRANCHED-CHAIN 2-OXO ACID 
OXIDATION IN RAT MUSCLE* 
5.1. INTRODUCTION 
Oxidative decarboxylation of branched-chain amino acids in muscle is 
reported or assumed to be increased during starvation (Meikle & Klain, 1972; 
Goldberg & Odessey, 1972; Adibì et al., 1974; Hutson et al., 1980; Tischler & 
Goldberg, 1980). There are two sources of branched-chain amino acids in incu-
bated muscles: the external medium and endogenous protein degradation. In 
most of the previous studies the contribution of endogenous protein degrada-
tion was neglected, and therefore quantitive conclusions regarding the extent 
of branched-chain amino acid oxidation would be inaccurate. 
In the present study the effect of starvation on branched-chain amino 
acid oxidation is re-evaluated. The oxidative decarboxylation rates of 
branched-chain 2-oxo acids have been investigated in intact preparations of 
skeletal and heart muscle of fed and starved rats to verify whether the 
increase in 1*C02 production from l*C-labelled branched-chain amino acids rep-
resents a real increase in the oxidative decarboxylation step. Furthermore, 
we have measured the transamination rates of both leucine and 4-methyl-2-oxo-
pentanoate and the incorporation of the 2-oxo acid into protein. 
An impression of the contribution of the amino acids derived from protein 
degradation to the oxidation precursor pool can be obtained in several ways. 
Provided that isotopie equilibrium exists between the branched-chain 2-oxo 
acid pool and the oxidation precursor pool, it would be best to measure spe-
cific radioactivities of intracellular branched-chain 2-oxo acids. However, 
Hutson et аі.(1980) previously argued, that intracellular branched-chain 2-oxo 
acid concentrations are too low to measure specific radioactivities. For this 
Adapted from Wagenmakers & Veerkamp (1984a) 
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reason we have determined the oxidative decarboxylation rates at various con­
centrations and incubation periods, and applied the transaminase inhibitors 
amino-oxyacetate and L-cycloserine to limit the production of branched-chain 
2-oxo acids from amino acids originating from endogenous protein degradation. 
5.2. MATERIALS AND METHODS 
Male albino Wistar rats weighing 110-120g before starvation were used, 
exept for the experiments of Table 5.1, in which the weights varied from 
90-120 g. Hemidiaphragms, soleus muscles and heart slices were obtained and 
handled as described in section 2.3. Oxidative decarboxylation rates of 
branched-chain amino acids and 2-oxo acids and transamination rates of 
branched-chain amino acids were measured as described in section 3.2. When the 
branched-chain 2-oxo acid concentration was decreased to 10 or 20 yM, the 
incubations were terminated after 30 min. The effects of amino-oxyacetate and 
L-cycloserine on transamination and oxidative decarboxylation rates were 
assayed in two parallel incubations of hemidiaphragms and soleus muscles or 
two sets of three heart slices obtained from one rat. 
The production of leucine from 4-methyl-2-oxo-[1-'"OJpentanoate and the 
incorporation of radioactive label into protein were assayed as follows. After 
termination of the incubations and collection of the released 1*C02, the hemi­
diaphragms were divided into small pieces with scissors and disrupted with a 
Polytron tissue homogenizer in the ice-cold 0.6 M perchloric acid containing 
incubation medium and an additional 5 ml of 5% (w/v) trichloroacetic acid. The 
resulting protein precipitate was pelleted and washed with 2 χ 5 ml of ice-
cold 5% trichloroacetic acid. The combined supernatants were neutralized and 
passed over a column (1 cm χ 10 cm) of DOWEX 50 W X2 (H+form; 50-100 mesh). 
4-Methyl-2-oxopentanoate was eluted with water, and leucine with 5 M NHjjboth 
with 100% recovery. Radioactivity was measured in both fractions. The protein 
pellet was washed with 5 ml of ethanol/diethyl ether (1:1, by vol) and dis­
solved in 1 ml of 1 M NaOH (60 min at 90 oC). The dissolved material was 
transferred with 3 ml more of water to scintillation vials. After addition of 
10 ml of Aquasol, radioactivity was measured. Leucine production and incorpo­
ration of label into protein were based on the specific radioactivity of 
4-methyl-2-oxo[l-1''C]pentanoate added to the incubation medium at the start of 
the experiment and expressed as nmol of [1-1*C]leucine produced or incorpo­
rated per g of muscle over the entire incubation period or per min. 
For protein degradation Studies the total amount of acid-soluble tyrosine 
was measured in separate incubations in the presence of 0.1 mM 4-methyl-2-oxo-
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pentanoate. Cycloheximide (0.5 mM) was added to inhibit protein synthesis. 
The incubations were terminated after 90 min by the addition of 0.5 ml of 50% 
trichloroacetic acid. Incubation medium and hemidiaphragms (cut into pieces 
with scissors) were transferred to centrifuge tubes and the tissue was further 
disrupted with a Polytron tissue homogenizer. Protein was pelleted by centri-
fugation, and acid-soluble tyrosine was measured in the supernatant by the 
method of Waalkes & Udenfriend (1957). 
Student's unpaired and paired t-test were used for the statistical analy­
sis of the data. Results are shown as means ± SD, with the numbers of experi­
ments (n) in parentheses. 
5.3. RESULTS 
Oxidative decarboxylation rates of branched-chain amino acids were 
reported to be increased in skeletal and atrial muscle preparations from 
starved rats as compared with those from fed rats (Goldberg & Odessey, 1972; 
Adibi et al., 1974; Hutson et al., 1980; Tischler & Goldberg, 1980).This was 
attributed to an acceleration of the rates of oxidative decarboxylation. To 
verify this assumption, we measured 1*C02 production in hemidiaphragms from 
fed and starved rats, not only with [1-1*C]leucine and -valine, but also with 
their derived 2-oxo acids. When calculated on the basis of the specific radio­
activity in the medium at the start of the incubation, the oxidative decarbox­
ylation rates of leucine and valine (Table 5.1) were increased significantly 
after 1 or more days of starvation. The same holds for the oxidative 
decarboxylation rate of 3-methyl-2-oxobutanoate, whereas that of 4-methyl-2-
oxopentanoate was only increased after 3 and A days of starvation. With the 
latter, a significant decrease was even found with hemidiaphragms from 
l-day-starved rats (Table 5.1). 
The transamination rate of leucine also was increased significantly after 
1 or more days of starvation (Table 5.2). In each nutritional condition 
tested, transamination rates of leucine were higher than its oxidative decar­
boxylation rates (Table 5.1), which means that 4-methyl-2-oxopentanoate 
accumulates. The accumulation was larger during incubations of hemidiaphragms 
from l-day-starved rats than from fed and 3-day-starved rats (6.510.3 versus 
3.4±0.2 and 3.611.1 nmol/min per g respectively; n=4). This correlates with 
the lower oxidative decarboxylation rate of 4-methyl-2-oxopentanoate in 
muscles from the former animals. The reverse reaction, transamination of 
4-methyl-2-oxo[1-''C]pentanoate taken up from the medium, was measured at con­
centrations of 10 and 100 μΜ (Table 5.2). At 100 μΜ concentration, production 
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Table 5.1. Effect of starvation on oxidative decarboxylation rates of 
branched-chain amino acids and Z-oxo acids by rat hemidiaphragms 
Oxidative decarboxylation rates are given as means ± SD for the number of 
experiments in parentheses. Concentrations of branched-chain amino acids 
and 2-oxo acids were 0.5 mM and 0.1 mM, respectively. ND, not determined. 
a
'
b
'
c
 Significantly different from fed animals at P<0.001, <0.01 and < 
0.05, respectively. 
Oxidative decarboxylation rate (nmol/min per g) 
[1-"С]-
substrate Fed 
Starved (days) 
Leucine 9.2 + 1.7 11.1 ± 2.1° 16.0 ± 2.5a 19.9 ± 3.2a 27.2 ± 7.9a 
Valine 
(12) 
Í ± С 
(7) 
2.6 0.4 4.7 ± 1.3b 5.8 ± 1.0a 
(16) 
' ±  
(9) 
f + ] 
(98) 
(4) 
Ì 1 
(4) 
) ± ] 
(11) 
(7) 
ND 
(4) 
15.4 ± 3.0a 
(4) 
4-Methyl-2-oxo- 7.5 ± 1.5 5.7 1.2a 7.0 1.7 12.6 + 2.3a 17.3 ± 4.1a 
pentanoate (31) ) ) (20) (4) 
3-Methyl-2-oxo- 3.2 ± 1.0 4.0 ± 1.3° 7.0 ± 2.0a 8.3 ± 1.9a 12.1 ± 3.4a 
butanoate (19) (90) (4) (11) (4) 
of leucine was proportional to the time of incubation and its rate was equal 
to or higher than the oxidative decarboxylation rate of the 2-oxo acid (Table 
5.1). There was, however, no difference in transamination rates of 
4-methyl-2-oxopentanoate between hemidiaphragms from fed, 1-day-starved and 
3-day-starved rats (Table 5.2). 
Since there are no evident reasons to assume that the supply of non-
radioactive amino acids from protein degradation is negligible, we tried to 
block the production of 2-oxo acids from these amino acids with the transami-
nase inhibitor amino-oxyacetate. At 1 mM, this inhibitor decreased the transa-
mination rates of 0.5 mM leucine to 25±3, 21+2 and 24+2% and the oxidative 
decarboxylation rates to 26±4, 21±3 and 24±2% in hemidiaphragms from fed, 
1-day-starved and 3-day-starved rats respectively (n=4). Raising the amino-
oxyacetate concentration to 2 mM decreased the oxidative decarboxylation rate 
of leucine further, to 16±4% of the control (n=4). Furthermore, 1 mM amino-
oxyacetate decreased the reverse transamination of 4-methyl-2-oxopentano- ate 
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Table 5.2. Transamination rates of leucine and 4-methyl-2-oxopentanoate by 
bemidiaphragms from fed and starved rats 
Transamination rates are given as means ± SD for four or five experiments. 
a b ND, not determined. ' Significantly different from fed animals at 
P<0.001 and < 0.01, respectively. 
Transamination rate (nmol/min per g) 
Starved (days) 
[l-^C] Concentration 
substrate (μΜ) Fed 1 3 
Leucine 500 11.6 ± 1.9 17.6 ± 1.7b 25.7 ± 0.2a 
4-Methyl-2-oxo- 10 3.0±0.3 ND 3.110.5 
pentanoate 
4-Methyl-2-oxo- 100 11.6 ± 1.8 9.9 ± 1.0 11.1 ± 2.4 
pentanoate 
taken up from the medium, to 28±4 and 31±6% at 10 μΜ 2-oxo acid and to 18±5 
and 16±2% at 100 μΜ in hemidiaphragms from fed and 3-day-starved rats respec­
tively (n=4). The production of branched-chain 2-oxo acids from amino acids 
orginating from endogenous protein degradation is probably decreased to about 
the same extent as the transamination of amino acids or 2-oxo acids taken up 
from the medium. Oxidative decarboxylation rates of branched-chain 2-oxo acids 
measured in the presence of amino-oxyacetate, will consequently be a better 
approximation to the real flux in vitro through the branched-chain 2-oxo acid 
dehydrogenase complex. 
Addition of amino-oxyacetate to the incubation medium raised the oxida­
tive decarboxylation rates of branched-chain 2-oxo acids more in hemidia­
phragms from fed than from 3-day-starved rats (Table 5.3). In hemidiaphragms 
from 1-day-starved rats the inhibitor increased the oxidative decarboxylation 
rate of 100 μΜ 4-methyl-2-oxopentanoate to 174±26 and that of 100 μΜ 
3-methyl-2-oxobutanoate to 176±27% of the control (n=9 and 7 respectively). 
The difference in the oxidative decarboxylation rates between muscle prepara­
tions from fed and 3-day-starved rats became much smaller in the presence of 
the transaminase inhibitor. At 100 μΜ 4-methyl-2-oxopentanoate this difference 
became even statistically insignificant, whereas it remained significant at 
the more physiological concentrations of 10 and 20 μΜ. The residual 
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Table 5.3. Oxidative decarboxylation rates of branched-chaln Z-oxo acids by 
hemidiaphragms from fed and starved rats measured in the presence 
and absence of amino-oxyacetate 
Values are given as means ± SD for five to nine experiments. The relative 
activity in the presence of 1 mM amino-oxyacetate (as % of the control, 
means ± SD) is given in parentheses. * · Significantly different from 
d e f 
the control at P<0.001, <0.01 and <0.05,respectively. ' * Significantly 
different from the comparable incubation with fed animals at P<0.001, 
<0.01 and <0.05, respectively. 
Oxidative decarboxylation rate (nmol/min per g) 
[l-l*C]-
substrate 
Fed Starved 3 days 
Cone. Control +Aniino-oxyacetate Control +Amino-oxyacetate 
(VM) 
4-Methyl-2-oxo- 10 
pentanoate 
20 
100 
3-Methyl-2-oxo- 100 
butanoate 
0.33 + 0.06 1.06 ± O.l?11 
(362 ± 79) 
0.96 ± 0.23 2.76 ± 0.19a 
(298 ± 59) 
6.5 ± 1.6 12.0 ± 1.8a 
(190 ± 26) 
4.3 ± 0.7 8.0 ± 0.7 
(189 ± 34) 
a 
0.85 ± 0.17d 1.39 ± 0.24b,f 
(176 ± 10) 
3.91 ± 0.7C 
(164 ± 3) 
13.7 ± l.S1 
(125 ± 18) 
11.1 ± 3.21 
(133 ± 13) 
2.38 ± 0.43d .70b,e 
11.1 ± 2.1d 1 5e 
8.4 ± 2.5e 2b,f 
transaminase activity in the presence of 1 mM amino-oxyacetate may, however, 
produce a relatively larger amount of endogenous 2-oxo acids at the lower 
2-oxo acid concentration in the medium. 
The time course of oxidative decarboxylation of 0.1 mM 4-methyl-2-oxopen-
tanoate in the presence and absence of amino-oxyacetate with hemidiaphragms 
from fed and 3-day-starved rats is shown in Fig. 5.1. Linearity was present 
from zero time to 60 min, but not to the usual assay time of 90 min, in con-
trast with results previously obtained with intact muscle preparations from 
1-day-starved animals (Fig. 3.1). The reason for this discrepancy is probably 
that radioactive substrate becomes limiting earlier owing to the higher oxida-
tive decarboxylation rates rather than lack of isotopie equilibrium. The same 
oxidative decarboxylation rate was measured when the specific radioactivity of 
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Fig. 5.1. Time course of 1''CQ1 production from 0.1 mM 4-methyl-2-oxo-
[1- CJpentanoate by rat diaphragm. Hemidiaphragms were incubated 
with (·) or without (o) 1 mM amino-oxyacetate. Values are 
means ± SD for four hemidiaphragms obtained from different rats on 
the same day. With muscles from fed rats (left panel) values 
obtained in the presence of amino-oxyacetate were significantly 
(P<0.001) higher than those obtained in its absence. With muscles 
from 3-days-starved rats (right panel) no significant difference 
was observed. 
4-methyl-2-oxopentanoate was varied from 500 to 3000 dpm/nmol in each 
nutritional condition. At all incubation times tested, amino-oxyacetate 
increased the oxidative decarboxylation of 4-methyl-2-oxopentanoate to the 
same extent in hemidiaphragms from fed rats, but it had no effect with 
3-day-starved animals (Fig. 5.1). This was also found for incubation times of 
10, 20 and 30 min with 10 μΜ 4-methyl-2-oxopentanoate (results not shown). 
Incorporation of label from 4-methyl-2-oxo[ l-^OJpentanoate into protein 
(Table 5.4) amounted to about 5 and 3% of the production of leucine in muscles 
from fed rats and from 3-day-starved rats, respectively (Table 5.2). Incorpo­
ration was significantly lower in muscles from 3-day-starved than from fed 
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Table 5.4. Incorporation of ^''C-label of 4-methyl-2-oxo[l-l''C]pentanoate into 
proteins of bemidiaphragms from fed and starved rats measured in 
the presence and absence of amino-oxyacetate 
Values are means ± SD for four or five experiments. The relative incorpo­
ration in the presence of 1 mM amino-oxyacetate (% of the control) is 
given in parentheses. 
P<0.01. Significantly different from the comparable incubations with fed 
Significantly different from the control at 
ff
animals at P<0.01. ND, not determined. 
Condition ( 
Fed 
Starved 1 day 
Starved 3 days 
Concentration 
(VM) 
10 
20 
100 
100 
10 
20 
100 
Incubation 
time 
(min) 
30 
30 
90 
90 
30 
30 
90 
Incorporation 
Control 
4.1 
8.7 
44 
82 
2.9 
5.1 
29 
± 
± 
+ 
± 
± 
± 
+ 
1.1 
0.9 
8 
13b 
0.7 
0.9b 
4 b 
+ 
(nmo: 1/8) 
Amino-oxyacetate 
1.7 
(42 
16 
(38 
ND 
(43 
1.2 
12 
(40 
± 0.6a 
± 15) 
ND 
± 3 a 
± 13) 
± ID 
± 0.2a 
ND 
± 4 a 
± 14) 
rats at 2-oxo acid concentrations of 10, 20 and 100 μΜ. In muscles from 
1-day-starved rats the incorporation was, however, larger than in those from 
fed rats at 100 μΜ concentration. At 1 mM, amino-oxyacetate decreased the 
extent of incorporation to about 40% of the control, independently of the 
nutritional state and the 2-oxo acid concentration. The inhibitory effect of 
amino-oxyacetate on the incorporation of label into protein is smaller than on 
the production of leucine, which was 28-31 and 16-18% of the control at 10 μΜ 
and 100 μΜ 4-methyl-2-oxopentanoate, respectively, independently of the nutri­
tional state. 
To interpret the results of this study, it is important to know the 
influence of amino-oxyacetate on the rate of protein degradation during the 
assay for oxidative decarboxylation. For this reason hemidiaphragms from fed 
and from 3-day-starved rats were incubated in the presence of 0.5 mM 
58 
cycloheximide (Fulks et al., 1975). To mimic the assay conditions, 0.1 mM non-
radioactive 4-methyl-2-oxopentanoate was added. After 90 rain incubation total 
acid-soluble tyrosine amounted to 0.61±0.05 and 0.74±0.05 nmol/mg of muscle in 
incubations of hemidiaphragms from fed and 3-day-starved rats respectively 
(n=5). These amounts did not change in the presence of 1 mM amino-oxyacetate 
(97±5 and 103110% of the control; n=5). 
To test whether the results obtained with amino-oxyacetate are unique for 
this compound or are reproducible with other transaminase inhibitors, some of 
the experiments were repeated in the presence and absence of L-cycloserine 
(Tischler et al., 1982). This inhibitor appeared to be less effective than 
amino-oxyacetate. With 10 mM L-cycloserine, transamination rates of 0.5 mM 
leucine were decreased to 47+13 and 39±12% of the control, and oxidative 
decarboxylation rates to 49±16 and 40114%, in hemidiaphragms from fed and 
3-day-starved rats, respectively (n=3). Just like amino-oxyacetate, L-
cycloserine (10 mM) increased the oxidative decarboxylation rate of 
4-methyl-2-oxopentanoate in hemidiaphragms from fed rats (123110% of the con-
trol; n=5) and not in those from 3-day-starved rats (10014%; n=5). 
Oxidative decarboxylation rates were also measured with 0.1 mM 
4-methyl-2-oxopentanoate in the absence and presence of 1 mM amino-oxyacetate 
in rat soleus muscles and in heart slices. In both preparations starvation 
increased the oxidative decarboxylation rates of the 2-oxo acid (Table 5.5). 
The differential effect of amino-oxyacetate in the two nutritional conditions 
was comparable with that in diaphragm (Table 5.3). 
5.4. DISCUSSION 
An increase with starvation has been reported for oxidative decarboxyla-
tion rates of all three branched-chain amino acids in rat quarter-diaphragms 
(Goldberg & Odessey, 1972) and for leucine in rat hemiatria (Tischler & Gold-
berg, 1980) and in slices of rat gastrocnemius muscle (Adibì et al., 1974). In 
these studies the effect of non-radioactive amino acids originating from pro-
tein degradation was neglected, and the specific radioactivity of the oxida-
tion precursor pool was assumed to be approximately equal to the specific 
radioactivity of the medium. A starvation-induced increase in the "ΌΟι pro­
duction from 1*C-labelled leucine was also found in the rat in vivo (Meikle & 
Klain, 1972), and in the oxidative decarboxylation rate of leucine in perfused 
rat hindquarters, when it was based on the specific radioactivity of perfusate 
4-methyl-2-oxopentanoate (Hutson et al., 1980). 
When oxidative decarboxylation rates are based on the specific 
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Table 5.5. Oxidative decarboxylation rates of 4-methyl-2-oxopentanoate by 
soleus muscle and heart slices from fed and starved rats measured 
in the presence and absence of amino-oxyacetate 
Oxidative decarboxylation rates are given as means ± SD for four experi­
ments. 4-Methyl-2-oxopentanoate concentration was 0.1 mM. The relative 
activity in the presence of 1 mM amino-oxyacetate (in % of the control) is 
given in parentheses. ND, not determined. 
a b 
' Significantly different from the control at P<0.001 and <0.01 respec­
tively. ' ' Significantly different from the comparable incubations 
with fed animals at P<0.001, <0.01 and <0.05, respectively. 
Oxidative decarboxylation rate (nmol/min per g) 
Soleus muscle Heart slices 
Condition 
Control + Amino-oxyacetate Control + Amino-oxyacetate 
Fed 6.5 ± 0.6 
Starved 1 day 6.0 ± 0.9 
3 days 10.7 ± 0.4' с
12.0 ± 1.0a 
(187 ± 28) 
11.5 ± 1.2 a 
(194 ± 20) 
14.0 ± 0 . 9 b , e 
(131 ± 10) 
3.3 ± 0.5 
ND 
5.4 ± 0 . 8 d 
6.5 ± l . l b 
(196 ± 29) 
ND 
7.2 ± 1.0b 
(133 ± 8) 
radioactivity in the medium, oxidative decarboxylation rates are increased in 
intact muscle preparations with starvation, not only for branched-chain amino 
acids (Table 5.1), but also for branched-chain 2-oxo acids (Tables 5.1, 5.3 
and 5.5). After 1 day of starvation, primarily the transamination of leucine 
to 4-methyl-2-oxopentanoate was increased, since transamination of leucine 
increased more than oxidative decarboxylation (Tables 5.1 and 5.2) and since 
oxidative decarboxylation of 4-methyl-2-oxopentanoate was even decreased 
(Table 5.1). It is not well understood why transamination increased in these 
preparations in one direction (leucine to 4-methyl-2-oxopentanoate) and not in 
the other (Table 5.2). Cellular changes in concentrations and ratios of amino 
group acceptors and donors may play an important role in this phenomenon. The 
other results taken together suggest that starvation increases the degradation 
of branched-chain amino acids in rat hemidiaphragms primarily by an accelera­
tion of the oxidative decarboxylation step. 
60 
The decrease in the production of branched-chain 2-oxo acids from 
non-radioactive amino acids orginating from protein degradation and the inhib-
ition of the reverse transamination of added [l-1''C]branched-chain 2-oxo acids 
towards the corresponding amino acids are probably the main causes for the 
apparent increase in the oxidative decarboxylation of branched-chain 2-oxo 
acids in the presence of the transaminase inhibitors (Tables 5.3 and 5.5). 
Effects of L-cycloserine on protein degradation and synthesis and on the 
transport of leucine into diaphragms were ruled out by Tischler et al. (1982). 
Amino-oxyacetate also had no effect on protein degradation. Other mechanisms 
that may cause an increase are a direct or indirect effect on the branched-
chain 2-oxo acid dehydrogenase activity and effects on the transport into or 
out of the cells or mitochondria of 4-methyl-2-oxopentanoate and/or leucine. 
Aminooxyacetate did not influence the branched-chain 2-oxo acid dehydrogenase 
activity measured in homogenates and mitochondria isolated from muscles of fed 
and starved rats (results not shown; assay as described in section 2.5). This 
seems to argue against an effect on the enzyme activity or on the transport of 
4-methyl-2-oxopentanoate into the mitochondria. In these disrupted cell 
preparations, however, the enzyme complex already has been activated (see 
chapter 8) and the mitochondrial permeability may already have been altered 
during preparation and preincubation. In that case the transaminase inhibitors 
may have no additional effect. The effect of amino-oxyacetate on activity 
state changes of the branched-chain 2-oxo acid dehydrogenase complex in rat 
diaphragms during incubation will be studied in detail in chapter 10. 
Since the apparent increase in the oxidative decarboxylation of branched-
chain 2-oxo acids in the presence of the transaminase inhibitors was consider-
ably larger in muscles from fed than in those from 3-day-starved rats (Tables 
5.3 and 5.5), the proces(ses) responsible for this increase is (are) influ-
enced by the nutritional state. Since there were no differences between mus-
cles from fed and 3-day-starved rats in the total transamination of 
4-methyl-2-oxo[ 1-'""CJpentanoate towards free and incorporated leucine (Tables 
5.2 and 5.4) and in the inhibition of that process by amino-oxyacetate, the 
differential effect of amino-oxyacetate can not be related to these processes. 
Although a differential effect on the branched-chain 2-oxo acid dehydrogenase 
complex or on transport processes cannot be excluded, it seems more plausible 
that the transaminase inhibitors have less effect in muscles of 3-day-starved 
rats because of a smaller dilution of the oxidation precursor pool with 2-oxo 
acids derived from amino acids originating from protein degradation in these 
muscles. In rat heart slices this may relate to the reported decrease in pro-
tein breakdown in atrial muscle preparations (Curfman et al.,1980) and 
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perfused hearts (Crie et al., 1980) from starved rats. In skeletal muscle 
preparations from 80-100 g rats, protein degradation increases, however, with 
starvation (Fulks et al., 1975; Millward et al., 1976; Li & Goldberg, 1976; Li 
et al., 1979; Goldberg et al., 1980; Goodman et al., 1981). In these muscles, 
our results may be explained by a metabolic model containing either two intra­
cellular branched-chain 2-oxo acid or two branched-chain amino acid pools, the 
segregation of which is more complete in muscles from 3-day-starved than from 
fed rats. Branched-chain 2-oxo acids arising from protein degradation may be 
less available to the mitochondria than are branched-chain 2-oxo acids taken 
up from the medium. Metabolic compartmentation was proposed for pyruvate in 
the isolated perfused rat heart (Peuhkurinen et al., 1983). Branched-chain 
amino acids arising from protein degradation may also form a separate pool, 
which is in some way protected against transamination. The finding in the 
present study that amino-oxyacetate inhibits the production of free leucine 
from 4-methyl-2-oxopentanoate more effectively than its incorporation into 
protein (Table 5.4) suggests the existence of different functional leucine 
pools. Other studies on branched-chain amino acid metabolism (Nissen & Hay-
mond, 1981; Schneible et al., 1981) and on amino acid incorporation (Airhart 
et al., 1974; O'Hare et al., 1981; Ranneis et al., 1982; Wheatley, 1982) also 
gave evidence for metabolic compartmentation of leucine and other amino acids. 
Our results with transaminase inhibitors in different conditions may 
imply that accurate oxidative decarboxylation rates can only be based on the 
specific radioactivity of the mitochondrial 2-oxo acid pool. The present study 
indicates that starvation influences oxidation of branched-chain amino acids 
and 2-oxo acids in intact rat skeletal and cardiac muscle preparations consid­
erable less than the data from Table 5.1 and a number of previous studies 
(Goldberg & Odessey, 1972; Adibi et al., 1974; Hutson et al., 1980; Tischler & 
Goldberg, 1980) suggest. This conclusion may explain the discrepancies between 
these studies in vitro and the studies in vivo on leucine clearance in the rat 
(Thomas et al., 1982), dog (Nissen Ь Haymond, 1981) and man (Sherwin, 1978; 
Rennie et al., 1982). Additional information on the effect of starvation on 
branched-chain 2-oxo acid oxidation in rat muscle will be given in chapters 9 
and 10. 
5.5. SUMMARY 
Oxidative decarboxylation rates of branched-chain amino acids in hemidia­
phragm and of branched-chain 2-oxo acids in hemidiaphragm, soleus muscle and 
heart slices of 110-120g rats were increased considerably by 3-4 days of 
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starvation, when they were calculated from the specific radioactivity in the 
medium. When the supply from endogenous protein degradation to the oxidation 
precursor pool was severely limited by transaminase inhibitors, oxidative 
decarboxylation rates of branched-chain 2-oxo acids rose significantly. Since 
this apparent increase was relatively larger in preparations from fed rats 
than from 3-day-starved rats, the differences in oxidation rates with nutri-
tional state became less or even insignificant. For rat heart the smaller 
dilution of the oxidation precursor pool after starvation is in accordance 
with the reported decrease in protein breakdown. Since protein degradation 
increases with starvation in skeletal muscles, we suggest that the amino acid 
pool arising from protein degradation is more segregated from the oxidation 
precursor pool in muscles from starved than from fed rats. We conclude that 
starvation increases branched-chain amino acid and 2-oxo acid oxidation in 
skeletal and cardiac muscle considerably less than has been suggested by pre-
vious studies. 
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CHAPTER 6 
INTERACTION OF VARIOUS METABOLITES AND AGENTS 
WITH BRANCHED-CHAIN 2-OXO ACID OXIDATION IN 
RAT AND HUMAN MUSCLE IN VITRO* 
6.1. INTRODUCTION 
Competition of respiratory fuels for oxidation was first noted by Krebs 
(1935) in a study on glucose and amino acid oxidation in kidney slices. Selec-
tion of respiratory substrates occurs mostly via effects on regulatory enzymes 
located at the entry to oxidative pathways. The branched-chain 2-oxo acid deh-
ydrogenase complex is the regulatory enzyme for oxidation of the branched-
chain amino acids. The regulation of the enzyme is still a subject of investi-
gation. Among others it is regulated by covalent modification with 
inactivation by phosphorylation and activation by dephosphorylation and by 
direct product inhibition of NADH and branched-chain acyl-CoA esters (reviewed 
by Rändle, 1983). 
In rat muscle in vitro oxidation rates of branched-chain amino acids and 
2-oxo acids are affected by hormonal factors (Buse et al., 1973, 1976; Paul & 
Adibì, 1976; Hutson et al., 1980), by metabolite regulation (Odessey & Gold-
berg, 1972; Buse et al., 1972, 1975; Paul & Adibi, 1976; Spydevold, 1979; 
Buffington et al., 1979; Veerkamp & Wagenmakers, 1981; Spydevold & Hokland, 
1983) and by carnitine levels and possibly acyl-carnitine/acyl-CoA ratios 
(Veerkamp et al., 1980; Van Hinsbergh et al., 1980; May et al., 1980; Bieber 
et al., 1982). All these factors may influence the enzyme activity directly or 
indirectly via mutual interactions. 
In this chapter we report oxidative decarboxylation rates of 
Adapted from Wagenmakers & Veerkamp (1984b) 
Abbreviations: KIC, a-ketoisocaproate (4-methyl-2-oxopentanoate) 
KIV, a-ketoisovalerate (3-methyl-2-oxobutanoate) 
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4-methyl-2-oxopentanoate (α-ketoisocaproate, KIC) and 3-methyl-2-oxobutanoate 
(α-ketoisovalerate, KIV) measured in rat hemidiaphragms in the presence and 
absence of other respiratory fuels, intermediates of KIC and KIV degradation, 
and agents which are known to interfere with branched-chain amino acid metabo­
lism. The effect of some of these compounds was also studied in other rat and 
human skeletal muscle and heart muscle preparations. Combination of the 
results with literature data permitted us to formulate possible mechanisms. 
6.2. MATERIALS AND METHODS 
Male albino Wistar rats weighing 90-120 g and starved for 1 day were 
used. Sources of human muscle biopsies have been given in section 2.2. Intact 
muscle preparations were obtained and handled as described in section 2.3. 
Muscle preparations were incubated and oxidation rates were measured as 
described in section 3.2. Specific radioactivities of [l-1''C]substrates in 
dpm/nmol were 750 for KIC; 1500 for KIV; 5000 for pyruvate; 4000 for isovaler-
ate and 2000 for isobutyrate. 
The effects of metabolites, intermediates and agents on oxidation rates 
were assayed in two parallel incubations of hemidiaphragms and soleus muscles 
and in two sets of three heart slices obtained from a single rat or one human 
auricular biopsy and in two sets of three fibers of pectoralis muscle from a 
single human biopsy. Results are given as means ± SD, with the number of 
experiments (n) in parentheses. Student's paired t-test was used for statisti­
cal analysis of the data. 
6.3. RESULTS AND DISCUSSION 
Oxidation rates of 0.1 raM [1-1*C]KIC and -KIV were measured in parallel 
incubations of rat hemidiaphragms with and without metabolites (Table 6.1). 
The presence of glucose had no effect on the oxidation rate of both 2-oxo 
acids. Previously, other investigators reported that glucose did not affect 
(Johnson et al.,1961; Manchester, 1965; Meikle & Klain, 1972; Goodlad & Clark, 
1980) or slightly inhibited (Buse et al., 1972; Odessey & Goldberg, 1972) leu­
cine oxidation by hemi- or quarterdiaphragms. All further experiments were 
done in the presence of 4 mM glucose, since this is the physiological concen­
tration in rat blood. 
The presence of 4 mM DL-carnitine had no effect either. This proves the 
intactness of muscle preparations, since addition of L-carnitine stimulates 
oxidative decarboxylation rates of branched-chain 2-oxo acids in mitochondria 
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and homogenates of rat and human heart and skeletal muscle (Veerkamp et aj., 
1980; Van Hinsbergh et al., 1980). At a higher 2-oxo acid concentration 
(1.0 mM), L-carnitine (2.0 mM) also had no effect on KIC and KIV oxidation 
(89±11 and 101+16%; n=10 and 6, respectively). 
2-0xoglutarate significantly stimulated KIC oxidation and had no effect 
on KIV oxidation. Buse et al. (1975) found a stimulation of the oxidation of 
the three branched-chain amino acids and of KIC in rat hemidiaphragm. As an 
amino-group acceptor, 2-oxoglutarate may accelerate the transaminase reaction 
of branched-chain amino acids and prevent the reverse formation of branched-
chain amino acids from branched-chain 2-oxo acids, thus increasing the intra-
cellular concentration of substrates. Furthermore, higher intracellular 2-oxo 
acid concentrations may increase the proportion of branched-chain 2-oxo acid 
dehydrogenase complex in the active form, since the 2-oxo acids itself are 
inhibitors of the kinase of the enzyme complex (Lau et al., 1982). The larger 
stimulation of KIC than of KIV oxidation is in agreement with such a mecha-
nism, since the K. for the kinase reaction is lower for KIC than for KIV (Lau 
et al., 1982). The divergent stimulation of KIC and KIV oxidation is not com-
patible, on the other hand, with a more direct effect of 2-oxoglutarate on the 
branched-chain 2-oxo acid dehydrogenase complex. 
Pyruvate significantly decreased branched-chain 2-oxo acid oxidation at 
2.0 mM (Table 6.1). A concentration of 5 mM pyruvate was earlier (Buse et al., 
1975) reported to decrease KIC oxidation by 40%. Leucine oxidation in rat dia-
phragm was also not affected by 1.0 mM (Odessey & Goldberg, 1972) and 
decreased by higher concentrations of pyruvate (Buse et al., 1972; Goodlad & 
Clark, 1980). Pyruvate also inhibited KIC and KIV oxidation in the perfused 
rat liver (Patel et al., 1981b), isolated rat liver cells (Williamson et al., 
1979) and perfused rat heart (Buffington et al., 1979; Waymack et al., 1980; 
Sans et al., 1980a). In rat liver mitochondria KIC and KIV appear to be trans-
ported by a system which is similar, if not identical to that of pyruvate 
(Patel et al., 1980; MacKay & Robinson, 1981). Therefore, pyruvate may 
inhibit the oxidation of KIC and KIV by competing for mitochondrial uptake. 
Competitive inhibition at the substrate binding site of the branched-chain 
2-oxo acid dehydrogenase complex is less probable, since pyruvate did not 
inhibit the oxidation of branched-chain 2-oxo acids by the enzyme complex iso-
lated from rat (Danner et al., 1978) and ox liver (Parker & Rändle, 1978a). 
The interaction with pyruvate may have physiological significance in condi-
tions in which considerable amounts of pyruvate are oxidized. 
3-Hydroxybutyrate and acetoacetate were tested together and in the indi-
cated ratio (Table 6.1) to minimize disturbances of the intracellular redox 
67 
Table 6.1. Effect of metabolites on oxidative decarboxylation of branched-
chain 2-oxo acids in rat hemidiaphragm 
Rat hemidiaphragms were incubated in Krebs-Ringer bicarbonate buffer with 
0.1 mM [l-1*C]branched-chain 2-oxo acids in the presence and absence of 
metabolites. The controls always contained 4 mM glucose except for the 
experiments, in which the effect of glucose was tested. Relative oxidation 
rates (in % of the control) are given as means ± SD for the number of 
experiments in parentheses. Control oxidation rates (in nmol/min per g 
diaphragm) were 5.7±1.2 (n=100) for KIC and 4.0±1.3 (n=90) for KIV. 
a
' *
c
 Significantly different from the control at P<0.001, <0.01 and 
<0.05, respectively. 
Addition Concentration Relative oxidation rate (%) 
(mM) KIC KIV 
Glucose 
D,L-Carnitine 
2-0xoglutarate 
Pyruvate 
D,L-3-Hydroxybutyrate/ 
Acetoacetate 
Palmitate-albumin (5:1) 
KIV 
KIC 
4.0 
4.0 
1.0 
1.0 
2.0 
4.0/ 
1.0 
0.12 
1.0 
2.0 
4.0 
1.0 
2.0 
4.0 
101 ± 21 (4) 
94 ± 18 (3) 
131 ± 6 (4)£ 
95 ± 3 (3) 
69 ± 13 (4)c 
67 ± 13 (3)c 
102 ± 8 (3) 
78 ± 8 (4)1 
50 ± 10 (3)c 
34 ± 8 (3)1 
97 ± 13 (3) 
95 ± 16 (4) 
112 ± 11 (3) 
80 ± 14 (3) 
65 ± 12 (3)c 
55 ± 1 (3)1 
102 ± 21 (3) 
95 ± 20 (3) 
67 ± 16 (3) 
43 ± 14 (3)c 
state (Zapalowski et al., 1981; Snell & Duff, 1982). Their inhibition of KIC 
and KIV oxidation may be the result of competition for CoA or NAD . Since 
ketone bodies can enter mitochondria as anions with a carrier similar or iden-
tical to that used by pyruvate (Robinson & Williamson, 1980) they may also 
compete with branched-chain 2-oxo acids for mitochondrial uptake. Previously, 
3-hydroxybutyrate was reported to inhibit (Buse et al. , 1972) and to have no 
effect (Odessey Ь Goldberg, 1972) on branched-chain amino acid oxidation in 
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rat hemidiaphragm. Ketone bodies inhibited branched-chain amino acid oxidation 
in the perfused hindquarter of diabetic rats (Zapalowski et al., 1981) and 
leucine, KIC and KIV oxidation in the perfused rat heart (Buffington et al., 
1979; Sans et al., 1980b). The high levels of ketone bodies present in the 
starved and diabetic condition (Robinson & Williamson, 1980) may inhibit oxi-
dation of branched-chain amino acids and 2-oxo acids in these conditions in 
muscle in vivo. In the perfused rat liver 3-hydroxybutyrate inhibited KIC 
oxidation, but stimulated KIV oxidation by about 100% (Patel et al., 1981b). 
Palmitate bound to albumin in a molar ratio of 5:1 had no effect on 
branched-chain 2-oxo acid oxidation in rat hemidiaphragm (Table 6.1). Palmi-
tate stimulated branched-chain amino acid oxidation in rat hemidiaphragm (Buse 
et al., 1972) and was also reported to have no effect in rat diaphragm (Odes-
sey & Goldberg, 1972) and in perfused rat heart (Buse et al., 1972). Sans et 
al. (1980b) found an inhibition of leucine oxidation in rat heart by palmi-
tate, together with an increase in the KIC release. 
Since the branched-chain 2-oxo acids compete with each other for oxida-
tive decarboxylation by the isolated branched-chain 2-oxo acid dehydrogenase 
complexes, it has been suggested that these 2-oxo acids are decarboxylated by 
a common enzyme complex (Danner et al., 1978; Parker & Rändle, 1978a,b; Pettit 
et al., 1978). The mutual interaction of the metabolism of branched-chain 
2-oxo acids was also demonstrated in the perfused rat hindquarter (Hutson et 
al., 1978) and in the perfused rat heart (Buffington et al., 1979). A 10-fold 
excess of KIC did not, however, inhibit the oxidation of KIV in rat diaphragm 
and a 10-fold excess of KIV only inhibited the oxidation of KIC by 22% (Table 
6.1). At still higher concentrations of the non-radioactive 2-oxo acids compe-
tition for oxidative decarboxylation became more evident, but remained small 
considering the large excess of the 2-oxo acid (20- and even 40-fold). When 
hemidiaphragms are incubated with higher 2-oxo acid concentrations, intracel-
lular 2-oxo acid concentrations may rise and inhibit the branched-chain 2-oxo 
acid dehydrogenase kinase reaction (Lau et al., 1982), thus increasing the 
proportion of enzyme present in the active form (see chapter 10). Furthermore, 
this activation may exceed the competitive inhibition at the level of the 
branched-chain 2-oxo acid dehydrogenase and/or the site of transport. 
The effects of glucose, carnitine and palmitate on KIC oxidation in vari-
ous rat and human muscle preparations are shown in Table 6.2. The omission of 
glucose and the addition of D,L-carnitine had no effect in any of the studied 
systems. Palmitate stimulated KIC oxidation in rat soleus muscle, but had no 
effect in the other systems. 
Isovalerate and 3-methylcrotonate are formed as CoA ester-intermediates 
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Table 6.2. Interaction of glucose, palmitate and carnitine with oxidative 
decarboxylation of KIC in rat and human muscle 
-, omission; +, addition. Palmitate was complexed to albumin in a ratio of 
5:1. Control oxidation rates are given in Table 3.4. ND, not determined. 
Other details are as given in Table 6.1. 
Muscle preparation 
Relative oxidation rate (%) 
4mM Glucose + 120 μΜ Palmitate + 4 mM D,L-Carnitine 
Rat hemidiaphragm 
soleus muscle 
heart slices 
Human pectoralis m. 
fibers 
heart slices 
99 ± 21 (4) 
ND 
108 ± 20 (4) 
ND 
93 ± 9 (4) 
102 ± 8 (3) 
139 ± 12 (4)b 
85 ± 13 (4) 
ND 
98 ± 19 (3) 
94 ± 18 (3) 
94 ± 12 (4) 
125 ± 22 (4) 
92 ± 18 (3) 
101 ± 8 (3) 
Table 6.3. Effect of intermediates on oxidative decarboxylation of branched-
chain 2-oxo acids in rat hemidiaphragm 
Details are as given in Table 6.1. 
Addition Concentration Relative oxidation rate (%) 
(mM) KIC KIV 
Isovalerate 1.0 
3-Methylcrotonate 1.0 
3-Hydroxyisovalerate 1.0 
Isobutyrate 1.0 
Methylacrylate 1.0 
D,L-3-Hydroxy-
isobutyrate 2.0 
97 ± 10 (6) 
81 ± 6 (3) c 
92 ± 9 (3) 
132 ± 17 (4) c 
77 ± 3 (3) c 
70 ± 8 (4)' 
141 ± 22 (4)1-
154 ± 7 (3) b 
95 ± 6 (3) 
108 ± 7 (4) 
102 ± 10 (3) 
72 ± 13 (4)° 
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during KIC degradation (Fig. 1.1). 3-Hydroxyisovalerate accumulates in ketoa-
cidotic patients and rats (Landaas, 1975) and is produced from KIC by a cyto-
solic oxygenase from rat liver (Sabourin Ь Bieber, 1982). Furthermore, isoval-
erate and/or 3-hydroxyisovalerate are released by rat diaphragms and hindquar­
ters incubated or perfused with leucine or KIC (chapter 4; Spydevold & 
Hokland, 1983). These organic acids influence KIC oxidation in rat hemidia-
phragm hardly at all (Table 6.3). Earlier we reported that the ^СОг produc­
tion rates from 0.1 and 1.0 mM [1-1*C] isovalerate are similar to and about 
twice that from 0.1 mM [I-^CIKIC (Table 3.7). The oxidation rate of 0.1 mM 
isovalerate, furthermore, is not influenced by the presence of 1.0 mM KIC 
(86±17% of the control; n=4). The increase of the isovaleryl-CoA concentration 
by the simultaneous oxidation of KIC apparently accelerates the degradation of 
isovaleryl-CoA towards CO2 to such an extent that the effect of dilution of 
the specific radioactivity of this CoA ester is not noticed. Since KIC does 
not inhibit isovalerate oxidation and isovalerate does not inhibit KIC oxida­
tion (Table 6.1), the intramitochondrial production of isovaleryl-CoA will be 
considerably larger in incubations containing both KIC and isovalerate, than 
in those containing only one of the two substrates. It is not probable, how­
ever, that isovaleryl-CoA accumulates to a marked extent in incubations con­
taining both substrates, since this ester inhibits the activity of the 
branched-chain 2-oxo acid dehydrogenase complex (Parker & Rändle, 1978a,b; 
Pettit et al., 1978; Danner et al., 1982). 
Isobutyrate and/or 3-hydroxyisobutyrate accumulate in rat diaphragms and 
hindquarters incubated or perfused with valine or KIV (chapter 4; Spydevold, 
1979). However, the degradation products of valine, isobutyrate and methyla-
crylate did not effect, and 3-hydroxyisobutyrate only slightly inhibited, oxi-
dative decarboxylation of KIV in rat hemidiaphragm (Table 6.3). In rat and 
human heart slices 1.0 mM isobutyrate even slightly increased the oxidative 
decarboxylation rate of 0.1 mM KIV (121±10 and 126±16?i of the control; n=4 and 
3, respectively). A 10-fold excess of KIV reduced the ^СОз production from 
0.1 mM [l-^C] isobutyrate in rat hemidiaphragm only to 46±7% (n=3). The 
increase of the isobutyryl-CoA concentration by the simultaneous oxidation of 
KIV apparently accelerates the degradation of isobutyryl-CoA towards CO2, 
which counteracts the effect of dilution of the specific radioactivity of the 
CoA ester just as found for the oxidation of isovalerate in the presence of 
KIC. The presence of the organic acid intermediates of KIV, besides KIV 
itself, apparently does not give rise to a considerably larger concentration 
of isobutyryl-CoA, since this ester also inhibits the activity of the isolated 
branched-chain 2-oxo acid dehydrogenase complex (Pettit et al., 1978; Danner 
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et al., 1982). 
In this study we also investigated the effects of agents, which are known 
to interfere with branched-chain amino acid metabolism (Table 6.4). Amino-ox-
yacetate limits the transamination of branched-chain amino acids originating 
from protein degradation and the reverse transamination of added 
[l-1*C]branched-chain 2-oxo acids to the corresponding amino acids. Its addi­
tion resulted in considerably higher oxidation rates of KIC and KIV (Table 
6.4). The interaction of amino-oxyacetate with branched-chain amino acid oxi­
dation in muscles from fed and starved rats has been studied in detail in the 
previous chapter. 
The transport of branched-chain 2-oxo acids and pyruvate into rat liver 
mitochondria is inhibited by the monocarboxylate translocater inhibitor 
2-cyanocinnaniate (Patel et al., 1980) and by derivatives of this compound 
(MacKay & Robinson, 1981). The inhibitory effect of 2-cyanocinnamate on the 
metabolic flux through the branched-chain 2-oxo acid dehydrogenase in the iso­
lated perfused rat liver was nearly identical to that seen in liver mitochond­
ria (Patel et al., 1980). In rat hemidiaphragm 2-cyanocinnamate, surprisingly 
stimulated the oxidation of KIC and KIV (Table 6.4). Since the "СОг produc­
tion from 0.1 mM [l-l*C]pyruvate was reduced by 1.0 mM 2-cyanocinnamate to 
57±4% (n=4), the former result apparently was not the consequence of an 
unability of 2-cyanocinnamate to enter the diaphragm. With mitochondria from 
rat quadriceps muscle, 0.1 mM of the inhibitor reduced KIC and KIV oxidation 
to 63±11 and 12±2%, respectively (n=3). The reason for the enhancing effect 
of 2-cyanocinnamate in rat hemidiaphragm is unclear since another transport 
inhibitor, 3-hydroxy-2-cyanocinnamate) reduced both KIC and KIV oxidation 
(Table 6.4). 
2-Chloro-4-methylpentanoate inhibits the branched-chain 2-oxo acid dehyd­
rogenase kinase which is responsible for phosphorylation and inactivation of 
the branched-chain 2-oxo acid dehydrogenase complex (Harris et al., 1982a). In 
rat hemidiaphragm this substance stimulated KIC and KIV oxidation by 27 and 
131%, respectively. The larger stimulation of KIV oxidation may be a conse­
quence of the lower K.-value of KIC than of KIV for the branched-chain 2-oxo 
acid dehydrogenase kinase reaction (Lau et al., 1982). The oxidative decarbox­
ylation rate of 0.5 mM leucine in rat hemidiaphragm in the presence of 0.5 mM 
2-chloro-4-methylpentanoate amounted to 206±14% of the control (n=3). The 
larger stimulation of leucine than of KIC oxidation is in accordance with 
inhibition of the kinase reaction by both KIC and 2-chloro-4-methylpentanoate. 
In the perfused rat heart the 1*C02 production from [1-1*C]leucine was also 
stimulated markedly by 2-chloro-4-methylpentanoate (Harris et al., 1982a). 
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Table 6.4. Effect of several agents on oxidative decarboxylation of branched-
chain 2-oxo acids in rat hemidiaphragm 
Details are as given in Table 6.1. ND, not determined. 
Addition Concentration Relative oxidation rate (%) 
(mM) KIC KIV 
Amino-oxyacetate 
2-Cyanocinnamate 
3-Hydroxy-2-
cyanocinnamate 
D,L-2-chloro-4-
methylpentanoate 
Clofibric acid 
1. 
1. 
0. 
1. 
0 
1 
,0 
.0 
.1 
.0 
.5 
.0 
174 + 26 (9)c 
129 ± 13 (4)h 
ND 
94 ± 1 (3)c 
127 ± 2 (ЗГ 
49 ± 14 (3)C 
176 ± 27 (7) 
122 ± 7 (4)1 
82 ± 10 (3) 
70 ± 6 (3)с 
231 ± 41 (3)1 
97 ± 11 (3) 
a 
Clofibric acid [2-p-(chlorophenoxy)-2-methyl-propionic acid], the free 
acid of the hypolipidemic drug Clofibrate, accumulates in patients and rats 
during drug treatment (Laker & Mayes, 1979). This compound inhibited KIC oxi­
dation by 51% and had no effect on KIV oxidation. In agreement with these 
results 2 mM clofibric acid was earlier found to inhibit the ^СОг production 
from [l-^C] leucine in rat diaphragm (Pardridge et al., 1980; Troke et al., 
1983) and in cultured rat skeletal muscle cells (Pardridge et al., 
1980, 1981), whereas the ^ СС^ production from [ 1- I*C] valine in rat diaphragms 
was not significantly inhibited by this acid (Troke et al., 1983). Clofibrate 
feeding did not affect leucine and branched-chain 2-oxo acid oxidation by hom-
ogenates of rat quadriceps muscle (Glatz et al., 1983), but clofibric acid has 
a direct inhibitory effect on the branched-chain 2-oxo acid dehydrogenase com­
plex purified from bovine liver (Danner et al., 1982). The inhibition of the 
oxidative decarboxylation of KIC in muscle may indirectly play a role in the 
myopathic effects of Clofibrate treatment in patients. 
In the next chapter special attention will be given to the interaction of 
octanoate with branched-chain 2-oxo acid oxidation. The complex metabolic reg­
ulation of the activity of the branched-chain 2-oxo acid dehydrogenase, which 
is not even known yet in detail, and the interference of transport processes 
make it difficult to explain and understand all interactions in studies with 
intact cell systems. In combination with these studies knowledge of regulatory 
mechanisms at the molecular level is essential, to unravel and understand 
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metabolism in vivo. Several of the compounds, which were found to be effec-
tive modulators of branched-chain 2-oxo acid oxidation in the present study, 
will be tested in chapter 10 on their ability to change the proportion of 
active branched-chain 2-oxo acid dehydrogenase complex in diaphragm during 
incubation. 
6.4. SUMMARY 
The interaction of various metabolites and agents with the 1''C0I produc-
tion from 0.1 mM [l-1*C]o-ketoisocaproate (KIC) and -o-ketoisovalerate (K1V) 
was studied in rat and human heart and skeletal muscle preparations. 
Glucose and carnitine had no effect in any of the studied systems; palmi-
tate gave a small increase of KIC oxidation only in soleus muscle. With rat 
hemidiaphragms a considerable decrease was found in the presence of high con-
centrations of a competitive branched-chain 2-oxo acid and of pyruvate, and in 
the presence of ketone bodies. A considerable increase was found in the pres-
ence of the branched-chain 2-oxo acid dehydrogenase kinase inhibitor 
2-chloro-4-methylpentanoate and the transaminase inhibitor amino-oxyacetate. 
2-0xoglutarate increased and clofibric acid decreased only KIC oxidation. Div-
ergent effects were given by intermediates of the degradation route of KIC and 
KIV and by monocarboxylate trans locator inhibitors. 
The observed interactions are discussed and related to regulatory mecha-
nisms, which are known to affect the branched-chain 2-oxo acid dehydrogenase 
complex. 
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CHAPTER 7 
INTERACTION OF OCTANOATE WITH BRANCHED-CHAIN 
2-OXO ACID OXIDATION IN RAT AND HUMAN 
MUSCLE IN VITRO* 
7.1. INTRODUCTION 
In the previous chapter we studied the interaction between various 
metabolites and other agents and the oxidative decarboxylation of 
o-ketoisocaproate (KIC) and a-ketoisovalerate (KIV) in rat and human muscle in 
vitro. Palmitate was the only fatty acid included in that study. Short- and 
medium-chain fatty acids occur in plasma in low concentrations (Idell-Wenger & 
Neely, 1978; Bachmann et al., 1979). Divergent results were reported on their 
effects on branched-chain amino acid oxidation in various muscle systems 
(e.g. Buse et al., 1972, 1975; Odessey & Goldberg, 1972; Buffington et al., 
1979). The remarkable stimulation of branched-chain amino acid oxidation in 
rat skeletal muscle in vitro by high concentrations (0.5-5 mM) of octanoate 
(Buse et al., 1972, 1975; Spydevold, 1979; Goodlad & Clark, 1980; Spydevold & 
Hokland, 1981, 1983) deserves special attention. 
Apart from the influence of acetate, butanoate and hexanoate on oxidative 
decarboxylation of KIC and KIV we, therefore, concentrate in this study on the 
effects of octanoate on various aspects of branched-chain 2-oxo acid metabo-
lism in rat hemidiaphragms. We investigated the effect of octanoate on transa-
mination, on oxidative decarboxylation, on incorporation of leucine, valine, 
KIC and KIV into protein, on oxidation of KIC and KIV beyond oxidative decar-
boxylation and on oxidation of isovalerate and isobutyrate. We studied oxida-
tive decarboxylation of KIC and KIV at various 2-oxo acid concentrations and 
Adapted from Wagenmakers & Veerkamp (1984c) 
Abbreviations: KIC, a-ketoisocaproate (4-methyl-2-oxopentanoate) 
KIV, a-ketoisovalerate (3-methyl-2-oxobutanoate) 
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in hemidiaphragms from rats in various nutritional states. For comparison, we 
investigated the effects of KIC, KIV and isovalerate on octanoate oxidation 
and the effect of octanoate on oxidative decarboxylation of KIC and KIV in 
other rat and human skeletal and heart muscle preparations. 
7.2. MATERIALS AND METHODS 
Male albino Wistar rats weighing 90-120 g were used. Unless otherwise 
stated, the rats were starved for 1 day. Sources of human muscle biopsies have 
been described in section 2.2. Intact preparations of rat and human muscle 
were obtained and handled as described in section 2.3. Muscle preparations 
were incubated and oxidation rates were measured as described in section 3.2. 
Specific radioactivities in dpm/nmol were 750, 250 and 100 for KIC and 
1500, 500 and 100 for KIV at 0.1, 1.0 and 5.0 mM concentrations, respectively; 
4000 for 0.1 mM isovalerate; 2000 for 0.1 mM isobutyrate, and 1600 and 350 for 
octanoate at 0.1 and 1.0 mM concentrations, respectively. Transamination rates 
of branched-chain amino acids were assayed as described in section 3.2. Tran­
samination rates of KIC and KIV towards leucine and valine, respectively, and 
the incorporation of radioactive label into protein were assayed as described 
in section 5.2. 
The effects of fatty acids on oxidation, transamination and incorporation 
rates were assayed in two parallel incubations of hemidiaphragms and soleus 
muscles and in two sets of three heart slices obtained from a single rat or 
one human auricular biopsy and in two sets of three fibers of pectoralis or 
gluteus muscle from a single human biopsy. Results are given as means ± SD, 
with the number of experiments (n) in parentheses. Student's paired and 
unpaired t-test were used for statistical analysis of the data. 
7.3. RESULTS 
The effect of straight-chain fatty acids on KIC and KIV oxidation in rat 
hemidiaphragms depends on the length of the carbon chain (Table 7.1). Acetate 
and butanoate inhibited, whereas hexanoate and octanoate stimulated the '^СОг 
production. In chapter 6 we reported that palmitate had no effect on KIC and 
KIV oxidation in rat hemidiaphragms. Acetate inhibited valine oxidation (Buse 
et al., 1972), but had no effect on leucine oxidation (Odessey & Goldberg, 
1972) in rat diaphragm. In the perfused rat heart it inhibited KIC and KIV 
oxidation (Buffington et al., 1979) and in the perfused rat liver it had no 
effect on KIC oxidation and markedly stimulated KIV oxidation (Patel et al., 
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Table 7.1. Effect of short- and medium-chain fatty acids on oxidative decar-
boxylation of branched-chain 2-oxo acids in rat hemidiaphragm 
As substrate 0.1 mM [l-1',C]branched-chain 2-oxo acid was used. Fatty acids 
were added in 1 mM concentration. Relative oxidation rates (in % of the 
control) are given as means ± SD for the number of experiments in paren-
theses. Control oxidation rates ( in nmol/min per g diaphragm) were 
5.7+1.2 (n=100) for KIC and 4.011.3 (n=90) for KIV. a' b' c Significantly 
different from the control at P<0.001, <0.01 and <0.05, respectively. 
Relative oxidation rate (in %) 
Addition KIC KIV 
Acetate 
Butanoate 
Hexanoate 
Octanoate 
(4)c 
(5)1 
(3)c 
154 ± 21 (16)£ 
72 
81 
161 
± 
+ 
+ 
8 
4 
25 
68 ± 15 (4)c 
91 ± 2 (3)c 
207 ± 30 (3)1 
240 ± 45 (16)е 
Table 7.2. Effect of octanoate on oxidative decarboxylation of branched-chain 
2-oxo acids in rat and human muscle 
Octanoate was added in a concentration of 1.0 mM. Control oxidation rates 
are given in Table 3.4. Other details are given in Table 7.1. ND, not 
determined. 
Relative oxidation rate (in %) 
Muscle preparation KIC KIV 
Rat 
Human 
hemidiaphragm 
soleus muscle 
heart slices 
gluteus muscle fibers 
pectoralis muscle fibers 
heart slices 
154 ± 
117 ± 
96 ± 
57 ± 
26 
38 ± 
21 
19 
11 
18 
22 
(16)a 
(3) 
(3) 
(4) C 
(1) 
(3) c 
240 ± 45 (16)c 
248 ± 59 
135 ± 12 
121 ± 39 
ND 
45 ± 5 
(3)1-
(3) C 
(5) 
(3) b 
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Table 7.3. Effect of octanoate on transamination and oxidative decarboxyla­
tion of branched-chain amino acids and Z-oxo acids in rat hemidia-
phragm 
Values are given as means ± SD for 3-16 experiments. The relative activity 
in the presence of 1 mM octanoate (in % of the control) is given in paren­
theses. ** ' c Significantly different from the control at P<0.001
>
 <0.01 
and <0.05, respectively. 
[l- l*C]-
substrate 
Leucine 
Valine 
KIC 
KIV 
Conen. 
(mM) 
0.1 
0.5 
0.1 
0.5 
0.1 
0.1 
Transamination rate 
Control 
3.4 ± 0.2 
17.1 ± 2.8 
3.2 ± 0.1 
12.6 ± 1.2 
10.0 ± 1.1 
9.4 ± 1.2 
+ Octanoate 
4.2 ± 0.3 
(124±11) 
20.9 ± 3.1 
(122115) 
3.3 ± 0.1 
(101± 3) 
14.3 ± 0.8 
(116±16) 
6.8 ± 0.6e 
(69113) 
6.7 1 1.4b 
(73116) 
Oxidative 
decarboxylation rate 
Control 
1.5 1 0.3 
12.9 1 3.0 
1.3 1 0.4 
6.3 1 0.8 
4.9 1 1.2 
3.1 1 0.9 
+ Octanoate 
2.9 i 0.6a 
(204+28) 
18.8 1 3.2e 
(141121) 
2.2 1 0.4ή 
(177135) 
11.8 1 0.6e 
(188132) 
7.5 i 1.3a 
(154121) 
7.4 i 2.0a 
(240145) 
1981a). Butanoate had no effect on valine oxidation and hexanoate stimulated 
leucine and valine oxidation in rat diaphragm (Buse et al., 1972). 
The effect of octanoate appears to depend on the used muscle preparation 
and the branched-chain 2-oxo acid (Table 7.2). A stimulation of KIC and KIV 
oxidation was found in rat skeletal muscles, an inhibition in human skeletal 
muscles and a divergent effect in rat and human heart slices. A stimulation by 
octanoate of KIC oxidation in rat hemidiaphragm was reported earlier by Buse 
et al. (1975) and of KIV oxidation in perfused rat hindquarter by Spydevold & 
Hokland (1981). Octanoate also stimulated the oxidation of branched-chain 
amino acids in rat hemidiaphragm (Buse et al., 1972, 1975; Goodlad & Clark, 
1980) and the perfused rat hindquarter (Spydevold, 1979; Spydevold & Hokland, 
1981, 1983). However, in the perfused rat heart octanoate inhibited the 
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Table 7.4. Effect of octanoate on incorporation of branched-cbain amino acids 
and Z-oxo acids in proteins of rat hemidiapbragms 
Incorporation rates (in nmol/rain per g muscle) are given as means ± SD for 
3-5 experiments. The relative activity in the presence of 1 mM octanoate 
(in X of the control) is given in parentheses. 
from the control at P<0.05. 
Significantly different 
[l-^C]-
substrate 
Conen. 
(mM) 
Incorporation rate 
Control + Octanoate 
Leucine 
Valine 
KIC 
KIV 
0.1 
0.5 
0.1 
0.5 
0.1 
0.1 
0.67 ± 0.05 
1.27 ± 0.28 
0.42 ± 0.05 
0.71 ± 0.17 
0.91 ± 0.15 
0.58 + 0.08 
0.46 ± 0.04" 
(69± 9) 
0.90 ± 0.12 
(72± 6) 
0.37 ± 0.01 
(87± 9) 
0.61 ± 0.14 
(86±10) 
0.58 ± 0.08a 
(64±10) 
0.44 ± 0.07 
(77± 1) 
a 
oxidation of KIC, KIV and leucine (Buffington et al., 1979; Waymack. et al., 
1980), although Buse et al. (1972) previously found an increase of leucine 
oxidation. 
Octanoate had no significant effect on the transamination rate of leucine 
and valine in rat hemidiaphragms (Table 7.3). It only stimulated the oxidative 
decarboxylation of these amino acids. Octanoate inhibited the reverse transa-
mination of KIC and KIV towards their corresponding amino acids less than that 
it stimulated their oxidative decarboxylation. These results indicate that 
octanoate primarily affects the process of oxidative decarboxylation. 
Label incorporation from [l-^C] leucine, -KIC and -KIV into protein of 
rat hemidiaphragms was significantly reduced in incubations with octanoate 
(Table 7.4). Label incorporation from the 2-oxo acids was inhibited to the 
same extent as their reverse transamination (Table 7.3). The rate of protein 
synthesis was probably not affected, since the incorporation of 0.1 mM 
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Table 7.5. Effect of octanoate on oxidative decarboxylation and further deg­
radation of branched-chain 2-oxo acids in rat quarterdiaphragms 
The 'СОг production was measured from 0.1 mM [1-1*C]· and 
[U-l*C]branched-chain 2-oxo acids in the presence and absence of 1 mM 
octanoate in parallel incubations of quarter-diaphragms and at similar 
specific radioactivities. Relative oxidation rates in the presence of 
octanoate (in % of the control) and ratios of the "ΌΟΐ production from 
the [U-1*C]- to that from the [1-1*C] 2-oxo acid are given as means ± SD 
for 4 experiments. The 1*C0 2 production from the [U-
l
*C]2-oxo acid by deg­
radation beyond oxidative decarboxylation was obtained by diminishing the 
total "COi production from this substrate with 1/5 th (KIV) or 1/6 th 
(KIC) of the 1*С0
г
 production from the [l-1*C]2-oxo acid. 
a
'
 , c
 Significantly different from the control at P<0.01, <0.05 and = 
0.05, respectively. 
KIC KIV 
Relative oxidation rate: 
[І-^Сіг-охо acid 
[и-^Сіг-охо acid 
Ratio [U-^CJ/tl-^C] 
Control 
+ Octanoate 
Relative oxidation rate 
beyond oxidative decarboxylation 
134 ± 22 
111 ± 36 
0.70 ± 0.16 
0.57 ± 0.13 
105 ± 45 
256 + 41е 
188 ± 25s 
0.42 ± 0.06 
0.31 ± 0.04Ь 
123 ± 16 
[U-l*C]tyrosine in the presence of 1.0 mM octanoate was 91±18% of the control 
(n=3). Furthermore, octanoate did not affect protein degradation in rat dia­
phragm (Fulks et al., 1975; Tischler, 1980). The higher oxidative decarboxyla­
tion rate in the presence of octanoate may result in lower intracellular con­
centrations of branched-chain 2-oxo acids (Spydevold, 1979) and thus decrease 
the reverse transamination and incorporation of the 2-oxo acids into protein. 
Furthermore, the proportion of endogenous leucine used for protein synthesis 
probably increases in the presence of octanoate, since the incorporation of 
leucine was inhibited (Table 7.4) while that of tyrosine did not change. 
The effects of octanoate on the degradation of the branched-chain 2-oxo 
acids beyond oxidative decarboxylation were investigated by measuring oxida­
tion rates of [l-^C]- and [U-^CJKIC and -KIV in parallel incubations of 
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Table 7.6. Mutual interaction of branched-chain 2-oxo acids and fatty acids 
in rat hemidiaphragm 
Relative oxidation rates in the presence of the addition (in % of the con­
trol) are given as means ± SD for the number of experiments in parenthe­
ses. The control oxidation rates of 25 and 100 yM octanoate amount to 
2.4±0.3 (4) and 8.9±1.8 (21) nmol/min per g muscle, respectively. The con­
trol oxidation rates of 0.1 mM isovalerate and isobutyrate amount to 
5.2±1.3 (12) and 1.2+0.2 (9) nmol/min per g muscle, respectively. 
[1-г,,С]- Conen. Addition Conen. Relative oxidation 
substrate (μΜ) (mM) rate (in %) 
Isovalerate 
Isovalerate 
Isovalerate 
Isobutyrate 
Octanoate 
Octanoate 
Octanoate 
Octanoate 
Octanoate 
100 
100 
100 
100 
100 
25 
100 
100 
100 
Octanoate 
Octanoate 
Acetate 
Octanoate 
Isovalerate 
Isovalerate 
KIC 
KIV 
KIV 
0.1 
1.0 
1.0 
1.0 
0.1 
1.0 
0.1 
0.1 
1.0 
63 
4 
85 
33 
92 
79 
101 
96 
91 
+ 
± 
+ 
± 
± 
± 
+ 
± 
+ 
15 (3) 
2 (3) 
14 (3) 
4 (3) 
11 (4) 
9 (4) 
13 (4) 
18 (5) 
21 (4) 
quarter-diaphragms in the presence and absence of octanoate (Table 7.5). The 
results reveal that octanoate increases oxidative decarboxylation without a 
concomitant increase in the COj production from the further degradation route. 
The next step beyond oxidative decarboxylation in which CO2 is liberated is 
located in the citric acid cycle in the degradation route of leucine and in 
the conversion of methylmalonic semialdehyde to propionyl-CoA in the degrada­
tion route of valine. The data from Table 7.5 suggest that there is more accu­
mulation of one or more of the intermediates preceding these steps in the 
presence of octanoate than in its absence. This is in accordance with the con­
siderable increase by octanoate of the accumulation of isobutyrate and 
3-hydroxyisobutyrate during incubation of diaphragms with KIV (Table 4.5), of 
3-hydroxyisobutyrate upon perfusion of rat hindquarters with valine (Spyde-
vold, 1979) and of isovalerate and 2-methylbutyrate upon perfusion of rat 
hindquarters with leucine and isoleucine (Spydevold & Hokland, 1983). 
Octanoate dramatically decreased the "'СОг production from 
[l-^CJisovalerate and [l-^CJisobutyrate (Table 7.6). Buse et al. (1972) 
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relative oxidation rateC/o) 
300 -ι 
Fig. 7.1. Effect of 1.0 mM octanoate on oxidation of various concentrations of 
[1-1*C]branched-chain 2-oxo acids by rat hemidiaphragms. Relative 
oxidation rates in the presence of octanoate (in % of the control) 
are given as means ± SD for 3 or more experiments. Control oxidation 
rates are given in Fig. 3.2. 
found a comparable decrease of isobutyrate oxidation by octanoate. The inhib­
ition by octanoate is considerably larger for oxidation of isovalerate than 
for that of isobutyrate , whereas acetate hardly inhibited isovalerate oxida­
tion. There is no mutual inhibition since a high concentration of isovalerate 
and of KIC and KIV hardly affected the oxidation of octanoate (Table 7.6). 
These results probably reflect various degrees of competition for one of the 
first steps of fatty acid oxidation preceding the conversion of the acyl-CoA 
esters in the mitochondria, since different acyl-CoA dehydrogenases oxidize 
octanoyl-CoA, isovaleryl-CoA and isobutyryl-CoA (Ikeda et al., 1983). 
At higher branched-chain 2-oxo acid concentrations the oxidative decar­
boxylation rates of KIC and KIV increase considerably (chapter 3) and the 
stimulatory effect of octanoate becomes smaller or even changes to an inhib­
ition (Fig. 7.1). The same phenomenon was observed by Buse et al. (1972) for 
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Table 7.7. Effect of octanoate on oxidative decarboxylation of branched-chain 
2-oxo acids in hemidiaphragms from fed and starved rats 
As substrate 0.1 mM [l-11'C]branched-chain 2-oxo acid was used. Values are 
means ± SD for the number of experiments in parentheses. Relative oxida-
tion rates in the presence of 1 mM octanoate (in % of the control) are 
a b given in square brackets. * Significantly different from the comparable 
incubation with fed animals at P<0.001 and <0.05, respectively. 
Significantly different from the control (without octanoate) at P<0.001. 
Oxidative decarboxylation rate (nmol/min per g) 
Nutritional 
state 
KIC 
Control + Octanoate 
KIV 
Control + Octanoate 
Fed 7.5+1.5 (31) 8.9±2.3 (6) 
[105+11] 
Starved 1 day 5.7±1.2(100)a 7.5±1.3(16)c 
Starved 3 days 12.6±2.3 (20)a 12.1±2.0 (6)b 
[154±21] 
[102±11] 
3.2±1.0(19) 7.0+1.3 p y 
[272±58] 
4.1±1.3(90)b 7.4+2.0(16)° 
[240+45] 
8.3±1.9(ll)a 8.3±1.4 (5) 
[101+11] 
the oxidation of isoleucine by hemidiaphragms. In the rat hindquarter octa-
noate gave a marked acceleration of the oxidation rate of 5 mM valine (Spyde-
vold, 1979) and of 0.5 mM KIV (Spydevold & Hokland, 1981). The increases 
caused by comparable concentrations of octanoate were considerably larger than 
we observed in hemidiaphragms (Tables 7.1 and 7.3). 
The effect of octanoate also depends on the nutritional state of the 
rats. Starvation as such increased the oxidative decarboxylation rates of KIC 
and KIV (Table 7.7). KIC oxidation was only stimulated by octanoate when the 
hemidiaphragms were obtained from 1-day-starved rats. Buse et al. (1975) found 
a stimulation with muscles from fed animals. This discrepancy is not clear. 
KIV oxidation was stimulated by octanoate in hemidiaphragms from fed and 
1-day-starved rats, but in muscles from 3-day-starved rats octanoate had no 
effect. In the presence of octanoate the variations of the oxidation rates 
with the nutritional state became smaller or even disappeared completely 
(Table 7.7). In chapter 5, we found that the transaminase inhibitor amino-oxy-
acetate considerably increased the oxidation rates of KIC and KIV in 
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hemidiaphragras from fed as well as 1-day-starved rats, but had hardly an 
effect in muscles from 3-day-starved rats. Therefore we concluded that the 
starvation-induced increase of the branched-chain 2-oxo acid oxidation arises 
from a different extent of dilution of the oxidation precursor pool with 2-oxo 
acids, derived from protein degradation, in muscles from fed and 3-day-starved 
rats. Octanoate (1.0 mM) stimulated KIV oxidation in paired incubations of 
hemidiaphragms from 1-day-starved rats, in the presence of 1.0 mM amino-oxy-
acetate, with 175±13% to 11.2±1.1 nmol/min per g diaphragm (n=4). This oxida­
tion rate is significantly higher than that measured in hemidiaphragms from 
1-day-starved rats in the presence of octanoate alone (Table 7.7; P<0.01) and 
than that measured in hemidiaphragms from 3-day-starved rats (Table 7.7; 
P<0.05). 
7.4. DISCUSSION 
The inhibitory effect of acetate and butanoate on branched-chain 2-oxo 
acid oxidation in rat hemidiaphragm (Table 7.1) may be attributed to increases 
in the NADH/NAD ratio and/or in the acetyl-CoA/CoASH ratio. These factors 
are also thought to contribute to the inhibition and inactivation of the pyru­
vate dehydrogenase complex during fatty acid oxidation by muscle (Ashour & 
Hansford, 1983; tfieland, 1983). When acetyl-CoA or other acyl-CoA esters accu­
mulate they may bind a considerable part of the intracellular carnitine and 
give the corresponding carnitine esters. Such a reduction of the free-carni-
tine pool may also inhibit branched-chain 2-oxo acid oxidation (Van Hinsbergh 
et al., 1980; Veerkamp et al., 1980; May et al., 1980; Bieber et al., 1982). 
In the presence of hexanoate and octanoate these inhibitory effects may 
also operate, but other stimulatory effects apparently predominate in that 
case (Table 7.1). E.g. these fatty acids may change the properties of muscle 
membranes and thus the rates of transport of branched-chain 2-oxo acids and 
their degradation products into and out of the muscle cell and its compart­
ments . 
Branched-chain acylcarnitines were found in rat muscle after hindquarter 
perfusion with KIC and KIV (Davis Ь Bremer, 1973; Spydevold et al., 1976) and 
in vivo (Choi et al., 1977, 1979; Kerner & Bieber, 1983). Accumulation of 
branched-chain fatty acids and hydroxylated branched-chain fatty acids has 
been found in skeletal muscle, perfused or incubated in vitro with branched-
chain amino acids and 2-oxo acids (Spydevold, 1979; Spydevold & Hokland, 1983; 
chapter 4). This suggests that the branched-chain acylcarnitines are trans­
ported to the cytosol, where they are de-esterified and released to the medium 
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(Scheme 7.1). The latter process may also occur in vivo, since Bachmann et 
al. (1979) found considerable amounts of isovalerate, 2-methylbutyrate and 
isobutyrate in human plasma. Landaas (1975) found low concentrations of the 
hydroxylated derivatives of these acids in the urine of healthy mean. 
The dramatic increase in the accumulation of the branched-chain fatty 
acids in the medium in the presence of octanoate (Spydevold, 1979; Spydevold & 
Hokland, 1983; chapter 4), suggests that octanoate accelerates in some way the 
mitochondrial export of branched-chain acylcarnitines and their subsequent 
release as free fatty acids to the medium. In that way the mitochondrial con-
tent of branched-chain acyl-CoA and -carnitine esters may be lowered. Oxida-
tive decarboxylation may be accelerated, since these CoA esters are inhibitors 
of the branched-chain 2-oxo acid dehydrogenase complex (Parker & Rändle, 
1978a,b; Pettit et al., 1978; Danner et al., 1982) and since isovaleryl-CoA 
promotes the ATP-dependent inactivation of the complex (Lau et al., 1982). 
The high oxidation rate of octanoate in rat hemidiaphragms (30.2±3.1 
nmol/min per g at 1 mM; n=4) indicates that considerable amounts of octanoyl-
carnitine will be formed in the cytosol. Since carnitine, branched-chain acyl-
carnitines and octanoylcarnitine are competitive co-substrates for the carni-
tine-acylcarnitine translocase (Pande & Parvin, 1980; Idell-Wenger, 1981), 
octanoylcarnitine may be exchanged directly against mitochondrial branched-
chain acylcarnitines and in this way lower intramitochondrial branched-chain 
acyl-CoA concentrations (Scheme 7.1). The same stimulatory mechanism appar-
ently also operates with hexanoate but not or to a lesser degree with acetate 
and butanoate (Table 7.1). Acetylcarnitine, nevertheless, also appeared to be 
a competitive co-substrate for the carnitine-acylcarnitine translocase (Pande 
& Parvin, 1980; Idell-Wenger, 1981). The K. value for carnitine-carnitine 
exchange across the membrane of rat heart mitochondria was, however, much 
lower for octanoylcarnitine than for acetylcarnitine (Idell-Wenger, 1981). 
Octanoate, furthermore, inhibited isovalerate oxidation in rat hemidiaphragm 
almost completely, whereas acetate hardly had any effect (Table 7.6). Cyto-
solic octanoylcarnitine, therefore, may promote the mitochondrial export of 
branched-chain acylcarnitines in muscle more strongly than cytosolic acetyl-
carnitine. Thus the competition for mitochondrial export by acetylcarnitine, 
formed intramitochondrially upon octanoate oxidation, may also be relatively 
small (Scheme 7.1). 
It is questionable whether the stimulatory effects of hexanoate and octa-
noate on branched-chain 2-oxo acid oxidation in rat skeletal muscle in vitro 
have physiological significance in vivo. In plasma these acids will be partly 
bound to albumin and the concentration of the free acids will be in the μΜ 
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Scheme 7.1. Representation of interactions of the metabolism of octanoate and 
branched-chain 2-oxo acids at the carnitine-acylcarnitine tran-
slocase in rat muscle. ВС, branched-chain; OA, 2-oxo acid; FA, 
fatty acid; earn, carnitine; ·, branched-chain 2-oxo acid dehyd­
rogenase; o, carnitine-acylcarnitine translocase;«, branched-
chain 2-oxo acid carrier; D, carnitine acyltransferase. 
range (Spector, 1975 Idell-Wenger & Neely, 1978; Bachmann et al., 1979). Per­
oxisomal oxidation of long-chain fatty acids, on the other hand, occurs in 
muscle (Small et al., 1980; Shumate & Choksi, 1981; Veerkamp et al., 1983). 
As in liver this may result in the production of medium-chain (С6-Св)fatty 
acid intermediates (Lazarow, 1978; Osmundsen et al., 1979), which may be shut­
tled out of peroxisomes as carnitine esters (Bieber et al., 1982). Conditions 
in which fatty acid oxidation in skeletal muscle is high, such as starvation, 
diabetes and exercise, may therefore, accelerate the oxidative decarboxylation 
of branched-chain amino acids and/or result in an increased release of 
(hydroxylated)branched-chain fatty acids into the circulation. An increased in 
vivo CO2 production from infused, injected and ingested leucine was found in 
rats after starvation (Meikle Ь Klain, 1972) and exercise (White & Brooks, 
1981; Lemon et al., 1982) and in man after exercise (Rennie et al., 1981; 
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Wolfe et al. y 1982; Hagg et al., 1982). The origin of the increased leucine 
oxidation in these conditions has, however, not been definitively established. 
Landaas (1975) found a large amount of the hydroxylated branched-chain fatty 
acids in the urine of ketoacidotic rats and patients. An increased ^COj pro­
duction from [l-1''C]branched-chain amino acids and 2-oxo acids was also found 
in skeletal muscle in vitro from diabetic (Buse et al., 1976; Zapalowski et 
al., 1981) and starved rats (chapter 5). However, this increase in vitro may 
be due to dilution phenomena of the oxidation precursor pool (chapter 5). The 
high levels of ketone bodies, which accompany these conditions in vivo (Robin­
son & Williamson, 1980), may also inhibit oxidative decarboxylation of 
branched-chain amino acids and 2-oxo acids in muscle (e.g. Zapalowski et al., 
1981; Table 6.1). 
In rat and human heart muscle and in human skeletal muscle (Table 7.2) 
the inhibitory effects of octanoate apparently compensate or overrule its pos­
sible stimulatory mechanisms. The balance of the various mechanisms may also 
depend on the 2-oxo acid concentration (Fig. 7.1) and the nutritional state 
(Table 7.7). On the other hand the smaller variations of oxidation rates with 
nutritional state in the presence of octanoate may indicate that starvation 
and octanoate increase KIC and KIV oxidation by the same mechanism. Starvation 
reduced the ratio of "СОг released from [U-1*C]valine to that from [1-1',C]-
valine in rat hemidiaphragm (Snell & Duff, 1982), just like octanoate reduced 
the ratio of "CO* released from [U-^CjKIV to that from [l-l*C]KIV (Table 
7.5). However, the experiments in which the effect of octanoate, starvation 
and amino-oxyacetate were tested indicate that the stimulation by octanoate is 
not due to inhibition of transamination (as with amino-oxyacetate) and is not 
or only partly related to the mechanism of stimulation by starvation. 
Conclusions 
The largest part of this study deals with the effects of octanoate on 
various aspects of branched-chain 2-oxo acid metabolism in rat skeletal mus­
cle. The main conclusions are that octanoate primarily affects the process of 
oxidative decarboxylation, has no effect on the CO* production beyond this 
step and considerably increases the release of (hydroxylated) branched-chain 
fatty acids. An exchange of cytosolic octanoylcarnitine against the mitochon­
drial branched-chain acylcarnitines (Scheme 7.1) may explain these findings. 
This explanation may be verified by the measurement of mitochondrial and cyto­
solic concentrations of (branched-chain) acyl-CoA and -carnitine esters and by 
studies of the exchange of carnitine esters across the membrane of muscle 
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mitochondria. We shall investigate the ability of octanoate to change the 
proportion of active branched-chain 2-oxo acid dehydrogenase complex in dia­
phragms during incubation (chapter 10). 
7.5. SUMMARY 
Acetate and butanoate inhibited and hexanoate and octanoate increased the 
"СОг production from 0.1 mM [l-l*C]a-ketoisocaproate (KIC) and 
a-ketoisovalerate (KIV) in rat hemidiaphragms. Octanoate also increased KIC 
and KIV oxidation in rat soleus muscle, inhibited it in human skeletal muscle 
and had a divergent effect in rat and human heart slices. 
In rat hemidiaphragms octanoate primarily affected the process of oxida­
tive decarboxylation. No effect was found on the transamination rates of 
branched-chain amino acids and on the CO2 production beyond oxidative decar­
boxylation. The reverse transamination of branched-chain 2-oxo acids and their 
incorporation into protein decreased in the presence of octanoate. Octanoate 
had no effect on KIC and KIV oxidation at higher 2-oxo acid concentrations and 
in hemidiaphragms from 3-day-starved rats. 
The observed interactions are discussed and related to regulatory mecha­
nisms, which are known to affect the branched-chain 2-oxo acid dehydrogenase 
complex. 
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CHAPTER 8 
THE ACTIVITY STATE OF THE BRANCHED-CHAIN 2-OXO ACID 
DEHYDROGENASE COMPLEX IN RAT TISSUES* 
8.1. INTRODUCTION 
Most conclusions about the capability of tissues to degrade branched-
chain amino acids and 2-oxo acids so far have been based on activity measure-
ments in tissue horaogenates and in intact tissue preparations (e.g. Odessey & 
Goldberg, 1972; Buse et al., 1975; Shinnick & Harper, 1976; Goldberg & Chang, 
1978; Odessey & Goldberg, 1979; Veerkamp et al., 1980; Veerkamp & Wagenmakers, 
1981). The results of these studies have given rise to the view that transami-
nation occurs predominantly in extrahepatic tissues and that oxidative decar-
boxylation is both hepatic and extrahepatic. Among the extrahepatic tissues, 
skeletal muscle is considered to be the major site of branched-chain amino 
acid degradation because of its high transaminase and considerable oxidative 
decarboxylation activity (e.g. Shinnick & Harper, 1976; Veerkamp & Wagenmak-
ers, 1981) and because it comprises about 40% of the total body weight. 
In recent years evidence has accumulated that the branched-chain 2-oxo 
acid dehydrogenase complex is subject to covalent modification in vitro, with 
inactivation by phosphorylation and activation by dephosphorylation (reviewed 
by Rändle, 1983). Therefore, the activity measured in vitro may not represent 
the actual activity present in the tissues in vivo. The activity may have been 
changed during preparation and incubation of tissues and horaogenates. 
In the present study we have adapted an assay described previously (Van 
Hinsbergh et al., 1978b; Veerkamp et al., 1980) in such a way that both actual 
and total activities can be measured in horaogenates of rat skeletal muscle, 
heart, liver, kidney and brain. The results obtained with this assay are com-
pared with those obtained with an assay which measures activities in crude 
* 
Adapted from Wagenmakers et al. (1984a) 
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tissue extracts before and after treatment with a broad-specificity protein 
phosphatase (Harris et s i . , 1982a,b; Gillim et ai., 1983). 
8.2. MATERIALS AND METHODS 
Fed male albino Wistar rats weighing 110-120 g were used, except for the 
experiments given in Table 8.4 (180-220 g animals). 
Basic assay for the total branched-chain 2-oxo acid dehydrogenase activity in 
homogenates 
This assay is performed as described in section 2.5 with homogenates pre­
pared as in section 2.4. 
Assay for the activity state in homogenates 
This assay is divided into two sub-assays, one to measure the actual 
activity present in tissues and one to measure the total activity (100% active 
state) under the same reaction conditions. Tissue samples were washed and hom­
ogenates prepared by the procedure described in section 2.4 in a buffer con­
sisting of 0.25 M sucrose, 5 mM EDTA, 10 mM Tris/HCl (pH 7.4), 5 mM ADP and 
50 mM NaF (for actual activity) or 0.25 M sucrose, 2 mM EDTA and 10 mM Tris/ 
HCl (pH 7.4) (for total activity). The tissue sample in which the actual 
activity was assayed was always homogenized first as quickly as possible. 
Homogenization was completed within 2 min after the rats were killed. The sec­
ond tissue sample, for the total activity assay, was kept in ice-cold washing 
buffer during that time. A volume (100 yl) of tissue homogenate was added to 
300 μΐ of a medium containing 16.7 mM КНгРО,., 25.0 mM NaHC03, 100 mM Tris/HCl 
(pH 7.4), 41.7 mM sucrose, 25.0 mM KCl, 8.33 mM EDTA, 1.67 mM 2-oxoglutarate, 
8.33 mM ADP and 3.33 mM L-carnitine in both sub-assays and, furthermore, 
83.3 mM NaF in the sub-assay for the actual activity. After preincubation for 
5 min at 37CC, 100 μΐ of 0.5 mM [l-^CJbranched-chain 2-oxo acid (actual 
activity) or 100 ul of 0.5 mM 2-oxo acid/250 mM NaF (total activity) was added 
in order to obtain the same conditions in both sub-assays during the incuba­
tions with radioactive substrate. Incubations at 370C were for 10 min (quad­
riceps muscle), 5 min (diaphragm and brain) or 2 rain (heart, liver and kid­
ney), unless otherwise stated. The activity state (%) is obtained from the 
ratio of the oxidative decarboxylation rates found with the sub-assays for the 
actual and the total activity. 
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Assay for the activity state in tissue extracts 
Heart, liver and kidneys from 180-200 g rats were removed and freeze-
clamped within 30 s at liquid N2 temperature. Extracts were prepared by the 
procedures of Parker & Rändle (1980) and Gillim et a./. (1983), with some minor 
modifications. Liver and heart tissue were powdered under liquid N2 with a 
pestle and mortar. After warming to about -10eC, the powder was extracted into 
an ice-cold buffer consisting of 30 mM KH2PO* (pH 7.5), 3 mM EDTA, 5 mM 
dithiothreitol, 0.5 mM 4-methyl-2-oxopentanoate, 1 mM TosLysCIbCl and 5% (v/v) 
Triton X-100 (about 5 ml/g of tissue) by vortex-mixing and freezing (liquid 
N2) and thawing (30oC) three times, followed by homogenization with a Teflon-
glass Potter-Elvehjem homogenizer. Kidneys were extracted in the same medium, 
except that 3% (v/v) calf serum was added to the extraction buffer.' The 
extracts were centrifuged at 33000g for 5 min at 40C. The supernatants were 
collected and centrifuged at 135000g for 120 min at 40C. The pellets originat-
ing from heart and liver extracts were suspended in 50 mM HEPES [4-(2-hydroxy-
ethyl)-l-piperazine-ethanesulphonic acid] (pH 7.0), 0.5 mM dithiothreitol and 
0.1% Triton X-100 (1-2 ml/g of original tissue) with a Teflon-glass Potter-El-
vehjem homogenizer. The pellet from kidney extracts was suspended in the same 
buffer containing 1 mM Тоз-Ьуз-СНгСІ and 3% calf serum. 
To activate the branched-chain 2-oxo acid dehydrogenase complex by 
dephosphorylation, 200 μΐ of extract was treated at 370C with 80 μΐ of a 
broad-specificity protein phosphatase, as described by Harris et al. (1982a,b) 
and Gillim et al. (1983). The phosphatase preparation was isolated from rat 
liver by a simplified procedure, which is a combination of the two procedures 
described by Brandt et al. (1974, 1975). Frozen rat livers (100 g) were homog­
enized with a Waring Blendor in 350 ml of ice-cold medium consisting of 0.1 mM 
NaCl in IED buffer [50 mM imidazole (pH 7.45), 5 mM EDTA and 0.5 mM dithioth­
reitol]. Further operations were carried out at 40C, unless otherwise stated. 
The homogenate was centrifuged at 10000g for 20 min. To the supernatant 200 ml 
of saturated (NH«)2S0« solution was added. The precipitate was collected by 
centrifugation (10000g, 20 min) and resuspended in 100 ml of IED buffer. Then 
95% (v/v) ethanol at room temperature (500 ml) was added. The precipitate was 
immediately collected by centrifugation (5000g, 10 min) and extracted with 
100 ml of IED buffer. After centrifugation (16000g, 15 min), the supernatant 
was dialysed overnight against the same buffer. To the dialysed extract satu­
rated (NHOjSOk solution was added to give 40% saturation. After 30 min, the 
precipitate was removed by centrifugation (10000g, 15 min) and discarded. The 
supernatant was adjusted to 75% saturation by the addition of saturated 
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(NHOzSO» solution. After 30 min, the precipitate was collected by centrifuga-
tion as above. The pellet was dissolved in 5 ml of IED buffer and dialysed 
overnight against two changes of the same buffer. The dialysed extract was 
then adjusted to 60% (v/v) glycerol and concentrated to about 5 ml with an 
Amicon PM 10 filter. The activity of this preparation was estimated with 
Phosphorylase a as substrate by the method described by Brandt et al. (1975). 
Since the activity falls gradually on storage at -70CC, we have only used 
fresh preparations in our experiments. 
Branched-chain 2-oxo acid dehydrogenase complex activities were measured 
in duplicate in tissue extracts before and after treatment with the phospha­
tase preparation by following reduction of NAD at 340 nm at 30<>C. The assay 
buffer (final volume 2.0 ml) consisted of 30 mM КНгРОі, (pH 7.5), 2 mM MgCb, 
0.4 mM thiamin pyrophosphate, 0.4 mM CoA, 1 mM NAD+, 1 mM dithiothreitol, 0.1% 
Triton X-100 and 0.2 mM 4-methyl-2-oxopentanoate. To assay activities in 
extracts from liver and kidney, 20 units of lipoamide dehydrogenase were 
included. Assays were started by the addition of 25-100 yl of tissue extract. 
Rates were corrected for the rate of change of A.,, in the absence of 
4-methyl-2-oxopentanoate (measured in duplicate). After a short stabilization 
period, rates were proportional to volume of extract and were constant for 2 
min or more. Activities are expressed in nmol of NADH produced/min per g of 
tissue. 
Phosphatase treatments were performed for 15 and 30 min. Maximal activa­
tion was assumed when the longer treatment gave no higher activity. This was 
always the case with a fresh phosphatase preparation. Although calf serum and 
Тоз-Ьуз-СНгСІ were added to inhibit proteolysis in kidney extracts, branched-
chain 2-oxo acid dehydrogenase activity decreased on incubation at 370C. In 
extracts incubated for 15 min (without phosphatase) the activity was 66+7% 
(n=3) of that in unincubated extracts. For that reason the activities measured 
in the phosphatase-treated samples were corrected for the loss of activity in 
a parallel incubation of kidney extracts without phosphatase present (Gillitn 
et al., 1983). 
Statistics 
Results are shown as means ± SD, with the numbers of experiments (n) in 
parentheses. Student's paired and unpaired t-tests were used for the statisti­
cal analysis. 
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8 3 RESULTS 
Although incubation of mitochondria from rat heart and skeletal muscle 
and perfusion of rat hearts without substrate and with branched-chain 2-oxo 
acids were reported to result in a rapid activation of the branched-chain 
2-oxo acid dehydrogenase complex (reviewed by Rändle, 1983), we could not 
detect this phenomenon with the assay used in our laboratory This basic assay 
measures the "СОг production from '""C-labelled branched-chain amino acids and 
2-oxo acids in intact mitochondria and in tissue homogenates (section 2 5 ) 
The reason for the inability to observe activation may be that it contains a 
preincubation step of 5 m m (originally meant for thermo-equilibration) Fur­
thermore, the assay medium contains 5 mM ADP, which inhibited the kinase of 
the branched-chain 2-oxo acid dehydrogenase complex (Lau et al , 1982) Aftr-
ing et al (1982), moreover, showed with liver mitochondria that extra-mito-
chondrial ADP (1 mM) more than doubled the intra-mitochondrial ADP concentra­
tion For these reasons the branched-chain 2-oxo acid dehydrogenase complex 
may be fully activated during the preincubation This was confirmed by the 
absence of an effect of another potent inhibitor of the kinase, 
2-chloro-4-methylpentanoate (Harris et al , 1982a) When 0 5 mM of this com­
pound was included during preincubation and incubation, together with ADP, no 
change was found in the activity measured in homogenates of heart, quadriceps 
muscle and liver (two paired experiments each) 
These indications that our basic assay gave total activities challenged 
us to try to adapt the assay in such a way that the actual activity could be 
measured, too Therefore it was necessary to block the kinase and phosphatase 
reactions Possible tools with which to block the kinase are, besides addition 
2+ 
of ADP, omission of Mg from the assay medium in combination with an increase 
2+ in the EDTA concentration to bind tissue Mg , since the branched-chain 2-oxo 
2+ 
acid dehydrogenase kinase reaction possibly requires Mg as a cofactor (Par­
ker & Rändle, 1978c, Lau et al , 1982) The phosphatase can be blocked with 
NaF in mitochondria (Odessey, 1980) and in the isolated enzyme complex (Fata-
2+ 2+ 
m a et al , 1983) and by the absence of Mg , since it also requires Mg as a 
cofactor (Fatania et al , 1983) 
The reaction conditions suitable for inhibition of the kinase activity 
have been tested with quadriceps muscle homogenates (Table 8 1) The basic 
assay gave a higher '''СОг production in the absence of ADP than in its pres­
ence The reason for this increase is not evident It was not found with 
3-methyl-2-oxobutanoate as substrate (87±7%, n=4) With liver and heart homo­
genates lower activities were found in the absence of ADP both with 
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4-methyl-2-oxopentanoate (64±19 and 41±2%, respectively; n=3) and with 
3-inethyl-2-oxobutanoate (75±6 and 55±9%, respectively; n=3) as substrate. 
Since the presence of 0.5 mM D)L-2-chloro-4-methylpentanoate during preincuba­
tion and incubation gave no increase in the presence or in the absence of ADP 
(quadriceps muscle, heart and liver; two experiments each), full activation 
2+ during preincubation was probably reached in both cases. The absence of Mg 
gave a small increase in the presence of ADP and had no effect in its absence 
(Table 8.1). Furthermore, in the presence of ADP no effect of the absence of 
2+ Mg was found on the oxidation of 4-methyl-2-oxopentanoate by liver and heart 
homogenates (104110 and 10015%, respectively; n=3) and on the oxidation of 
3-methyl-2-oxobutanoate by quadriceps muscle homogenates (9914%, n=4). These 
results indicate that the 5 rain preincubation also gave full activation in the 
absence of Mg 
Table 8.1. Production of 1''C0i from 4-methyl-2-oxo[l-1'>C]pentanoate by 
quadriceps muscle homogenates in the presence and absence of ADP 
and Mg 
Except for the indicated changes, assays were performed as for the basic 
assay. When MgClz was omitted, the EDTA concentration of the medium was 
simultaneously increased to 8.33 mM (to bind tissue Mg2 +). D,L-2-Chlo-
ro-4-methylpentanoate was added in a concentration of 0.5 mM. After 5 min 
preincubation 50 mM NaF was added in some of the experiments as well as 
radioactive 2-oxo acid (0.1 mM). Values (means 1 SD for four paired exper­
iments) are given as % of the ''СОг production given by the basic assay 
during a 15 min incubation (488 1 20 nmol/g of muscle). ND, not deter­
mined. a,b Significantly different at P<0.001 and <0.01, respectively. 
Presence of 
NaF 
(after preincubation) 
Mg 2+ 2-Chloro-4-
methylpentanoate 
ADP (5 mM) no ADP 
+ 
+ 
+ 
+ 
+ 
+ 
100 
111 1 з1 
48 1 4 
ND 
80 1 З1 
80 1 3h 
а 
147 1 11° 
148 i 10 b 
31 i 3 a 
46 i 4 a 
66 i 5 a 
ND 
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The presence of kinase activity will be most evident when the 
branched-chain 2-oxo acid dehydrogenase complex is fully active and when at 
the same time the phosphatase is inhibited. For that reason 50 mM NaF was 
added in some experiments after the preincubation (Table 8.1). Its addition 
decreased ^СОг production under all conditions. The decrease was largest when 
Mg2 + was present and ADP was omitted. Since the presence of 0.5 mM D,L-
2-chloro-4-methylpentanoate during preincubation and incubation increased the 
1,
'C02 production in that case by 42+12% (n=4), the decrease in the presence of 
NaF was probably due to kinase activity, not compensated by phosphatase activ­
ity. The decrease in the presence of NaF was smallest when ADP was present 
2+ 
and Mg was omitted. Since 2-chloro-4-methylpentanoate had no effect in that 
case, kinase activity was probably adequately blocked by ADP and omission of 
Mg . 
Under these conditions the optimal concentration of NaF to block the 
phosphatase activity was determined. When 5 mM or 25 mM NaF was present during 
preincubation and incubation, the activity increased during preincubation and 
the first minutes of incubation. For that reason a NaF concentration of 50 mM 
was used. This concentration of NaF, 5 raM ADP and extra EDTA (up to 5 mM) were 
also added to the homogenization buffer, to block kinase and phosphatatse 
activity as soon as possible after the tissues had been isolated. Furthermore, 
tissues were homogenized as quickly as possible, to arrest interconversion, 
although no significant changes were observed when the tissues were kept 
deliberately in ice-cold homogenization buffer for a few minutes before the 
homogenization was started. Under the applied conditions, the actual activity 
in quadriceps muscle homogenates did not change on preincubation (Fig.8.1) and 
the time-dependence of the ^СОг production from 4-methyl-2-oxo[ 1- ""CJpentano-
ate was linear from zero time until 10-15 min of incubation (Fig.8.2). The 
basic assay for the total activity was adapted in such a way that the same 
conditions were applied as for the assay of the actual activity during the 
incubation with radioactive substrate (see section 8.2). The main modifica­
tion was that NaF was added after the preincubation. The activity measured 
with this assay rose on preincubation (Fig. 8.1) and reached a maximal value 
after 5 min of preincubation. The ability to achieve full activation in the 
2+ 
absence of Mg is remarkable, since Fatania et al. (1983) reported that the 
2+ phosphatase reaction is dependent on Mg . Under the conditions used, the 
2+ 
intraraitochondrial Mg concentration was apparently kept high enough to main­
tain a phosphatase activity which gave full enzyme activity within 5 min of 
2+ 
preincubation, while kinase activity was blocked by ADP and the low Mg con­
centration. During the incubation rates were constant up to 10 min (Fig.8.2). 
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Fig. 8.1. Effect of time of preincubation on actual and total activities in 
quadriceps muscle homogenates. Activities were measured with 0.1 mM 
4-methyl-2-oxo[l-1*C]pentanoate as substrate. Assays without 
preincubation were started with the addition of homogenate to a 
prewarmed assay medium containing all additions, including radioac­
tive substrate. The assay for the actual activity (n) contains all 
components to block both kinase and phosphatase activity during 
homogenization, preincubation and incubation. In the assay for the 
total activity (·), the phosphatase is blocked only after the 
preincubation by the addition of 50 mM NaF. Values are means ± SD 
for at least three experiments. 
The conditions developed with quadriceps muscle were also applicable for 
the assay of the activity state of the enzyme in diaphragm, heart, liver, kid­
ney and brain. The time-dependences of "'СОг production are shown in Fig. 8.2. 
Especially for heart, the actual activity still rose at incubation times of 
more than 5 min. An increase of the NaF concentration to 75 mM lengthened the 
linear part of the time curve, without an effect on the initial rate. Total 
activities measured with the modified assay fell for most tissues at incuba­
tion times of more than 5 rain, whereas those measured with the basic assay 
were constant for 15 min. This difference may be due to inhibition of 
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Fig. 8.2. Time dependence of ''СС^ production for the actual and total 
activity assays. The oxidation of 0.1 mM 4-methyl-2-oxo[1-'"Cjpen-
tanoate was measured in homogenates of quadriceps muscle, dia­
phragm, heart, liver, kidney and brain. Straight lines were drawn 
through the points indicating the amount of ''CC^ produced at the 
two shortest assay times to illustrate initial linearity from zero 
time on, both for actual (·—·) and total (•—•) activity assay. 
Values are means ± SD for three to four experiments. 
extramitochondrial ATPases by EDTA and NaF in the modified assay. The result­
ing increase of ATP may cause phosphorylation (inactivation) at longer incuba­
tion times. For these reasons we chose to maintain exactly the same assay con­
ditions for all tissues, except for the assay time. On the basis of the 
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results shown in Fig. 6.2 we chose assay periods of 10 min for quadriceps mus-
cle, of 5 min for diaphragm and brain and of 2 min for heart, liver and kidney 
for both sub-assays. 
The assay would be simpler if the preparation of one homogenate would 
suffice. Actual activities (in nmol/min per g) rose, however, when NaF, ADP 
and extra EDTA were omitted from the homogenization buffer for quadriceps mus-
cle [1.6±0.3 (n=12) to 2.9±0.4 (n=3)], heart [20±3 (n=6) to 43 (n=2)] and kid-
ney [109±7 (n=5) to 158 (n=2)]. When the horaogenates were prepared in the 
indicated way, however, both actual and total activity did not change when the 
horaogenates were kept on ice for 30 min (all tissues). 
The activities measured with the basic assay and with the two modified 
assays and the activity states are given in Table 8.2. The total activity 
measured with the basic assay was in most cases somewhat higher than that 
measured with the modified assay. This difference was probably caused by an 
effect of the changed reaction conditions on the total activity and not by an 
inability to achieve full activation within the 5 min preincubation. The abil-
ity to achieve full activation has been discussed above, on the basis of the 
results given in Table 8.1, and is supported by the results of Fig. B.l. 
The activity state is a property of the branched-chain 2-oxo acid dehyd-
rogenase complex. Since the enzyme complex catalyses the oxidative decarboxy-
lation of the branched-chain 2-oxo acids from leucine, valine and isoleucine 
(Danner et al., 1978,1979; Parker & Rändle, 1978a,b; Pettit et al., 1978), we 
expected to measure the same activity state independently of the branched-
chain 2-oxo acid used as substrate. This indeed appeared to hold for the 
enzyme complex of quadriceps muscle, heart and liver. No statistically signif-
icant difference was found between the activity states measured with 
4-methyl-2-oxopentanoate (Table 8.2) and 3-methyl-2-oxobutanoate (Table 8.3) 
as substrate. 
While we were developing our assay, Gillim et al. (1983) published 
another method to measure the activity state of the branched-chain 2-oxo acid 
dehydrogenase complex. In their assay activities were measured in crude 
extracts from rat heart, liver and kidney before and after treatment with a 
broad-specificity protein phosphatase. This enzyme appeared to be able to 
dephosphorylate the branched-chain 2-oxo acid dehydrogenase complex and to 
produce full enzyme activity (Harris et al., 1982a,b). They found activity 
states of 48, 94 and 77% in heart, liver and kidney of fed normal 200-300 g 
rats. Apart from the liver, their results do not agree with the values in 
Table 8.2 and 8.3. Our results are, however, in accordance with previous esti-
mations of the activity state of rat heart in vivo, or perfused in vitro with 
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Table 8.2. Activities and activity state of the branched-chain 2-oxo acid 
dehydrogenase complex in rat tissues measured with 4-methyl-2-oxo-
pentanoate 
Total activities were measured in homogenates with the basic assay (A) or 
with the assay for the activity state (B) under the same conditions as the 
actual activity. As substrate 0.1 mM 4-methyl-2-oxo[l-1*C]pentanoate was 
used. The activity state (100 χ ratio actual activity/total activity, 
measured with assay B) was obtained in paired measurements. Values are 
means ± SD for the number of experiments in parentheses. 
' ' Significantly different from the total activity measured with assay 
A at P<0.001, <0.01 and <0.05, respectively. 
Tissue 
Quadriceps 
muscle 
Diaphragm 
Heart 
Liver 
Kidney 
Brain 
Activity (nmol/rain per g 
Total 
A 
32± 3.6(18) 
46±12 (10) 
330±42 (7) 
178±28 (10) 
300+15 (5) 
39± 4.0 (7) 
В 
29± 4.1(10)C 
38± 9.3 (5) 
279123 (6) c 
171+18 (5) 
234115 (5) a 
32± 2.4 (6) b 
tissue) 
Actual 
В 
1.610.3(12) 
7.8+2.3 (5) 
20 +3.4 (6) 
167 124 (5) 
109 1 7 (5) 
19 +2.5 (6) 
Activity state 
(%) 
6.0+ 1.4(6) 
20 ± 2.5(5) 
7.1+ 1.0(6) 
98 +12 (5) 
47 1 1.6(5) 
60 ± 5.2(6) 
glucose, which amounted to 5-15% (Parker & Rändle, 1978c, 1980; Waymack et 
al., 1980; Harris et al., 1982a,b). In 200 g rats we also measured an activity 
state of 7.810.9% (n=4) with our assay. The weight of the rats consequently 
cannot be the basis for the observed discrepancy. To elucidate this discrep-
ancy, we repeated part of the experiments of Gillim et al.(1963). The results 
of these experiments (Table 8.4) agreed quite well with the results of Tables 
8.2 and 8.3. The actual activity of skeletal muscle was too low to allow a 
reliable spectrophotometric assay on crude extracts. The enzyme activities 
measured before and after phosphatase treatment were considerably lower than 
those found by Gillim et al. (1983). The actual enzyme activity and the activ-
ity state that we found in heart extracts agreed, however, quite well with 
those measured by others (Parker & Rändle, 1980; Waymack et al., 1980). 
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Table 8.3. Activities and activity state of the branched-chain Z-oxo acid 
dehydrogenase complex in rat tissues measured with 3-methyl-Z-oxo-
butanoate 
As substrate 0.1 mM 3-methyl-2-oxo[l-1*C]butanoate was used. Other details 
are as given in Table 8.2. 
Tissue 
Activity (nmol/min per g tissue) 
Total Actual Activity state 
«) 
Quadriceps 
muscle 
Heart 
Liver 
82±18(12) 57±12(7)c 2.2±0.7(6) 
430±32 (5) 411+20(3) 30 ±2.1(3) 
253±51 (6) 279±33(5) 275 ±64 (5) 
4.3± 2.0(6) 
7.3± 0.6(6) 
99 ±19 (5) 
Table 8.4. Activity state of the branched-chain Z-oxo acid dehydrogenase com-
plex measured in crude tissue extracts 
Activities were measured, before and after treatment with a broad-specif-
icity protein phosphatase, as described in section 8.2. Values are 
means ± SD for the number of extracts given in parentheses. 
Activity (nmol/min per g tissue) 
Tissue 
Control Phosphatase-treated 
Activity state 
(%) 
Heart 
Liver 
Kidney 
22 ± 6.6 (6) 
354 ± 16 (4) 
90 ± 19 (5) 
221 ± 16 (3) 
387 ± 32 (3) 
197 ± 10 (5) 
12 ± 2.6 (3) 
93 ± 4.9 (3) 
49 ± 8.8 (3) 
100 
8.4. DISCUSSION 
The assay described above for the determination of the the activity state 
of the branched-chain 2-oxo acid dehydrogenase complex in tissue homogenates 
has several advantages over the assay in tissue extracts. The enzyme activity 
is assayed in intact mitochondria, with the enzyme complex located at its 
original site on the mitochondrial inner membrane. The laborious part of the 
assay (not including 1*C02 collection and measurement of radioactivity) only 
lasts 15-30 min and consists of several relatively simple operations. The 
assay with tissue extracts, including the isolation of the phosphatase prepa-
ration, takes several days. Since the phosphatase preparation loses its activ-
ity on storage, it can be used for only a few days. The operations necessary 
to prepare the extracts are complex. The loss of activity of kidney extracts 
on incubation at 370C is a serious disadvantage. The activity measured in 
heart extracts (without phosphatase treatment) is at the lower level of 
detectability. Larger quantities of extract cause disturbances of the spec-
trophotometric measurements (precipitation of protein). Hence, the assay is 
not sensitive enough to determine the actual activity and the activity state 
in skeletal muscle and other tissues that contain low activities. With our 
assay using homogenates it is possible to measure activities one-tenth the 
actual activity of rat skeletal muscle with about 100 mg of tissue. 
Earlier activity measurements in homogenates have suggested that a con-
siderable part of the degradation of branched-chain amino acids and 2-oxo 
acids occurs in skeletal muscle (see section 1.3). However, the activities 
measured in this study indicate that the degradation of branched-chain 2-oxo 
acids predominantly occurs in liver and kidney and is limited in skeletal mus-
cle in fed rats. The transfer in vivo of 2-oxo acids produced in skeletal mus-
cle to the liver (Livesey & Lund, 1980) is in agreement with this conclusion. 
Furthermore, in liver and kidney an activator protein was found (Fatania et 
al., 1982), which may be involved in directing branched-chain 2-oxo acid deg-
radation towards these organs (Rändle, 1983). 
The total activity in rat brain is not high, but the actual activity is 
considerably higher than that of skeletal muscle and as high as that of heart. 
Thus it will be interesting to study the significance of branched-chain amino 
acids and 2-oxo acids as metabolic fuels for this organ, especially during 
periods of diminished glucose availability. 
The rapidity and ease of our assay with homogenates make it very suitable 
to study the significance of covalent modification in regulating the branched-
chain 2-oxo acid dehydrogenase complex under various nutritional and hormonal 
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conditions. An attempt to do this has been made by Gillim et al. (1983). How-
ever, on the basis of the data from our present study, it is evident, that 
the correctness of their results and conclusions is open to question. Our 
assay should be able to define the proportion of the enzyme in the active 
state in tissues of starved and exercised rats (chapter 9) and in skeletal 
muscle after incubation in vitro with various metabolites (chapter 10). 
8.5. SUMMARY 
An assay is described to define the proportion of the branched-chain 
2-oxo acid dehydrogenase complex that is present in the active state in rat 
tissues. Two activities are measured in homogenates: the actual activity, by 
blocking both the kinase and phosphatase of the enzyme complex during homogen-
ization, preincubation, and incubation with [l-'^OJbranched-chain 2-oxo acid, 
and the total activity by blocking only the kinase during the 5 min preincuba-
tion (necessary for activation). The kinase is blocked by 5 mM ADP and absence 
2+ 
of Mg and the phosphatase by the simultaneous presence of 50 mM NaF. 
About 6% of the enzyme is active in skeletal muscle of fed rats, 7% in 
heart, 20% in diaphragm, 47% in kidney, 60% in brain and 98% in liver. An 
entirely different assay, which measures activities in crude tissue extracts 
before and after treatment with a broad-specificity protein phosphatase, gave 
similar results for heart, liver and kidney. Advantages of our assay with 
homogenates are the presence of intact mitochondria, the simplicity, the short 
duration and the high sensitivity. The actual activities measured indicate 
that the degradation of branched-chain 2-oxo acids predominantly occurs in 
liver and kidney and is limited in skeletal muscle in the fed state. 
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CHAPTER 9 
EFFECT OF STARVATION AND EXERCISE 
ON ACTUAL AND TOTAL ACTIVITY OF THE 
BRANCHED-CHAIN 2-OXO ACID DEHYDROGENASE COMPLEX 
IN RAT TISSUES* 
9.1. INTRODUCTION 
Starvation increased the ^СОг production from '"C-labelled branched-
chain amino acids and 2-oxo acids by intact rat skeletal muscle (Goldberg & 
Odessey, 1972; Adibì et al., 1974; Hutson et al., 1980; chapter 5) and heart 
muscle (Tischler & Goldberg, 1980; chapter 5) in vitro and by homogenates of 
rat skeletal muscle (Paul & Adibi, 1976, 1978). Starvation, therefore, is 
thought to be attended by increased branched-chain amino acid oxidation in 
rat muscle in vivo. During physical exercise, skeletal muscle can increase 
its metabolic rate at least 33-42 times (Welch & Stainsby, 1967). The exer-
cise-induced increase in the in vivo production of 13C02 and 1*C02 from " C -
and 1*C-labelled leucine in man (Rennie et al., 1981; Hagg et al., 1982; Mill-
ward et al., 1982; Wolfe et al., 1982) and rat (White & Brooks, 1981; Lemon et 
al., 1982) was therefore suggested to represent increased oxidation in skele-
tal muscle. 
The assay, described in the previous chapter, revealed that only a small 
proportion of the branched-chain 2-oxo acid dehydrogenase complex is present 
in the active state in muscles of fed rats and that the actual activity in 
muscle is only about 1% of that in liver and kidney. These findings cast doubt 
on the generally accepted significance of skeletal muscle for the degradation 
of branched-chain amino acids in fed rats. 
Effective mechanisms for increasing branched-chain amino acid degradation 
in muscle during starvation and exercise would be a rise of the total activity 
Adapted from Wagenmakers et al. (1984b) 
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of the branched-chain 2-oxo acid dehydrogenase complex and of the proportion 
present in the active state. Therefore we studied the effect of starvation for 
1, 2 and 3 days on oxidative decarboxylation rates of 4-methyl-2-oxopentano-
ate, 3-methyl-2-oxobutanoate and leucine in homogenates of various rat mus-
cles, with the branched-chain 2-oxo acid dehydrogenase complex in the fully 
active form. We also studied the effect of starvation for 3 days and of exer-
cise on the activity state of the enzyme in skeletal muscles and heart and, 
for comparison, in liver, kidney and brain. The actual branched-chain 2-oxo 
acid dehydrogenase activities present in whole tissue were compared to evalu-
ate the contribution of muscle to branched-chain 2-oxo acid oxidation in the 
different physiological conditions. 
9.2. MATERIALS AND METHODS 
Animals 
For the starvation experiments we used rats of 110-120 g and for the 
exercise experiment rats of 200-240 g. Five and two days before the exercise 
experiment the rats were subjected to a test-run of 30 min on a motor-driven 
treadmill at 12 m/min up a 15 incline. Those who were able to perform both 
runs without problems were selected for the exercise experiment, in which they 
were made to run on the treadmill for 60 min. The incline was chosen to obtain 
an adequate work-load on quadriceps muscle. Armstrong et al. (1983) showed, by 
means of measurements of oxygen consumption, that the incline has a signifi-
cant effect on the metabolism of running rats. In one series of experiments 
younger rats (110-120 g) were used. During the time of running neither exer-
cised nor control rats received food and water. 
Assays 
Tissues were dissected and homogenates were prepared as described in sec-
tion 2.4 or as in section 8.2 (for determination of the activity state). 
Oxidative decarboxylation rates of 4-methyl-2-oxopentanoate, 3-methyl-2-oxobu-
tanoate and leucine were measured with the basic assay for the total activity 
as described in section 2.5. Actual and total activities of the branched-chain 
2-oxo acid dehydrogenase complex were assayed in paired experiments to deter-
mine the activity state as described in section 8.2. Citrate synthase activi-
ties and palmitate oxidation rates were measured as described in section 2.5. 
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Statistics 
Results are shown as means ± SD, with the numbers of experiments (n) in 
parentheses. Student's unpaired t-test was used for the statistical analysis 
of the data. 
9.3. RESULTS 
Upon starvation for 3 days, the rats lost 23% of their body weight. The 
loss of body weight was paralleled by a reduction in weight of all tissues 
(Table 9.1). The 12-16% loss of weight in quadriceps muscle, diaphragm and 
soleus muscle is probably representative of the loss of weight of the whole 
body muscle mass. By far the largest loss was found in liver. 
Table 9.1. Effect of starvation on rat and tissue weights 
Values (in g) are means ± SD for the numbers of observations given in 
parentheses. For quadriceps muscle, soleus muscle and kidney the weight of 
the left and right organs were combined. Only brain hemispheres were 
weighed. ' ' Signifie; 
and <0.05, respectively. 
 a
'
 ,c Significantly different from fed animals at P<0.001, <0.01 
Fed Starved 3 days % Change 
Rat 114.2 ± 4.0 (25) 87.7 ± 5.3a (25) 23 
Quadriceps m. 1.56 ± 0.12 ( 5) 1.38 ± 0.13e ( 5) 12 
Diaphragm 0.186 ± 0.012 (25) 0.157 ± 0.013a(25) 16 
Soleus m. 0.073 ± 0.005 ( 8) 0.064 ± 0.005b( 8) 12 
Heart 0.40 ± 0.02 ( 5) 0.32 ± 0.01a ( 5) 20 
Liver 5.03 ± 0.53 (10) 3.15 ± 0.22a (15) 37 
Kidneys 1.08 ± 0.05 ( 5) 0.91 ± 0.08b ( 5) 16 
Brain 1.16 ± 0.04 ( 5) 1.03 ± 0.06b ( 5) 11 
When oxidative decarboxylation rates were measured after complete activa-
tion of the branched-chain 2-oxo acid dehydrogenase complex, a divergent 
response to starvation was found in different skeletal muscles (Table 9.2). 
Oxidative decarboxylation rates of 4-methyl-2-oxopentanoate and 3-methyl-
2-oxobutanoate increased significantly in homogenates of quadriceps muscle. 
Citrate synthase activity (Table 9.2) and palmitate oxidation rates [127±3 
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Table 9.2. Effect of starvation on oxidative decarboxylation rates of 
branched-chain 2-oxo acids and leucine in rat skeletal muscle hom-
ogenates 
Values are means ± SD for the numbers of experiments in parentheses. Oxi­
dative decarboxylation rates of 0.1 mM [1-1*C]branched-chain 2-oxo acids 
and of 0.5 mM leucine are given in nmol/min per g muscle. Under the 
applied assay conditions (described in section 2.5) the branched-chain 
2-oxo acid dehydrogenase complex was fully activated by a preincubation of 
5 min. Citrate synthase activities are given in ymol/min per g muscle. 
a b 
• Significantly different from the comparable value obtained with fed 
animals at P<0.001 and ^.OS, respectively. 
Quadriceps muscle 
4-Methyl-2-oxo-
pentanoate 
3-Methyl-2-oxo-
butanoate 
Leucine 
Citrate synthase 
Diaphragm 
4-Methyl-2-oxo-
pentanoate 
3-Methyl-2-oxo-
butanoate 
Leucine 
Citrate synthase 
Soleus muscle 
4-Methyl-2-oxo-
pentanoate 
3-Methyl-2-oxo-
butanoate 
Citrate synthase 
Fed 
32± 3.6(18) 
82±18 (12) 
27± 2.4 (5) 
16± 1.7(10) 
46±12 (10) 
197±13 (4) 
30± 9.4 (4) 
34± 3.2 (4) 
42± 1.5 (4) 
126±15 (4) 
33± 4.0 (4) 
1 
36± 4. 
ND 
ND 
17+ 0. 
41+10 
143±39 
ND 
33+ 1, 
42± 2 
127+ 9 
34+ 2 
3(7) b 
7(3) 
(4) 
(4) b 
.0(4) 
.4(4) 
.6(4) 
• 4(4) 
Starved 
2 
ND 
ND 
ND 
14± 2. 
43± 7. 
148±38 
ND 
30± 2, 
37± 3 
116+20 
27± 3 
(days) 
6(3) 
8(4) 
(А) Ь 
.6(4) 
.3(4)b 
(4) 
.0(4) 
3 
42± 4.1(9)a 
104± 7.8(5)b 
36± 3.3(6)a 
17± 1.3(6) 
40+ 8.5(B) 
124±50 (4) b 
21± 5.7(4) 
30± 3.6(8) 
33+ 7.6(4) 
91±29 (4) 
24+ 3.5(4)b 
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(n=6) and 119±θ (η=4) nmol/min per g in the fed state and after 3 days of 
starvation, respectively] did not change. However, oxidative decarboxylation 
rates tended to decrease gradually upon starvation in homogenates of diaphragm 
and soleus muscle. Since a comparable decrease was found in citrate synthase 
activity (Table 9.2) and palmitate oxidation rates (Glatz Ь Veerkamp, 1962) 
this decrease may be related to a reduction of the mitochondrial content. The 
difference in response to starvation of quadriceps muscle and diaphragm was 
also found when oxidative decarboxylation rates were measured with leucine 
(Table 9.2). 
The assays used to determine the activity state of the branched-chain 
2-oxo acid dehydrogenase complex were evaluated with tissues from fed rats 
(chapter 8). We observed similar effects of the preincubation on the measured 
activities with tissues from 3-day-starved rats and similar time dependences 
of ''COj production during the incubation with radioactive 2-oxo acids (data 
not shown). The assay consequently can be applied in both nutritional condi­
tions. 
Starvation for 3 days had no effect on actual and total activities in rat 
diaphragm, heart and brain (Fig. 9.1). In liver and kidney both activities 
increased without a change of the activity state of the enzyme complex. In 
quadriceps muscle only the total activity increased and consequently the 
activity state decreased (Fig. 9.1). A similar effect of starvation was found 
in quadriceps muscle, heart and liver, when activities were measured with 
3-methyl-2-oxobutanoate as substrate (data not shown). Although the total 
activities measured with the assay for the activity state generally are 
slightly lower than those measured with the basic assay (Table 8.2), the 
effect of starvation on total activities appeared to be similar with both 
assays (compare Table 9.2 and Fig. 9.1). 
Since actual branched-chain 2-oxo acid dehydrogenase activities in muscle 
did not change with starvation (Fig. 9.1) and the weight of muscles decreased 
(Table 9.1), the activity present in the whole body muscle mass will also 
decrease with about 14%. The marked increase upon starvation of the branched-
chain 2-oxo acid dehydrogenase activity in liver homogenates (Fig. 9.1) was 
acompanied by a comparable increase of citrate synthase activity [from 
13.0±0.8 (n=7) to 19.7±2.5 (n=6) ymol/min per g] and of palmitate oxidation 
rates [from 508±81 (n=7) to 728±48 (n=6) nmol/min per g]. When expressed per 
whole liver, these activities and also carnitine palmitoyl transferase activ­
ity (DiMarco Ь Hoppel, 1975) did not change, or hardly changed, with starva­
tion. These data suggest that in liver mitochondrial enzymes, or even the 
total mitochondrial mass are protected against starvation-induced proteolysis. 
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Fig. 9.1. The activity state of the branched-chain 2-oxo acid dehydrogenase 
complex in tissues of fed (F) and 3-day-starved (S) rats. Rats 
weighed 110-120 g in the fed state. Actual and total activities of 
the branched-chain 2-oxo acid dehydrogenase complex were measured 
as described in section 8.2 with 0.1 mM 4-methyl-2-oxo[l-1''C]penta-
noate as substrate. Values are means ± SD for five or more experi­
ments. *,**,*** Significantly different from the comparable value 
obtained with fed animals at P<0.05, <0.01 and 0.001, respectively. 
The activity present in the kidneys increases, even when it is related to 
organ weight. Since the activity state did not change (Fig. 9.1), an unknown 
mechanism will be responsible for this increase. 
Exercise of 200-240 g rats for 1 hr caused a significant and almost sig­
nificant (0.1<P<0.05) increase in the actual activity of the branched-chain 
2-oxo acid dehydrogenase complex in heart and quadriceps muscle, respectively 
(Fig. 9.2). The total activities did not change and the activity state of the 
enzyme complex consequently increased in both muscle types. In liver and kid­
ney actual and total activities increased without a change in the activity 
state. The cause of these increases is not clear. In brain exercise had no 
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Fig. 9.2. Effect of acute exercise (1 hr) on the activity state of the 
branched-chain 2-oxo acid dehydrogenase complex in rat tissues. 
Control (C) and exercised (E) rats weighed 200-240 g. Rats were 
made to run on a motor-driven treadmill at 12 m/min up a 15° 
incline. Actual and total activities of the branched-chain 2-oxo 
acid dehydrogenase complex were measured as described in section 
8.2 with 0.1 mM 4-methyl-2-oxo[l-1*C]pentanoate as substrate. Val­
ues are means ± SD for 5 or 6 experiments. *,** Significantly dif­
ferent from the comparable value obtained with fed animals at 
P<0.05 and <0.01l respectively. 
effect on the measured activities. Only marginal differences existed between 
control values obtained with 110-120 g and 200-240 g fed rats (compare Figs. 
9.1 and 9.2). 
Since the 1*C02 and "СОг production from injected, ingested or infused 
1
*C- and 13C-labelled leucine increased immediately upon the start of exercise 
in rat (White & Brooks, 1981; Lemon et al., 1982) and man (Rennie et aj. , 
1981; Wolfe et al., 1982) and since the rise in fact was highest in the early 
phase of exercise, we also studied the effect of 15 min of exercise on 
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Table 9.3. Effect of acute exercise (15 min) on the activity state of the 
branched-chain 2-oxo acid dehydrogenase complex in rat quadriceps 
muscle and heart 
Exercised rats (110-120 g) were made to run on a motor-driven treadmill at 
10 m/min up a 15 incline. Values are means ± SD for 4 experiments. Other 
details are as given in the legend of Fig. 9.2. a Significantly different 
from the unexercised controls (given in Table 9.2) at P<0.01. 
Tissue Activity (nmol/rain per g tissue) Activity state 
Actual Total (% of total) 
Quadriceps m. 2.4 ± 0.5 32 ± 5.9 7.5 ± 2.2 
Heart 34 ± 8.0a 308 ± 41 10.9 ± 2.5a 
branched-chain 2-oxo acid dehydrogenase activities. The experiments of White Ь 
Brooks (1981), Lemon et al. (1982) and Millward et al. (1982) suggested more­
over that leucine oxidation increased with exercise intensity. A higher inten­
sity may therefore cause a larger activation of the branched-chain 2-oxo acid 
dehydrogenase complex. The untrained 200-240 g rats became in terror, however, 
when we tried to make them running at a higher velocity and stopped running. 
We therefore used younger animals (110-120 g). Five of these animals out of 
sixteen were able to run at a speed of 10 m/min up a 15 incline for 15 min, 
without previous training. This type of exercise caused a small but signifi­
cant increase in the actual activity of the branched-chain 2-oxo acid dehyd­
rogenase complex in quadriceps muscle and heart (Table 9.3). However, the 
activity state increased only in heart. 
9.4. DISCUSSION 
Gillim et al. (1983) determined branched-chain 2-oxo acid dehydrogenase 
activities in crude extracts of heart, liver and kidney of fed and starved 
rats before and after treatment with a broad-specificity protein phosphatase. 
They found no effect of starvation on activity states of the complex in liver 
and kidney, but in contrast with our observations, a considerable decrease in 
heart. However, in the previous chapter we disputed their values of the activ­
ity state in heart and kidney extracts of fed rats. 
The branched-chain 2-oxo acid dehydrogenase and pyruvate dehydrogenase 
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complex show much structural resemblance and both are regulated by phosphory-
lation/dephosphorylation of the o-subunit of the E.-component (Rändle, 1963; 
Cook et al., 1983a,с). Nevertheless their activity states are entirely differ­
ent in all tissues except brain (compare Fig. 9.1 and Wieland, 1983). Further­
more, starvation has a strongly inhibiting effect on the activity state of the 
pyruvate dehydrogenase complex in liver, heart, skeletal muscle and kidney 
(Hennig et s i . , 1975; Wieland, 1983), but only marginal effects on the activ­
ity state of the branched-chain 2-oxo acid dehydrogenase complex (Fig. 9.1). 
This indicates that the physiological factors modulating interconversion of 
these enzyme complexes in vivo are different. Exercise, however, appears to 
have comparable effects. The proportion of active pyruvate dehydrogenase com­
plex was increased in rat skeletal muscle by electrical stimulation in situ 
(Hennig et al., 1975) and in isolated perfused rat hearts by increased cardiac 
work (Kerbey et al., 1976; Kobayashi & Neely, 1983). 
The relative importance of organs for the degradation of branched-chain 
2-oxo acids can be estimated from branched-chain 2-oxo acid dehydrogenase 
activities in whole tissues (Table 9.4). Liver appears to be by far the most 
important site in each physiological condition. Kidney and skeletal muscle are 
of minor but comparable importance in fed and exercised rats. The relative 
importance of skeletal muscle appears to be reduced somewhat by starvation. In 
agreement with these conclusions Livesey & Lund (1980) found a release of 
branched-chain 2-oxo acids (about 175 nmol/min per 100 g body weight) by skel­
etal muscle into the circulation and a comparable uptake by the liver of fed 
400 g rats. Small quantities of branched-chain 2-oxo acids were also removed 
from the circulation by the kidney. In man skeletal muscle released only small 
quantities of branched-chain 2-oxo acids (Abumrad et al., 1982; Elia & 
Livesey, 1983). No such data are available on man and rat during and after 
exercise. 
The data in Table 9.4 indicate that the exercise-induced increase in the 
in vivo production of l3C0j and ^''СОг from l ,C- and l*C-labelled leucine in 
man (Rennie et al., 1981; Hagg et al., 1982; Millward et al., 1982; Wolfe et 
al., 1982) and in rat (White & Brooks, 1981; Lemon et al., 1982) reflects 
increased oxidation in liver rather than in muscle. It also cannot be 
excluded that the increased labelled COj production does not reflect increased 
leucine oxidation. An indication for this is the discrepancy between the 
increase in the CO2 production and the absence of an increase of urinary N-ex-
cretion and even of plasma urea levels during and after acute exercise 
(reviewed by Lemon & Nagle, 1981,). This discrepancy is well-illustrated in 
the study of Wolfe et ai. (1982). To explain this discrepancy we have to 
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Table 9.4. Estimation of actual branched-chain Z-oxo acid dehydrogenase 
activities in whole tissues 
Actual branched-chain 2-oxo acid dehydrogenase activities in whole tissues 
of 110-120 g rats were calculated from actual activities per g tissue 
(Figs. 9.1 and 9.2 and Table 9.3) and tissue weights (Table 9.1). Applying 
the data from Table 9.1, muscle weight in fed rats was assumed to be 
45.7 g (40% of body weight) and in starved rats 39.3 g (14% change from 
fed rats). The actual activity in quadriceps muscle was assumed to be rep­
resentative of all muscle activity. The relative effect of exercise on 
activities in liver, kidney and brain of 200-240 g rats (Fig. 9.2) was 
assumed to represent the relative effect in tissues of 110-120 g rats. 
Tissue weights were assumed to be similar in exercised and control rats. 
Activity (nmol/min) 
Tissue 
Fed Starved 3 days Exercised 
Muscle 73 55 110 
Heart 8 6 14 
Liver 840 879 1075 
Kidneys 118 137 148 
Brain 22 20 22 
abandon the general opinion that there is only one intracellular leucine pool 
and/or 4-methyl-2-oxopentanoate pool, which are identical for all aspects of 
leucine metabolism. When exercise induces the preferential oxidation of plasma 
leucine and limits the oxidation of leucine originating from protein degrada­
tion in one or more tissues, the COj production from labelled leucine can 
increase without a change in the oxidation rate of total leucine. In chapter 5 
we indicated that the increase in " Ό Ο Σ production from '""C-labelled branched-
chain amino acids and 2-oxo acids in muscles in vitro from starved as compared 
with those from fed rats related to this phenomenon. Schneible et al. (1981) 
found that in cultured muscle cells 70% of the oxidized leucine and only 40% 
of the leucine used for protein synthesis originated extracellularly. Evidence 
of metabolic compartmentation was also given for leucine and other amino acids 
in incorporation studies (e.g. Airhart et al. 1974; O'Hara et al., 1981; Ran-
nels et al., 1982; Wheatley, 1982; Stirewalt & Low, 1983; Schneible & Young, 
1984) and for pyruvate in perfused rat heart (Peuhkurinen et al., 1983) and 
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skeletal muscle (Schadewaldt et al., 1983). 
However, rises in serum urea, indicating increased amino acid catabolism, 
are found during and after prolonged (longer than 1 hr) exercise in rat and 
man (Lemon & Nagle, 1981; Rennie et al., 1981; Dohm et al., 1982). During pro­
longed exercise in man, branched-chain amino acids are released by the 
splanchnic bed and taken up by leg muscle (Ahlborg et al., 1974). Branched-
chain amino acid aminotransferase activity is low in liver and high in muscle 
(Shinnick & Harper, 1976; Table 3.3). These data indicate that during exercise 
skeletal muscles are the most probable site of increased transamination of 
branched-chain amino acids. 
After prolonged exercise, the levels of plasma free fatty acids increase 
(Gollnick, 1977; Rennie et al., 1981). Fatty acids may displace branched-chain 
2-oxo acids from serum albumin and increase the concentration of free circu­
lating 2-oxo acids (Livesey & Lund, 1982; Nissen et al., 1982). The decrease 
in the concentration of branched-chain 2-oxo acids in plasma during exercise 
in man (Rennie et al., 1981) suggests that this may result in increased oxida­
tion. Liver appears to be a probable site for this oxidation, since the uptake 
and oxidation of branched-chain 2-oxo acids by isolated rat hepatocytes are 
dependent on the concentration of free 2-oxo acids in the medium and are lim­
ited by their binding to serum albumin (Livesey, 1983). Furthermore, branched-
chain 2-oxo acid concentrations in rat liver and kidney are much lower than in 
skeletal muscle (Livesey & Lund, 1980; Hutson & Harper, 1981). 
We conclude from our findings and from literature data that, whenever the 
degradation of branched-chain 2-oxo acids is increased during exercise, the 
increase may be largely confined to the liver. Liver also appears to be the 
main site of branched-chain 2-oxo acid oxidation in unexercised-fed and 
starved rats. Our observations in this chapter and in chapter 5 explain the 
discrepancy between the increased oxidation in rat muscle in vitro (Goldberg Ь 
Odessey, 1972; Adibì et al., 1974; Paul & Adibì, 1976, 1978; Hutson et al., 
1980; Tischler & Goldberg, 1980) and the unchanged or decreased metabolic 
clearance and/or oxidation of leucine upon starvation in vivo in rat (Thomas 
et al., 1982), dog (Nissen Ь Haymond, 1981) and man (Sherwin, 1978; Elia et 
al., 1980; Rennie et al., 1982). 
9.5. SUMMARY 
Starvation does not change the actual activity per g tissue of the 
branched-chain 2-oxo acid dehydrogenase in skeletal muscles, but affects the 
total activity to a different extent depending on the muscle type. The 
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activity state of the enzyme does not change in diaphragm and decreases in 
quadriceps muscle. Liver and kidney show an increase of both activities, with-
out a change of the activity state. In heart and brain no changes were 
observed. Related to organ wet weights the actual activity present in the 
whole body muscle mass decreases upon starvation, whereas the activities pres-
ent in liver and kidney do not change or increase slightly. 
Exercise (treadmill-running) of untrained rats for 15 and 60 min causes a 
small increase of the actual activity and the activity state of the branched-
chain 2-oxo acid dehydrogenase complex in heart and skeletal muscle. Exercise 
for 1 hr increased the actual and total activity in liver and kidney, without 
a change of the activity state. In brain no changes were observed. The actual 
activity per g tissue in skeletal muscle was less than 2% of that in liver and 
kidney, both before and after exercise and starvation. 
Our data indicate that the degradation of branched-chain 2-oxo acids 
occurs mainly in liver and to a smaller extent in kidney and skeletal muscle 
in fed, starved and exercised rats. 
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CHAPTER 10 
INCREASE OF THE ACTIVITY STATE AND LOSS OF TOTAL ACTIVITY 
OF THE BRANCHED-CHAIN 2-OXO ACID DEHYDROGENASE IN 
RAT DIAPHRAGM DURING INCUBATION 
EFFECT OF STARVATION AND METABOLITES* 
10.1. INTRODUCTION 
The branched-chain 2-oxo acid dehydrogenase complex is subject to cova-
lent modification in vitro, with inactivation by phosphorylation and activa-
tion by dephosphorylation. Incubation of mitochondria from rat heart and skel-
etal muscle and perfusion of rat hearts without substrate and with 
branched-chain 2-oxo acids resulted in a rapid activation of the enzyme com-
plex (reviewed by Rändle, 1983). In chapter 8 we described a method to define 
the activity state of the branched-chain 2-oxo acid dehydrogenase complex in 
rat tissues. In the present study we use this assay in a slightly modified 
form to study changes of the activity state in rat diaphragms incubated in 
Krebs-Ringer bicarbonate buffer. 
Actual branched-chain 2-oxo acid dehydrogenase activities were nearly 
equal in diaphragms from fed and starved rats (chapter 9). However, oxidative 
decarboxylation rates of branched-chain amino acids and 2-oxo acids were much 
higher in hemidiaphragms from starved than from fed rats (chapter 5). A dif-
ferential contribution of endogenous amino acids to the oxidation precursor 
pool appears to be the main factor causing the increased in vitro oxidation 
(chapter 5). In the present study we obtain information on differences in 
activation during in vitro incubation of diaphragms from fed and starved rats. 
We also investigate the effect of branched-chain 2-oxo acids, glucose, pyru-
vate, ketone bodies, octanoate and the metabolic agents amino-oxyacetate and 
D,L-2-chloro-4-methylpentanoate on the in vitro interconversion of the 
branched-chain 2-oxo acid dehydrogenase complex in this muscle system. 
Adapted from Wagenmakers et al. (1984c) 
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10.2. MATERIALS AND METHODS 
Male albino Wistar rats weighing 110-120 g before starvation were used in 
all experiments. Hemidiaphragms were obtained and handled as described in sec­
tion 2.3. 
Experimental procedure 
Both hemidiaphragms isolated from one rat were incubated together for 15, 
30 or 60 min at 370C in 4 ml of Krebs-Ringer bicarbonate buffer, gassed with 
O2/CO2 (95:5) and containing substrates and additions as indicated in the 
Tables. Immediately after the incubation the hemidiaphragms were transferred 
to ice-cold buffer, consisting of 0.25 M sucrose, 2 mM EDTA and 10 mM Tris-HCl 
(pH 7.4). A homogenate (5%, w/v) was prepared in the same buffer by the proce­
dure described in section 2.4. To assay the total activity of the branched-
chain 2-oxo acid dehydrogenase complex 100 μΐ of the homogenate was added to 
300 yl of a medium containing 16.7 mM КНгРОі,, 25.0 mM NaHCOj, 100 mM Tris/HCl 
(pH 7.4), 41.7 mM sucrose, 25.0 mM KCl, 8.33 mM EDTA, 1.67 mM 2-oxoglutarate, 
8.33 mM ADP and 3.33 mM L-carnitine. To assay the actual activity 100 yl of 
the homogenate was added to 300 yl of the same medium containing in addition 
83.3 mM NaF. After a preincubation for 5 min at 370C, 100 yl of 0.5 mM 
4-methyl-2-oxo[l-1*C]pentanoate was added (actual activity) or 100 yl of 
0.5 mM 4-methyl-2-oxo[l-1''C]pentanoate/250 mM NaF (total activity). After 
incubation for 5 min at 370C, reactions were terminated and ^СОг was col­
lected and measured as described in section 2.5. Activities were calculated 
from the specific radioactivity in the medium (3000 dpm/nmol) and were 
expressed in imol of 4-methyl-2-oxopentanoate decarboxylated/min per g of dia­
phragm. Activities were constant for at least 5 min. 
Other assays 
Palmitate oxidation rates and citrate synthase activities were assayed as 
described in section 2.5. 
Statistics 
Results are shown as means ± SD, with the numbers of experiments (n) in 
parentheses. Student's unpaired t-test was used for the statistical analysis 
of the data. 
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10.3. RESULTS 
When the procedure described in chapter 8 is applied to assay the activ-
ity state of the branched-chain 2-oxo acid dehydrogenase complex in rat dia-
phragm, one hemidiaphragm is homogenized in the presence of inhibitors of the 
kinase and the phosphatase of the complex and assayed to determine the actual 
activity. The other is homogenized in a buffer without inhibitors and assayed 
to determine the total activity. The activity states found with this procedure 
were rather variable with heraidiaphragms, which were first subjected to an 
incubation in Krebs-Ringer bicarbonate buffer (Table 10.1). The reason for the 
large variability may be the induction of unequal changes in the individual 
hemidiaphragms. Hence, we modified the procedure as follows. Actual and total 
activities were measured as described in section 10.2 in a single horaogenate 
prepared from both hemidiaphragms without inhibitors. With diaphragms, freshly 
isolated from fed rats, the modified procedure gave a comparable actual activ-
ity, but a higher total activity (compare Tables 10.1 and 10.2). Since the 
assay for the total activity is identical in both procedures, this difference 
is probably due to experimental and/or biological variations. With incubated 
diaphragms the two procedures gave comparable values for the activity state, 
but the variability was considerably smaller with the modified procedure (com-
pare Tables 10.1 and 10.2). 
Incubation of diaphragms from fed and starved rats in Krebs-Ringer bicar-
bonate buffer increased the activity state of the branched-chain 2-oxo acid 
dehydrogenase complex and caused a loss of total activity, especially after 
incubations longer than 15 min (Table 10.2). The addition of NAD , CoA and 
thiamin pyrophosphate (1 mM each) increased the actual and total activities 
measured after 60 min of incubation only by 52±10 and 35±8% (n=4; fed rats), 
respectively. In diaphragm homogenates from fed rats total palmitate oxidation 
rates did not change significantly by an incubation of the diaphragm for 
60 min (273±32 and 2A4±9 nmol/min per g muscle, respectively; n=4), as did 
citrate synthase activities (27.7+5.1 and 26.3+1.3 umol/min per g muscle 
respectively; n=4). The marked loss of total branched-chain 2-oxo acid dehyd-
rogenase activity, therefore, appears to be a specific deterioration of this 
mitochondrial activity. 
A higher activity state and a loss of total activity were also observed 
after incubation in the presence of 0.1 mM 4-methyl-2-oxopentanoate (Table 
10.3). In comparison to incubations without substrate (Table 10.2) this 
concentration of 4-methyl-2-oxopentanoate had hardly any effect on the 
measured activities. Simultaneous addition of 4-methyl-2-oxopentanoate and 
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Table 10.1. Effect of incubation on the activity of the branched-chain 2-oxo 
acid dehydrogenase complex in rat diaphragm 
Diaphragms from fed rats were incubated for the indicated time in Krebs-
Ringer bicarbonate buffer. After that time one hemidiaphragm was homogen-
ized to assay the actual activity and the other to assay the total activ-
ity as described in section 8.2. Values are means ± SD. Activities are 
given in nmol/min per g muscle. The activity state (% of total) and the 
number of experiments (n) are given in parentheses. 
a
' '
c
 Significantly different from the unincubated control at P<0.001, 
<0.01 and <0.05, respectively. 
Incubation 
time (min) Actual activity Total activity 
15 
30 
60 
7.8 ± 2.3 
13.1 ± 1.7fc 
11.9 ± 2.1t 
7.2 ± 2.1 
38.3 ± 9.3 
(20±3; n=5) 
37.1 ± 5.1 
(37±9b; n=6) 
24.4 ± 6.8° 
(53±20b; n=7) 
13.0 ± 4.2a 
(59±18b; n=6) 
amino-oxyacetate caused a higher activity state both after 15 and 60 min of 
incubation and decreased the loss of total activity in muscles from fed and 
starved rats (Table 10.3). In all cases (Tables 10.2 and 10.3) the conversion 
of inactive to active complex was larger after 15 min of incubation in dia-
phragms from starved rats, but the same activity state was reached after 
60 min of incubation. In all cases the loss of total activity upon incubation 
appeared to be smaller in muscles from starved than from fed rats. 
Addition of 1.0 mM 4-methyl-2-oxopentanoate increased the activity state 
after 15 and 60 min of incubation and slightly increased the total activity 
present after 60 min of incubation (Table 10.4). Addition of 0.1 and 1.0 mM 
3-methyl-2-oxobutanoate had little effect; the higher 2-oxo acid concentration 
slightly increased the activity state and the total activity present after 60 
min of incubation. 
D,L-2-Chloro-4-methylpentanoate inhibits the branched-chain 2-oxo acid 
dehydrogenase kinase reaction (Harris et al., 1982a). This metabolic agent 
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Table 10.2. Effect of incubation on the activity of the branched-chain 2-oxo 
acid dehydrogenase complex in rat diaphragm 
Rat diaphragms were incubated for the indicated time in Krebs-Ringer 
bicarbonate buffer. After that time a homogenate was prepared and the 
actual and total activity of the branched-chain 2-oxo acid dehydrogenase 
complex were assayed as described in section 10.2. Values are means ± SD. 
Activities are given in nmol/min per g muscle. The activity state (% of 
total) and the number of experiments (n) are given in parentheses. 
^ '
c
 Significantly different from the unincubated control at P<0.001, 
d e 
<0.01 and <0.05) respectively. ' Significantly different from the com-
parable value obtained with diaphragm^ from fed rats at P<0.01 and <0.05, 
respectively. 
Fed 
Incubation 
time (rain) Actual Total 
Starved 3 days 
Actual Total 
15 
30 
60 
6.7 ± 2.0 55.2 ± 11.4 
(12±2; n=5) 
13.2 ± 2.2b 41.9 ± 9.3 
(32±3a; n=5) 
8.6 ± 2.4 17.0 ± 6.4a 
(53±9a; n=6) 
4.3 ± 0.8C 9.5 ± 1.2a 
(46±8a; n=6) 
4.1 ± 1.1e 31.4 ± 10.5b 
(14±5; n=5) 
14.6 ± 4.3b 31.8 ± 9.5 
(47+6a,d; n=4) 
11.9 ± l.la,e 28.4 ± 2.6e 
6.5 ± 1.9 c,e 
(42±2a'e; n=4) 
13.2 ± 3.1b,e 
(49±7a; n=6) 
increased the 1*C02 production from "C-labelled branched-chain 2-oxo acids 
(chapter 6) and caused a rapid increase of the activity state to about 75% 
(Table 10.4). 
Glucose (4 mM and 10 mM) and pyruvate (2 mM) had no effect on the activi-
ties measured after incubation (Table 10.4). Glucose also had no effect on 
branched-chain 2-oxo acid oxidation by rat hemidiaphragms, but pyruvate inhib-
ited this process probably by competition for mitochondrial uptake (chapter 
6). 
3-Hydroxybutyrate and acetoacetate were tested together in the indicated 
ratio (Table 10.4) to minimize disturbances of the intracellular redox state 
(Zapalowski et al., 1981; Snell & Duff, 1982). Although the ketone bodies 
inhibit branched-chain 2-oxo acid oxidation by rat hemidiaphragms (chapter 6), 
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Table 10.3. Effect of 4-methyl-2-oxopentanoate addition to the medium on the activity of the branched-
chain 2-oxo acid dehydrogenase complex in incubated rat diaphragm 
Diaphragms from fed and 3-day-starved rats were incubated for the indicated time in Krebs-Ringer 
bicarbonate buffer. The concentration of 4-inethyl-2-oxopentanoate was 0.1 mH and of amino-oxyacetate 
1.0 mM. Other details are given in the legend of Table 10.2. ' ' Significantly different from the 
appropriate control (without addition; see Table 10.2) at Ρ < 0.001, < 0.01 and < 0.05, respectively. 
d e f 
' ' Significantly different from the comparable value obtained with hemidiaphragms from fed rats at 
Ρ < 0.001, < 0.01 and < 0.05, respectively. 
Incubation 
time (min) 
Addition Fed 
Actual Total 
Starved 3 days 
Actual Total 
15 4-Methyl-2-oxopentanoate 
60 4-Methyl-2-oxopentanoate 
15 4-Methyl-2-oxopentanoate 
and Amino-oxyacetate 
60 4-Methyl-2-oxopentanoate 
and Amino-oxyacetate 
12.8 + 2.8 
5.6 ± 1.2 
17.8 ± 1.5 
9.5 ± 1.7° 
38.9 ± 3.3 
(33+7 ; n=7) 
10.7 ± 2.6 
(53±4 ; n=4) 
39.2 ± 6.2 
(46±6b; n=5) 
14.9 ± 2.3b 
(64±8b; n=4) 
15.7 + 0.9 
9.8 ± 2.8 c,f 
30.5 ± 1.3 
12.0 ± 2.4 
a,d 
35.7 ± 4.6 
(44±4f; n=4) 
18.1 ± 4.7f 
(54±3 ; n=6) 
49.4 ± 7.4a 
(63±8C'f n=4) 
20.3 ± 3.4 b.f 
(60±9 ; n=4) 
Table 10.4. Effect of substrate addition to the medium on the activity of the branched-chain 2-oxo acid 
dehydrogenase complex in incubated rat diaphragm 
Diaphragms from fed rats were incubated for 15 or 60 min in Krebs-Ringer bicarbonate buffer, contai­
ning the indicated additions. Other details are given in the legend of Table 10.2. ' ' Significant­
ly different from the control (without addition) at Ρ < 0.001, < 0.01 and < 0.05, respectively. ND, 
not determined. 
Addition Cone. 
(mM) 
15 min Incubation 
Actual Total 
15 min Incubation 
Actual Total 
4-Methyl-2-oxopentanoate 1.0 
3-Methyl-2-oxobutanoate 0.1 
3-Methyl-2-oxobutanoate 1.0 
D,L-2-Chloro-4-methylpentanoate 0.5 
Pyruvate 2.0 
Glucose 4.0 
Glucose 10.0 
D,L-3-Hydroxybutyrate 4.0 
and Acetoacetate 1.0 
Octanoate 1.0 
3-Methyl-2-oxobutanoate 0.1 
and Octanoate 1.0 
13.2 ± 2.2 
24.9 ± 7.5° 
11.7 ± 2.2 
14.9 ± 3.3 
27.9 ± 4.2a 
11.2 ± 0.8 
12.0 ± 1.8 
ND 
12.8 + 1.3 
24.4 ± 3.0a 
25.8 + 6.4b 
41.9 ± 
(32+3 ; 
36.0 ± 
(69±4a; 
36.9 ± 
(32±7 ; 
37.5 ± 
(39±6 ; 
37.4 ± 
(75±7a; 
33.1 ± 
(34±3 ; 
33.6 ± 
(36±2 ; 
ND 
26.3 ± 
(49±5 ; 
37.1 + 
(66+5a; 
36.3 ± 
(71±5a; 
9.3 
n=5) 
9.6 
n=4) 
1.8 
n=4) 
4.4 
n=4) 
3.4 
n=4) 
1.5 
n=4) 
5.4 
n=4) 
3.2C 
n=4) 
3.2 
n=4) 
8.5 
n=4) 
4.3 ± 
10.2 ± 
ND 
8.9 + 
7.5 ± 
ND 
ND 
5.6 ± 
4.5 + 
9.5 + 
ND 
0.8 
1.1* 
1.7a 
3.7 
1.9 
1.0 
о.я
а 
9.5 ± 1.2 
(46±8 ; n=6) 
12.7 ± 1.1 
(80±2a; n-4) 
ND 
v, 
15.4 + 3.6 
(58±4C; n=4) 
10.2 ± 4.9 
(73+2a; n»4) 
ND 
ND 
12.8 ± 4.5 
(44±2 ; n=4) 
7.5 ± 2.3 
(63+13°; n=4) 
11.3 ± 0.8е 
(84±3a; n=4) 
ND 
they increased the activity state present after 15 min and 60 min of incuba­
tion (Table 10.4). Thus it appears likely that ketone bodies inhibit branched-
chain 2-oxo acid oxidation in rat hemidiaphragms by direct competition for CoA 
or NAD , or by competition for mitochondrial uptake. Ketone bodies can enter 
mitochondria by diffusion as undissociated acids and as anions with a carrier 
similar or identical to that used by pyruvate (Robinson & Williamson, 1980). 
Octanoate stimulated branched-chain 2-oxo acid oxidation in intact rat 
skeletal muscle in vitro (chapter 7). In agreement with this observation octa­
noate increased the activity state measured after 15 and 60 min of incubation 
(Table 10.4). The simultaneous presence of octanoate (1 mM) and 3-methyl-2-
oxobutanoate (0.1 raM) had the same effect as octanoate alone. 
10.4. DISCUSSION 
The results from the present study show that hemidiaphragm incubated in 
vitro is not an adequate system for measuring oxidation rates of branched-
chain amino acids and 2-oxo acids, although the time courses of ^СОг produc-
tion from 4-methyl-2-oxo[l-I*C]pentanoate were linear for 60 or more min (Figs 
3.1 and 5.1). Considering the results given in Tables 10.1 - 10.4, this lin­
earity can only be apparent. Loss of the total activity is more or less 
compensated by conversion of inactive to active complex. The measured rates, 
therefore, will not reflect activities present in vivo. Similar objections 
can be raised against experiments in which hemidiaphragms are preincubated 
before the assay of oxidation (e.g. Buse et al., 1975; Snell & Duff, 1982). 
The results given in Table 10.3 show that the simultaneous presence of 
4-methyl-2-oxopentanoate and of the transaminase inhibitor amino-oxyacetate 
increases the activity state present after 15 and 60 min of incubation to a 
comparable extent in muscles from fed and starved rats. Thus the fact that 
amino-oxyacetate stimulates ^COj production from 1*C-labelled branched-chain 
2-oxo acids less in muscles from starved than from fed rats (chapter 5), can­
not result from a different extent of activation of the branched-chain 2-oxo 
acid dehydrogenase complex. These results sustain our earlier conclusion that 
amino-oxyacetate has less effect on 1*C02 production rates in muscles of 
3-day-starved rats, because the oxidation precursor pool is less diluted with 
2-oxo acids derived from amino acids originating from protein degradation. 
The faster conversion of inactive to active complex and the smaller loss 
of total activity in muscles from starved than from fed rats (Tables 10.2 and 
10.3) in part can explain the higher ''СОг production from ^C-labelled 
branched-chain amino acids and 2-oxo acids measured in muscles from starved 
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rats in vitro (Table 5.1). However, this does not explain, the three to four 
times higher 1*C0Î production from 10 and 20 μΜ 4-methyl-2-oxo[l-I,'C]pentano-
ate (Table 5.3). At a 10 μΜ concentration, this difference was already present 
after 10 min of incubation [2.8±0.7 (n=9) for fed rats and 12.5±5.3 (n=ll) 
nmol '^CCb/g for starved rats ] . However, during the first 15 min of incuba­
tion the actual activity in muscles from fed and starved rats was of compara­
ble magnitude (Tables 10.2 and 10.3). As we concluded in chapter 5, part of 
the increased 1*C02 production in muscles from starved rats must, therefore, 
be due to a smaller contribution of endogenous amino acids to the oxidation 
precursor pool. 
Conversion of inactive to active branched-chain 2-oxo acid dehydrogenase 
complex was also found in rat hearts perfused without substrate, with 
branched-chain 2-oxo acids or with 2-chloro-4-methylpentanoate (Parker & Rän-
dle, 1980; Sans et al., 1980a; Waymack et al., 1980; Harris et al., 1982a,b; 
Paxton St Harris, 1984a). In contrast to our results obtained with diaphragm 
(Table 10.4), glucose, pyruvate and ketone bodies prevent the activation 
observed in the perfused heart without substrate. However, glucose was unable 
to prevent activation by branched-chain 2-oxo acids (Parker St Rändle, 1980; 
Paxton St Harris, 1984a) and by 2-chloro-4-methylpentanoate (Harris et al., 
1982a). 
The regulation of the branched-chain 2-oxo acid dehydrogenase kinase 
reaction was studied in enzyme complexes, containing intrinsic kinase activ-
ity, isolated from ox kidney (Lau et al., 1982) and from rabbit liver (Paxton 
St Harris, 1984a). Both groups found inhibition by ADP and branched-chain 2-oxo 
acids. These mechanisms may be involved in the conversion of inactive to 
active complex observed in the present study. The significance of changes in 
concentrations of ATP and ADP is not clear. ATP concentrations decreased in 
diaphragms during the first 30 rain of incubation (Goldberg et al., 1975), but 
in the presence of glucose ATP and ADP concentrations did not change during an 
incubation for 14 rain (Bessman St Geiger, 1980), whereas activation still 
occurs in the presence of glucose (Table 10.4). The larger extent of 
activation by 4-methyl-2-oxopentanoate than by 3-methyl-2-oxobutanoate (Table 
10.4) is in agreement with the K.- and I,--values of the respective 2-oxo 
acids for the kinase reaction (Lau et al., 1982; Paxton St Harris, 1984a). The 
higher concentrations of branched-chain 2-oxo acids in muscles from starved 
than from fed rats (Hutson St Harper, 1981) may play a role in the faster acti-
vation in muscles from starved rats (Tables 10.2 and 10.3). 
Acetoacetyl-CoA inhibition of the kinase (Paxton St Harris, 1984a) prob-
ably causes the activation by ketone bodies (Table 10.4). Octanoate may also 
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induce conversion to active complex by direct inhibition of the kinase (Paxton 
& Harris, 1984a). However, it is questionable whether a considerable amount of 
octanoate will enter the mitochondria in the free acid form in rat diaphragms 
incubated with octanoate. Alternatively, octanoate may decrease the intramito-
chondrial concentration of branched-chain acyl-CoA esters, as we concluded in 
chapter 7. This decrease may relieve the direct product inhibition of the 
branched-chain 2-oxo acid dehydrogenase complex (Rändle, 1983) and may 
decrease inactivation of the complex by phosphorylation. High isovaleryl-CoA/ 
CoA ratios accelerate the kinase reaction according to Lau et al. (1982). How-
ever, Paxton & Harris (1984a) found an inhibition of the kinase reaction by 
isobutyryl-CoA and isovaleryl-CoA. 
The branched-chain 2-oxo acid dehydrogenase complex was only once iso-
lated with intrinsic phosphatase activity (Fatania et al., 1983). No informa-
tion available on its regulation appears to be relevant for the present study. 
The rapid and extensive activation in vitro contrasts with the marginal 
differences between the activity states of the branched-chain 2-oxo acid deh-
ydrogenase complex in tissues of fed, starved and exercised rats (Figs. 9.1 
and 9.2). This suggests the existence in vivo of an additional regulatory 
mechanism which limits interconversion of the complex. Although future experi-
ments have to give evidence, it is prompting to speculate that hormones and 
neural influences are involved in that kind of regulation. Indications for 
hormonal regulation of branched-chain amino acid oxidation are given both by 
studies in vitro (Buse et al., 1973, 1976; Hutson et al., 1980; Buxton et al., 
1982; Palmer et al., 1983) and in vivo (McCallister et al., 1983). 
10.5 SUMMARY 
Actual and total branched-chain 2-oxo acid dehydrogenase activities were 
determined in homogenates of incubated diaphragms of fed and starved rats. 
Incubation in Krebs-Ringer buffer increased the activity state of the 
branched-chain 2-oxo acid dehydrogenase complex, but caused considerable loss 
of its total activity. Palmitate oxidation rates and citrate synthase activi-
ties did not significantly change upon incubation. Muscles from starved ani-
mals showed a higher extent of activation after 15 min of incubation (but not 
after 30 and 60 min) and a smaller loss of total activity. Experiments with 
the transaminase inhibitor amino-oxyacetate support our conclusion in chapter 
5 that the contribution of endogenous amino acids to the oxidation precursor 
pool is smaller in diaphragms from starved rats at incubation in vitro. These 
phenomena together explain the higher "СОг production from ^C-labelled 
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branched-chain amino acids and 2-oxo acids in muscles from starved than from 
fed rats. High concentrations of branched-chain 2-oxo acids, and the presence 
of 2-chloro-4-methylpentanoate, octanoate or ketone bodies increase the extent 
of activation; glucose and pyruvate have no effect. The observed changes of 
the activity state by these metabolites are discussed in relation to their 
interaction with branched-chain 2-oxo acid oxidation in incubated hemidia-
phragms. 
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CHAPTER 11 
SUMMARY AND CONCLUSIONS 
11.1. INTRODUCTION 
Fatty acids and carbohydrates represent the main fuels for energy produc-
tion in muscle. Amino acids (stored in large amounts in the form of protein) 
are another potential source of energy. Muscle degrades only a few amino 
acids, among which the branched-chain amino acids (leucine, isoleucine and 
valine) are an important group. They are essential amino acids and have a 
unique role in the regulation of protein turnover in muscle. Furthermore, 
branched-chain amino acids may have therapeutic effects in a variety of disor-
ders in man, including conditions associated with wasting of muscle protein. 
The biochemical investigations described in this thesis deal with three 
major aspects of the degradation of branched-chain amino acids in muscle: the 
metabolic fate of the carbon-skeletons of the branched-chain amino acids, the 
role of muscle in the total body degradation and the regulation of the activ-
ity of the branched-chain 2-oxo acid dehydrogenase complex. These aspects have 
been studied in homogenates and in intact preparations of rat skeletal and 
cardiac muscle. In some instances human muscle material has been used. In this 
chapter we will summarize the results described in this thesis and conclude 
with some general remarks. 
11.2. METABOLIC FATE OF THE CARBON-SKELETONS OF BRANCHED-CHAIN AMINO ACIDS IN 
MUSCLE 
The ratios reported for the ^COi production from [U-^C]- to that from 
[l-1*C]branched-chain amino acids and 2-oxo acids and the absence of CO2 pro-
duction from the corresponding branched-chain fatty acids (chapter 3) indicate 
that in homogenates and mitochondria of rat and human muscle COj is only pro-
duced by the oxidative decarboxylation reaction. In agreement with this con-
clusion homogenates of rat heart and skeletal muscle produced radioactive 
branched-chain fatty acids, hydroxylated fatty acids and their derived 
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carnitine esters as endproducts during incubation with [U-1*C]branched-chain 
2-oxo acids (chapter 4). The enzymes 3-methylcrotonyl-CoA carboxylase and 
3-hydroxyisobutyric acid dehydrogenase appear to be inactive during incubation 
of muscle homogenates. 
In intact preparations of rat and human muscle branched-chain amino acids 
are oxidized more to completeness (chapters 3 and 4). Rat hemidiaphragms incu-
bated with [U-1*C]leucine, valine and isoleucine accumulated the corresponding 
branched-chain 2-oxo acids, fatty acids and hydroxylated fatty acids. The deg-
radation of valine was markedly limited by the release of these metabolites. 
Considerable amounts (relatively smaller for valine) of radioactivity were 
also recovered in CO2 and glutamine and glutamate. Incubations with branched-
chain 2-oxo acids gave the same radioactive products, except for glutamine and 
glutamate. 
Radioactivity was never found in lactate, pyruvate or alanine (chapter 
4). These data indicate that the carbon-chains of amino acids entering the 
citric acid cycle in muscle (valine, isoleucine, asparagine, aspartate and 
glutamate), are not used for oxidation or for alanine synthesis, but are con-
verted exclusively to glutamine. Part of the carbon-chains of the newly syn-
thesized glutamine may also be derived from glucose or glycogen. Only the 
branched-chain amino acids appear to be able to deliver significant amounts of 
energy to muscle, by the energy-producing steps in their degradation routes 
towards the citric acid cycle and by oxidation of acetyl groups derived from 
leucine and isoleucine. 
11.3. ROLE OF MUSCLE IN THE TOTAL BODY DEGRADATION OF BRANCHED-CHAIN AMINO 
ACIDS 
The data present at the start of our investigation suggested that skele-
tal muscle could take a large part in the degradation of branched-chain amino 
acids (see section 1.3). The branched-chain 2-oxo acid dehydrogenase activi-
ties in homogenates (chapter 3) at first appeared to confirm this. However, we 
showed in chapter 8 that these activities represent total activities (100% 
active state). The percentage of active enzyme (activity state) is only 6-7% 
in skeletal muscle and heart of fed rats and, therefore, seriously limits the 
degradation of branched-chain amino acids. Other organs have much higher 
activity states: kidney, 47%, brain, 60% and liver, 98%. Based on the activ-
ity present in whole tissues (chapter 9) liver is by far the most important 
site for the degradation of branched-chain amino acids in fed rats. Kidney and 
skeletal muscle are of minor but comparable importance. 
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Enzyme assays in tissue extracts and homogenates usually indicate a 
potential which is not necessarily realized in vivo (Krebs Ь Lund, 1977). The 
whole-body leucine flux in fed rats amounted to about 1 ymol/min per 100 g 
body weight (Thomas et al., 1982). In normal fed men the ratio of oxidation to 
flux of leucine amounted to 20% (Reimie et al., 1982). When we apply this 
ratio to rats, we estimate that leucine oxidation in 110-120 g rats amounts to 
about 230 nmol/min and the oxidation of the three branched-chain amino acids 
to 690 nmol/min. Summation of the whole tissue activities of the branched-
chain 2-oxo acid dehydrogenase complex (Table 9.4), gives a whole body activ­
ity of 1060 nmol/min. This indicates that the actual activities measured with 
the assay described in chapter 8 are about equal to those realized in the tis­
sues in vivo or slightly higher. The used branched-chain 2-oxo acid concentra­
tion (0.1 mM) is higher than that occurring in rat plasma and tissues. So, we 
estimate that skeletal muscle in fed rats maximally decarboxylates per min 73 
nmol (Table 9.4), that is to say 7-10% of the whole body degradation. 
Although starvation and exercise were thought to be attended by increased 
branched-chain amino acid degradation in muscle, these conditions have only 
small effects on actual activities, activity states and whole tissue activi­
ties (chapter 9). The relative importance of skeletal muscle appears to be 
reduced somewhat with starvation and to be unchanged with exercise. 
The most important reason to assume that starvation increases the oxida­
tion of branched-chain amino acids in muscle, was the finding of a higher 
1
*C02 production from the 1*C-labelled branched-chain amino acids by muscles 
in vitro from starved than from fed rats (chapter 5). However, this increase 
does not reflect increased in vivo oxidation. Experiments with the transami­
nase inhibitors amino-oxyacetate and L-cycloserine indicate that the contribu­
tion of endogenous amino acids to the oxidation precursor pool is smaller in 
muscles from starved rats (chapter 5). Moreover, at incubation in vitro the 
activity state of the branched-chain 2-oxo acid dehydrogenase complex 
increases faster and the total activity decreases less in muscles from starved 
than from fed rats (chapter 10). Together these three phenomena explain the 
higher 1*C02 production in muscles from starved rats. 
11.4. REGULATION OF THE ACTIVITY OF THE BRANCHED-CHAIN 2-0X0 ACID 
DEHYDROGENASE BY METABOLITES AND OTHER AGENTS 
The interaction of various metabolites and agents with the 1 , ,C0 2 produc­
tion from [l-1*C]branched-chain 2-oxo acids was studied in intact preparations 
of rat and human skeletal muscle and heart (chapters 6 and 7). Glucose, 
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palmitate, 2-oxoglutarate, acetate, butanoate, intermediates of the 
degradation route of 4-methyl-2-oxopentanoate and of 3-methyl-2-oxobutanoate, 
carnitine and monocarboxylate translocator inhibitors have no or only small 
effects. The most remarkable effects in rat hemidiaphragms are the inhibition 
by high concentrations of competitive branched-chain 2-oxo acids and of pyru­
vate, the inhibition by ketone bodies and the stimulation by the branched-
chain 2-oxo acid dehydrogenase kinase inhibitor 2-chloro-4-methylpentanoate 
and by hexanoate and octanoate. Octanoate primarily affects the process of 
oxidative decarboxylation, has no effect on the '"СОг production beyond this 
step and considerably increases the release of (hydroxylated) branched-chain 
fatty acids. These findings may be explained by an exchange of cytosolic octa-
noylcarnitine against mitochondrial branched-chain acylcarnitines on the car-
nitine-acylcarnitine translocase (chapter 7). 
During incubation of rat diaphragms the activity state increases and the 
total activity decreases (chapter 10). High concentrations of branched-chain 
2-oxo acids increase the conversion to active complex and limit the loss of 
total activity. This is the reason that competition for oxidation is only 
observed at very high concentrations of the competing branched-chain 2-oxo 
acid (chapter 6). Octanoate and 2-chloro-4-methylpentanoate, in agreement with 
their effect on the oxidation in vitro, increase activation by direct inhib­
ition of the branched-chain 2-oxo acid dehydrogenase kinase reaction. Alterna­
tively, octanoate may increase in vitro oxidation by decreasing intramitochon­
drial branched-chain acyl-CoA concentrations (chapter 7). Ketone bodies 
surprisingly also increase conversion to active complex and pyruvate has no 
effect. These compounds, therefore, probably inhibit the in vitro oxidation of 
branched-chain 2-oxo acids by competition for mitochondrial uptake. Although 
starvation is attended by high ketone body concentrations in plasma, it does 
not increase the activity state in rat muscle in vivo. So in vivo the inhib­
ition of the oxidation of branched-chain 2-oxo acids by ketone bodies may be 
even more pronounced. Glucose has also no effect on the conversion to active 
complex in incubated rat diaphragms. 
11.5. CONCLUDING REMARKS 
The proportion of the branched-chain 2-oxo acid dehydrogenase complex 
present in the active state in liver is 100% in fed, starved, exercised and 
streptozotocin diabetic rats (chapters 8 and 9; Gillim et aJ. , 1963). Liver 
probably has such a high activity to degrade the branched-chain 2-oxo acids 
produced by other organs. Each time after a protein containing meal large 
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amounts of amino acids will be extracted from the gut. Branched-chain amino 
acids escape hepatic uptake (Felig, 1961), because of the low transaminase 
activity. They are taken up in large amounts by muscle tissues (Felig, 1981; 
Elia & Livesey, 1983). Part of these amino acids will be used for protein 
synthesis. Muscle will transaminate the remainder. Rat muscle will not be able 
to oxidize all the produced 2-oxo acids, because of the low branched-chain 
2-oxo acid dehydrogenase activity. Therefore, large amounts of branched-chain 
2-oxo acids are released by rat muscle and taken up and oxidized by the liver 
(Livesey & Lund, 1980). Accumulation of branched-chain 2-oxo acids has to be 
prevented, since a high concentration of these compounds is toxic. When the 
daily exposure to large amounts of branched-chain amino acids and 2-oxo acids 
is taken away by feeding rats a low protein diet for 12 days, the activity 
state in liver decreases to about 30% (Gillim et al., 1983). When these rats 
consume one meal containing extra leucine, the activity state returns within 
1 hr to about 80% (Harper et al., 1983). After feeding rats a synthetic amino 
acid diet the hepatic branched-chain 2-oxo acid dehydrogenase activity is low 
and can be increased by incubation of homogenates and mitochondria (Hauschildt 
et al., 1982). A similar finding for liver of rats fed a standard laboratory 
chow (Paul & Adibì, 1982) is in contrast with all other literature data (e.g. 
Odessey, 1980; Gillim et al., 1983; review of Rändle, 1983; this thesis). 
Although skeletal muscle in man also takes up large amounts of branched-
chain amino acids after a protein meal, it releases only small amounts of the 
corresponding 2-oxo acids (Elia & Livesey, 1983). A large release of glutamine 
indicates that an extensive transamination occurs. So in human muscle most of 
the branched-chain 2-oxo acids appear to be oxidized. Since the total 
branched-chain 2-oxo acid dehydrogenase activity per g tissue is even lower in 
human than in rat muscle (chapter 3) this may suggest that the activity state 
is higher in human muscle. When muscle in man does not produce large amounts 
of branched-chain 2-oxo acids after protein feeding, the daily exposure to 
these 2-oxo acids may be considerably smaller than in rats and, therefore, the 
hepatic activity state may be lower. Khatra et al. (1977) measured similar 
branched-chain 2-oxo acid dehydrogenase activities in rat and human muscle and 
a more than fifteen times lower activity in human than in rat liver. However, 
we do not know whether these results reflect actual or changed activities. 
A question which arises is that of the physiological reason for the low 
activity state of the branched-chain 2-oxo acid dehydrogenase complex in rat 
skeletal muscle and heart. A dramatic increase of this activity state, by e.g. 
nutritional state or exercise, probably would cause a decreased concentration 
of branched-chain amino acids and 2-oxo acids. Since these compounds have a 
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unique function in the regulation of protein turnover in muscle (see section 
1.1), such a decrease might induce wasting of muscle protein and a rapid deg-
radation of the myofibrils. So large increases of the activity state have to 
be prevented. 
We have not yet had the opportunity to measure activity states in tissues 
of rats given the hypolipidemic drug Clofibrate. There are several indications 
that this treatment causes higher activity states in heart and skeletal mus-
cle. During Clofibrate treatment the free acid derivative of the drug, clofi-
bric acid, accumulates. Apart from being a direct (mixed or competitive) 
inhibitor of the branched-chain 2-oxo acid dehydrogenase complex (Danner et 
al., 1982), clofibric acid also is a powerful inhibitor of the kinase of the 
enzyme (Paxton & Harris, 1984b). The overall effect of this compound on flux 
through the branched-chain 2-oxo acid dehydrogenase complex will depend on the 
concentration of physiological substrates and modulators and on the activity 
state. In rat heart perfused with clofibric acid and glucose, the in vitro 
flux through the branched-chain 2-oxo acid dehydrogenase complex is increased 
13 times and the activity state 20 times (Paxton & Harris, 1984b). In rat hem-
idiaphragms incubated with clofibric acid and glucose the in vitro flux is 
reduced or unchanged (Table 6.4). In the first case inhibition of the kinase 
and in the second case direct inhibition of the complex appears to be the 
major effect. Hearts perfused with glucose maintain a low activity state, 
(Parker & Rändle, 1980; Paxton & Harris, 1984a), whereas conversion to active 
complex occurs in skeletal muscle incubated with glucose (Table 10.4). Since 
activity states in heart and skeletal muscle in vivo are low, they will prob-
ably be increased by Clofibrate treatment. Paul & Adibi (1980) measured higher 
oxidation rates of leucine and 4-methyl-2-oxopentanoate in muscle homogenates 
from clofibrate-treated rats. However, it is unknown whether their assay gives 
actual or changed activities. Total branched-chain 2-oxo acid dehydrogenase 
activities do not change in skeletal muscle and heart, but increase in liver 
(Glatz et al., 1983). So, Clofibrate treatment appears to increase the oxida-
tion of branched-chain amino acids in skeletal muscle, heart and liver. This 
causes decreased concentrations of branched-chain amino acids in rat muscle 
and plasma and induces protein degradation in rat muscle ¿o vitro (Paul & 
Adibi, 1980). It may also be the reason for the wasting of muscle protein 
observed in some patients chronically treated with the hypolipidemic drug. 
In man bedrest, postoperative trauma, injury, sepsis, cancer and muscular 
dystrophy all are characterised by wasting of muscle proteins. However, these 
conditions differ from clofibrate-induced muscle wasting in that they are 
attended by increased branched-chain amino acid concentrations in muscle and 
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mostly also in plasma (Burt et al., 1979; Fürst, 1983; Rennie, 1984). A compa-
rable increase is found for the muscle concentration of aromatic amino acids 
and methionine, which compete with the branched-chain amino acids for trans-
port out of the muscle by the leucine-preferring system (Fürst, 1983). High 
concentrations of branched-chain amino acids will increase the 2-oxo acid con-
centration and, therefore, may increase the proportion of active branched-
chain 2-oxo acid dehydrogenase complex by inhibition of the kinase (Rändle, 
1983; Paxton & Harris, 1984a). The oxidation of leucine is increased in mus-
cles in vitro from tumor-bearing rats (Goodlad & Clark, 1980; Goodlad et al., 
1981), and after physical injury (Tischler & Fagan, 1983) and burn injury of 
rats (Odessey & Parr, 1982). Although the starvation experiments in this the-
sis illustrate the ambiguity of results obtained in vitro, this may mean that 
the activity state of the branched-chain 2-oxo acid dehydrogenase complex is 
higher in these pathological conditions. The rise in the concentration of the 
branched-chain amino acids in human muscle appears to indicate that their oxi-
dation can increase only to a limited extent. However, in severe catabolic 
states the high concentrations of aromatic amino acids and methionine competi-
tively reduce the outflow of branched-chain amino acids (Fürst, 1983). So, in 
severe injury and at the onset of sepsis (Fürst, 1983) and in muscular dystro-
phy (Rennle, 1984) the increase of the concentration of the branched-chain 
amino acids in plasma is much smaller than in muscle or even absent. In these 
cases most of the branched-chain amino acids produced by the increased net 
protein catabolism apparently are degraded in the muscle. This degradation 
must involve more than only transamination to the corresponding branched-chain 
2-oxo acids, since Elia & Livesey (1983) found the same ratio between the con-
centration of branched-chain amino acids and 2-oxo acids in plasma of fed and 
starved controls and of muscular dystrophy patients. 
In muscle-wasting diseases, in which branched-chain amino acid concentra-
tions are greatly increased, the therapeutic effects of branched-chain amino 
acids and branched-chain 2-oxo acids may be small. It is doubtful whether 
administration of these compounds further increases their muscle concentra-
tion. They probably are taken up and metabolized by other organs with a more 
favourable plasma-organ gradient. When branched-chain amino acid oxidation in 
muscle is indeed higher in these clinical conditions, better results may be 
expected from treatments which decrease the activity state of the branched-
chain 2-oxo acid dehydrogenase complex. A search for such treatments and more 
knowledge and a better understanding of the metabolism of branched-chain amino 
acids in normal man and patients may be essential for the development of ther-
apies to reduce the wasting of muscle protein. 
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SAMENVATTING 
AFBRAAK VAN VERTAKTE AMINOZUREN IN DE SPIER 
Vetzuren en koolhydraten leveren de belangrijkste bijdrage aan de ener-
gievoorziening van hart en skeletspieren. Aminozuren (in grote hoeveelheden 
opgeslagen in de vorm van eiwitten) zijn een derde potentiële energiebron. De 
meeste aminozuren worden geoxideerd in de lever. De spier kan slechts enkele 
aminozuren oxideren. Hiervan vormen de vertakte aminozuren (leucine, isoleu-
cine en valine) een belangrijke groep. Het zijn essentiële aminozuren met een 
unieke rol bij de regulatie van eiwitsynthese en -degradatie in de spier. 
Bovendien hebben ze bij toediening therapeutische effecten bij verschillende 
metabole stoornissen bij de mens. Bij condities die gepaard gaan met een ver-
lies van spiereiwitten (verwondingen, infecties, kanker, spierdystrophie) kun-
nen ze dit verlies mogelijk beperken. De huidige kennis van het verloop en de 
regulatie van de oxidatie van vertakte aminozuren in de spier (beschreven in 
hoofdstuk 1) is beperkt. Het biochemisch onderzoek in dit proefschrift is ge-
richt op uitbreiding van deze kennis. 
In hoofdstuk 2 worden de materialen en enkele methoden beschreven, die 
bij het verdere onderzoek veelvuldig gebruikt worden. De methoden omvatten de 
preparatie van intacte spiersystemen en homogenaten, een meetsysteem voor de 
transaminering en oxidatieve decarboxylering van vertakte aminozuren en 
2-oxozuren in homogenaten, een meetsysteem voor de oxidatie van palmitaat en 
de bepaling van de activiteit van enkele enzymen. 
In hoofdstuk 3 wordt een geschikt meetsysteem beschreven voor transami-
nering en oxidatieve decarboxylering in intacte spiersystemen van rat en mens. 
De oxidatie waarden verkregen met dit systeem zijn lager dan die in homogena-
ten. Spieren van de rat vertonen hogere waarden dan die van de mens. De ratio 
van de ^СОг productie gemeten met [U-1*C] substraten ten opzichte van die ge­
meten met [l-l*C]substraten geeft aan dat in homogenaten alleen CO2 vrijkomt 
bij de oxidatieve decarboxyleringsstap, terwijl in intacte spiersystemen ook 
CO2 geproduceerd wordt door verdere afbraak. 
In overeenstemming hiermee wordt in hoofdstuk 4 gevonden dat tijdens 
incubatie van spierhomogenaten met vertakte 2-oxozuren intermediairen van de 
135 
afbraakroutes naar de citroenzuur cyclus en derivaten daarvan als eindprodukt 
accumuleren. Tijdens incubatie van hemidiafragma's van de rat met U-1*C-ge-
merkt leucine, valine of isoleucine accumuleren de corresponderende 2-oxozu-
ren, vetzuren en (3-hydroxy)vetzuren. De degradatie van valine wordt aanzien-
lijk beperkt door de accumulatie van deze metabolieten. Daarnaast worden aan-
zienlijke hoeveelheden radioactiviteit (relatief kleiner voor valine) terugge-
vonden in CO2 en glutamine en glutamaat. Incubaties met vertakte 2-oxozuren 
geven dezelfde radioactieve produkten, met uitzondering van glutamine en glu-
tamaat. In geen enkel geval wordt radioactiviteit gevonden in lactaat, pyru-
vaat en alanine. Dit betekent dat de koolstofketens van aminozuren, die in de 
spier afgebroken worden tot citroenzuur cyclus intermediairen, niet volledig 
geoxideerd worden tot COj (via pyruvaat) en niet omgezet worden in alanine. Ze 
worden uitsluitend gebruikt voor de synthese van glutamine. Daarom kunnen ver-
takte aminozuren als enige energie leveren aan de spier via de energieprodu-
cerende stappen in hun degradatieroutes naar de citroenzuur cyclus en via oxi-
datie van acetylgroepen afkomstig van leucine en isoleucine. 
In hoofdstuk 5 wordt het effect van vasten op de afbraak van vertakte 
aminozuren en 2-oxozuren in geïsoleerde spiersystemen van de rat bestudeerd. 
De oxidatieve decarboxyleringssnelheid neemt geleidelijk toe met een langere 
vasten periode. Deze stijging is echter geen afspiegeling van een toegenomen 
In vivo oxidatie. Als de aanvoer van 2-охогигеп vanuit endogene eiwitafbraak 
naar de oxidatie precursor pool beperkt wordt door transaminase remmers, wordt 
met vasten een veel kleinere stijging van de oxidatieve decarboxyleringssnel-
heid van vertakte 2-oxozuren gevonden. De bijdrage van de eiwitafbraak aan de 
oxidatie precursor pool lijkt in spieren van gevoede ratten groter te zijn dan 
in spieren van gevaste ratten. 
In hoofdstuk 6 en 7 wordt de invloed van verschillende metabolieten en 
andere agentia op de oxidatie van vertakte 2-cxozuren bestudeerd in intacte 
spierpreparaten van rat en mens. Glucose, palmitaat, 2-oxoglutaraat, acetaat, 
butanoaat, intermediairen van de degradatieroutes van de vertakte 2-oxozuren, 
carnitine en remmers van de monocarbonzuur translocator hebben geen of slechts 
kleine effecten. De meest opmerkelijke effecten in hemidiafragma's van de rat 
zijn de remming door hoge concentraties competitieve vertakte 2-oxozuren en 
pyruvaat, de remming door ketonlichamen en de stimulering door 2-chloor-4-
methylpentanoaat ( een remmer van de kinase van het vertakte 2-oxozuur dehy­
drogenase complex) en door hexanoaat en octanoaat. Octanoaat beïnvloedt voor-
namelijk de oxidatieve decarboxyleringsstap, heeft geen effect op de verdere 
COj productie en verhoogt de accumulatie van (3-hydroxy)vetzuren. Deze resul-
taten kunnen verklaard worden door een uitwisseling van cytosolisch 
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octanoylcarnitine tegen mitochondriele vertakte acylcarnitines via het carni-
tine-acylcarnitine trans locase. 
Uit resultaten van andere onderzoekers bleek dat het vertakte 2-oxozuur 
dehydrogenase complex gereguleerd wordt door covalente modificatie, met inac-
tivering door fosforylering en activering door defosforylering. Wij hebben een 
meetsysteem ontwikkeld om de werkelijke activiteit en de totale activiteit 
(100% actieve vorm) van dit enzym in ratteweefsels te bepalen (hoofdstuk 8). 
In de skeletspier was 6% van het enzym in de actieve vorm, 7% in hart, 20% in 
diafragma, 47% in de nier, 60% in de hersenen en 98% in de lever. De werke-
lijke activiteiten suggereren dat de degradatie van vertakte aminozuren in 
hart en skeletspieren van gevoede ratten meer beperkt is dan gedacht werd op 
basis van eerdere activiteitsbepalingen. 
Omdat er aanwijzingen bestonden dat vasten en inspanning de degradatie 
van vertakte aminozuren in de spier doen toenemen, werd het meetsysteem van 
hoofdstuk 8 toegepast op weefsels van ratten na vasten en inspanning (hoofd-
stuk 9). Vasten verlaagt echter het percentage actieve vorm van het 2-oxozuur 
dehydrogenase complex in de skeletspier. In andere weefsels wordt hetzelfde 
percentage actieve vorm gevonden. Inspanning veroorzaakt een kleine stijging 
van het percentage actieve vorm in hart en skeletspier. Op basis van de in 
hele weefsels aanwezige werkelijke activiteit, is de lever verreweg de meest 
belangrijke plaats voor de afbraak van vertakte aminozuren in gevoede ratten 
voor en na inspanning en in gevaste ratten. De nier en skeletspier zijn van 
minder maar vergelijkbaar belang. 
In hoofdstuk 10 blijkt dat het percentage actieve vorm van het vertakt 
2-oxozuur dehydrogenase complex toeneemt tijdens incubatie van hemidiafrag-
ma's, terwijl de totale activiteit daalt. In spieren van gevaste ratten stijgt 
het percentage actieve vorm sneller en is het verlies van totale activiteit 
kleiner dan in die van gevoede ratten. Deze fenomenen dragen ook bij aan de 
hogere oxidatieve decarboxyleringssnelheid in vitro in spieren van gevaste 
ratten (hoofdstuk 5). De aanwezigheid van 2-chloor-4-methylpentanoaat, octano-
aat, ketonlichamen en hoge concentraties vertakte 2-oxozuren doen het percen-
tage actieve vorm nog verder toenemen; glucose en pyruvaat hebben geen effect. 
De resultaten beschreven in dit proefschrift hebben enkele duidelijke 
wijzigingen gebracht in de bestaande inzichten omtrent het metabolisme van 
vertakte aminozuren in de rat. De rol van de spier bij de afbraak van vertakte 
aminozuren is veel kleiner dan vroeger onderzoek suggereerde. Vasten en 
inspanning verhogen de afbraak in de spier niet of nauwelijks. Het vrijwel 
constante, lage percentage actieve vorm van het vertakt 2-oxozuur dehydroge-
nase complex in hart en skeletspier van gevoede ratten voor en na inspanning 
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en van gevaste ratten doet vermoeden dat beperking van de afbraak een fysiolo-
gische noodzaak is. Deze noodzaak wordt mogelijk gevormd door de rol van ver-
takte aminozuren bij de regulatie van de eiwitturnover in de spier. Opvallend 
is dat bij metabole stoornissen bij de mens die gepaard gaan met verlies van 
spiereiwitten de afbraak van vertakte aminozuren in de spier ook verstoord 
lijkt te zijn. Uitbreiding van de kennis van en een beter begrijpen van het 
metabolisme van vertakte aminozuren bij de mens in normale en pathologische 
situaties kan essentieel zijn voor het ontwikkelen van therapieën om een 
ernstig verlies van spiereiwitten tegen te gaan. 
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